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 The sites where the basic unit of chromatin, the nucleosome, is assembled 
greatly affects the dynamic compaction/decompaction of eukaryotic genetic material 
and how the DNA is accessed, read, and interpreted. The nucleosome, which consists 
of ~147 base pairs of DNA wrapped in a left-handed superhelix around an octameric 
core made up of histone proteins, is the targeted substrate for ATP-dependent protein 
machineries called chromatin remodelers. Remodelers are essential regulators of DNA 
accessibility and are often grouped into four families: SWI/SNF, INO80/SWR1, ISWI, 
and CHD. Though remodelers can act as large multi-subunit complexes, all have a 
unique core SNF2-like ATPase that utilizes the energy from ATP hydrolysis to 
translocate along DNA. This DNA translocase activity of the catalytic ATPase domain 
acts in coordination with auxiliary domains or accessory subunits to disrupt histone-DNA 
contacts, resulting in distinct remodeling outcomes. Furthermore, the assembly of DNA 
into nucleosomal arrays is a specialized activity catalyzed by a subset of remodelers. 
Identifying remodeler proteins responsible for nucleosome assembly and delineating the 
mechanisms through which remodelers assemble and remodel nucleosomes are key 
goals in the field of chromatin biology.   
 CHD proteins have important roles in regulating gene expression through their 
remodeling activities. While yeast cells only have one CHD protein (CHD1), 
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mammalians possess nine proteins (CHD1-9) that are further categorized into 
subfamilies on the basis of additional sequences flanking the central ATPase domain. 
CHD2 is in the same subfamily as CHD1 and has been linked to developmental 
regulation but the enzymatic activity of CHD2 has not been well characterized. Given 
the homology between human CHD2 and CHD1, which is an important assembly 
protein in other species (S. cerevisiae and D. melanogaster), we set out to delineate the 
biochemical properties of human CHD2 and the CHD1 human counterpart. 
 In this dissertation work, we examined the biochemical activities of recombinant 
human CHD1 and CHD2. We used in vitro chromatin assembly and remodeling assays 
and showed CHD2 assembles nucleosomal arrays and remodels nucleosomes while 
CHD1 exhibits less robust activity by comparison. We used radiometric ATPase and 
electrophoretic mobility gel shift assays to measure the ATPase and DNA-binding 
activities of human CHD1 and CHD2 and assessed the contribution from conserved 
accessory domains using systematic protein truncations. We found the N-terminal 
chromodomains are inhibitory for the ATPase and DNA-binding activities of both CHD1 
and CHD2 while providing substrate specificity for the latter. Moreover, we showed the 
DNA-binding domain of CHD2 enhances its ATPase and remodeling activities. The 
distinct in vitro activities exhibited by human CHD1 and CHD2 suggest they have non-
redundant roles in vivo with important mechanistic implications for remodeling by CHD 
proteins. In a broader sense, our findings have added to the number of known assembly 
motor proteins and aids in our understanding of how remodelers have evolved auxiliary 
domains to carry out specific functions such as chromatin assembly.  
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Largely driven by the realization that a global view of our genome would 
accelerate biomedical research, the initial sequencing of the human genome in 2001 
(Lander et al., 2001; Venter et al., 2001) served as a significant turning point for both 
the scientific and medical communities (Dulbecco, 1986; Lander, 2011). As a result, 
much effort has gone into the “-omics”: now whole-genome sequencing can be 
performed across tumor cells and for patients with specific developmental disorders 
(Lander, 2011; Altshuler et al., 2008). Patterns are emerging in which whole gene 
networks are perturbed (Lander, 2011; Hanahan and Weinberg, 2000; Stratton et al., 
2009; Stankiewicz and Lupski, 2010; Cirulli and Goldstein, 2010), many of which are 
correlated with mutation or deletion of genes coding for proteins involved in the 
maintenance of chromatin architecture and accessibility (Foster and Bridger, 2005; 
Dagliesh et al., 2010; Gui et al., 2011; Morin et al., 2011; Zang et al., 2012; Fujimoto et 
al., 2012; Shain and Pollack, 2013; Kadoch et al., 2013). As disease-related genes are 
being identified, the relationship between maintenance of chromatin structure and 
proper gene regulation is becoming increasingly clear (Foster and Bridger, 2005; Zang 
et al., 2012; Fujimoto et al., 2012; Berger, 2000; Berger and Felsenfeld, 2001; Huang et 
al., 2003). This underscores the importance of understanding how proper packaging 
and organization of our genetic material is controlled and regulated.  
 
1.1. PACKAGING AND ORGANIZATION OF EUKARYOTIC CHROMATIN  
For humans, during interphase, roughly two meters of DNA is compacted into a 
nuclear space three to ten microns in size and exists in our cells as a highly condensed 
structure called chromatin (Flemming, 1882). How DNA is organized inside the nucleus 
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and how this three-dimensional organization affects the way DNA is accessed, read, 
and interpreted are longstanding questions in the chromatin field (Dekker et al., 2013). 
Chromatin serves as the template for general processes such as DNA replication and 
transcription; delineating mechanisms of chromatin compaction remains an important 
goal for understanding the relationship between chromatin structure and DNA-
dependent processes (Dekker et al., 2013; Woodcock, 2006).  
Most models outline the hierarchical compaction of eukaryotic DNA (Figure 1.1) 
(Hansen and Turgeon, 1999), suggesting the packaging of chromatin in the nucleus is 
not random. Indeed, microirradiation and fluorescent in situ hybridization (FISH) 
experiments reveal each interphase chromosome occupies a distinct nuclear territory 
(Rabl, 1885; Boveri, 1909; Manuelidis, 1985; Cremer and Cremer, 2001; Cremer et al., 
2006; Zorn et al., 1979; Cremer et al., 1982). While the internal structure of 
chromosome territories is poorly understood, recent studies using the Chromosome 
Conformation Capture (3C) technique (Dekker et al., 2002) have provided evidence that 
chromosome territories are made up of multiple chromosome loop domains containing a 
few hundred to a few million kilobases (Figure 1.1) (Hansen and Turgeon, 1999; Tolhuis 
et al., 2002; Simonis et al., 2006; reviewed in Dekker et al., 2013; Fraser, 2006). These 
loop domains are proposed to be comprised of clusters of chromatin fibers (Hansen and 
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Such chromatin fibers have been observed in images of purified chromatin visualized 
under the electron microscope (EM) with diameters on the order of ~30 nm (Kornberg, 
1977; Thoma et al., 1979; Olins and Olins, 2003; Felsenfeld and Groudine, 2003). 
Higher resolution X-ray crystallography and cryo-EM structures of compacted 
nucleosomal arrays (Schalch et al., 2005; Song et al., 2014) have led to the proposal of 
 
 
Figure 1.1. Compaction of interphase chromatin into the nucleus. Model for 
hierarchical packaging of eukaryotic chromatin during interphase. DNA is first 
wrapped around core histones to form the nucleosome core particle (NCP). Arrays of 
NCPs make up the 10 nm filament. Linker histones bind to the linker DNA separating 
NCPs to form secondary structures such as the proposed 30 nm fiber. The 30 nm 
fiber then undergoes further compaction to form chromatin loops, which associate to 
form chromosome territories in the eukaryotic nucleus. Adapted from Hansen and 
Turgeon, 1999. 
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several structural models of what the 30 nm fiber might look like in vivo (Thoma et al., 
1979; Schalch et al., 2005; Song et al., 2014; Finch and Klug, 1976; McGhee et al., 
1983; Worcel et al., 1981; Woodcock et al., 1984; Williams et al., 1986; Smith et al., 
1990; Dorigo et al., 2004). Use of EM to visualize purified chromatin under low ionic 
conditions reveals these 30 nm fibers can further unravel into 10 nm filaments that look 
like “beads-on-a-string” (Figure 1.1) (Finch and Klug, 1976; Olins and Olins, 1974, 2003; 
Oudet et al., 1975; Finch et al., 1975; Woodcock, 1980). A combination of structural and 
biochemical studies has confirmed that each bead in the 10 nm fiber is actually a single 
nucleosome core particle (NCP), which forms the basic structural unit of chromatin 
(Kornberg, 1977; Kornberg and Thomas, 1974; Kornberg, 1974). Separating each NCP 
is a stretch of short DNA segments called linker DNA that, in conjunction with the NCP, 
is important for the formation of higher-order structures (Tremethick, 2007; Luger et al., 
2012). Analogous to the assignment of primary, secondary, and tertiary structures for 
proteins, the 10 nm fiber is sometimes referred to as the primary structure of chromatin 
that in turn defines the formation of secondary (30 nm fiber) and tertiary higher-order 
chromatin structures (Figure 1.1) (Williams et al., 1986; Woodcock and Dimitrov, 2001). 
While modeling the hierarchichal packagaing of interphase DNA provides a 
framework for understanding the biophysical properties of compacting DNA into 
chromatin, the actual organization of genetic material within the nucleus is quite 
heterogeneous. The various electron-dense regions seen in early EM images of fixed 
and sectioned interphase nuclei are due to different levels of chromatin compaction and 
correlate with specialized regions of gene activity (Figure 1.2) (Fawcett, 1966; reviewed 
in Trojer and Reinberg, 2007; Sexton et al., 2007). For example, the nucleolus is an 
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electron-dense region near the center of the 
nucleus (“n” in Figure 1.2) where rRNA 
transcription and processing and aspects of 
ribosomal synthesis occur (Lamond and 
Earnshaw, 1998; Olson et al., 2000). 
Heterochromatin (“h” in Figure 1.2) is densely 
packaged chromatin typically found at the nuclear 
periphery in terminally differentiated cells (Heitz, 
1928; Heitz, 1929; reviewed in Politz et al., 2013) 
and is generally associated with inaccessible or 
transcriptionally silent loci (Politz et al., 2013; 
Brown, 1966; Elgin, 1996). Euchromatin, on the 
other hand (“e” in Figure 1.2), is typically found in the nuclear interior (Heitz, 1928; 
Heitz, 1929), is considered more open or accessible, and is associated with 
transcriptionally active regions (Politz et al., 2013; Ghirlando and Felsenfeld, 2013).  
Chromatin structure undergoes dynamic rearrangements throughout phases of 
the cell cycle and as cells differentiate, suggesting chromatin compaction and 
organization are important factors in determining the properties of a cell (Parada et al., 
2004; Wade and Kikyo, 2002). For example, during each round of mitosis, 
heterochromatic and euchromatic regions disappear and most reform after mitosis has 
completed (Politz et al., 2013). In development and cellular differentiation, the relative 
levels of euchromatic versus heterochromatic regions in different cell types undergo 
striking changes (Politz et al., 2013). For instance, in the nucleus of a nerve cell (Figure 
 
 
Figure 1.2. The nucleus is 
structurally heterogeneous. Electron 
microscopy image of nucleus from bat 
pancreatic cell fixed, sectioned, and 
negatively stained with uranyl acetate. 
n, nucleolus; h, heterochromatin; e, 
euchromatin. Adapted from Fawcett, 
1966.   
	   7 
1.3A) (Caous et al., 2013), the majority of chromatin exists as euchromatin, and 
heterochromatic regions are limited to the nuclear periphery. In the case of the plasma 
cell (Figure 1.3B) (Fawcett, 1966), there is a higher predominance of heterochromatin 
that extends into the nuclear interior. In noticeable contrast to chromatin in the nucleus 
of a nerve cell, which has a very different function from that of a sperm cell, the 
chromatin in the nucleus of the latter exists almost exclusively as heterochromatin 
(Figure 1.3C) (Skowronek et al., 2012).  
Global rearrangements in nuclear reorganization also occur after transfer of a somatic 
nucleus into an enucleated oocyte during somatic cloning (Wade and Kikyo, 2002). 
Because chromatin structure is generally inhibitory to gene transcription, these 
examples suggest the regulation of assembly and compaction of chromatin is highly 
coordinated with the cellular machinery that needs to access the DNA (Wasylyk and 
Chambon, 1979; reviewed in Workman and Kingston, 1998).  
 
 
Figure 1.3. Chromatin packaging changes with cell type. Electron microscopy 
images of nuclei from (A) nerve cell, (B) plasma cell, and (C) sperm cell. Nuclei were 
fixed, sectioned, and negatively stained. h, heterochromatin; e, euchromatin. (A) is 
adapted from Caous et al., 2013, (B) from Fawcett, 1966, and (C) from Skowronek et 
al., 2012. 
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1.1.1. Structural Features of the Nucleosome Core Particle (NCP)  
At the very basic level, nuclear processes are regulated through how DNA is 
assembled into the nucleosome core particle (Workman and Kingston, 1998). As the 
basic structural unit of chromatin, (Kornberg, 1977; Kornberg and Thomas, 1974; 
Kornberg, 1974), the NCP consists of ~146-150 base pairs of DNA wrapped ~1.65 turns 
in a flat, left-handed superhelix around an octameric protein core. This octameric protein 
core contains two copies each of the four canonical histone proteins H2A, H2B, H3, and 
H4, which come together to form a single (H3-H4)2 heterotetramer flanked by two H2A-
H2B dimers (Kornberg, 1974; Kornberg, 1974; Richmond et al., 1984; Luger et al., 
1997). Crystal structures of the NCP from several different species (Luger et al., 1997; 
White et al., 2001; Clapier et al., 2008; Davey et al., 2002; Tsunaka et al., 2005) reveal 
the overall structural features of canonical histones are highly conserved across 
eukaryotes and may have similar functional roles in regulating chromatin packaging and 
gene regulation (Chakravarthy et al., 2005; Andrews and Luger, 2011).  
High-resolution crystal structures of the NCP also reveal a network of histone-
histone and histone-DNA interactions that render the NCP highly stable (Luger et al., 
1997; Davey et al., 2002). The core histones all have a central histone fold domain that 
consists of three alpha helices connected by short loops (Luger et al., 1997). Each 
histone pair comes together in a head-to-tail fashion to form discrete DNA-binding 
surfaces within the histone octamer (Luger et al., 1997; Davey et al., 2002). The NCP 
has pseudo-two-fold symmetry around a central axis called the nucleosomal dyad 
(superhelix location 0), which is used as a reference point for defining the 14 histone-
DNA binding sites numbered for their superhelix locations (SHL ± 0.5 to ± 6.5) (Figure 
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1.4A) (Luger et al., 1997; Davey et al., 2002). At each SHL, histone-DNA binding is 
mainly accomplished by three to six hydrogen bonds between protein main-chain 
amides and the DNA phosphate backbone, explaining why nucleosomes are able to 
bind throughout the genome, regardless of DNA sequence (Luger et al., 1997; Davey et 
al., 2002). Consistent with this observation, positively charged side chains of histone 
residues also stabilize the NCP by binding to the DNA phosphate backbone without 
making base-specific contacts (Luger et al., 1997; Muthurajan et al., 2004). However, 
there are sequences that are more amenable for nucleosome formation, such as (A+T)-
rich sequences that increase the statistical preference for the DNA minor groove to face 
the histone octamer and DNA sequences that are greater in bendability (Luger et al., 
1997; Davey et al., 2002; Travers, 1987; Flaus and Richmond, 1998; Kaplan et al., 
2009). Even the DNA does not follow a uniform path around the histone octamer; DNA 
binding is strongest near the dyad axis at SHL ± 0.5 while significant distortion of the 
DNA backbone occurs at SHLs ± 1.5 and ± 4.5 (Luger et al., 1997; Davey et al., 2002; 
Hall et al., 2009).  
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In addition to the canonical core histones, highly related histone variants have 
also been found in nucleosomes in vivo (reviewed in Henikoff and Ahmad, 2005; Talbert 
and Henikoff, 2010). Unlike the canonical core histones, which are synthesized during S 
phase, histone variants are synthesized throughout the cell cycle and incorporated 
across the genome for regulatory purposes (reviewed in Henikoff and Ahmad, 2005; 
 
 
Figure 1.4. Structural features of the nucleosome core particle. Histones H2A, 
H2B, H3, and H4 are colored yellow, red, blue, and green, respectively. The DNA is 
shown in gray. All are shown as surface representations. Images were made using 
molecular visualization software PyMOL. (A) Positions along DNA superhelix 
(superhelix locations or SHLs) where significant histone-DNA contacts occur (SHL 
+0.5 to +6.5) are highlighted in pink. Only one face of the nucleosome is shown for 
visual clarity. SHLs of the opposite face would be numbered -0.5 to -6.5. The arrow 
points to the nucleosome dyad axis, which has been assigned SHL 0. (B) The 
nucleosome has been slightly rotated to the left from view shown in (A). This view 
shows the DNA entry and exit points forming the left-handed superhelix around the 
histone octamer core. N-terminal histone tails visible in the crystal structure 
protruding from the nucleosome core through grooves created in the DNA superhelix 
are labeled H2A, H2B, H3, and H4. (C) This view is a complete 90° rotation to the left 
from the view shown in (A). The flatness of the nucleosome is clearly seen along with 
the N-terminal tails visible in the crystal structure protruding from the nucleosome 
core. Once again, N-terminal tails for one set of histones H2A, H2B, H3, and H4 are 
labeled. Adapted from Luger et al., 1997 (PDBID: 1AOI). 
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Talbert and Henikoff, 2010). High-resolution crystal structures of NCPs containing 
histone variants (Suto et al., 2000; Chakravarthy et al., 2005; Tachiwana et al., 2011) 
reveal the effects of their incorporation on the structural stability of the NCP (reviewed in 
Henikoff and Ahmad, 2005; Talbert and Henikoff, 2010). Understanding the structural 
features of NCPs composed of various histone variants has helped shed light on the 
molecular mechanisms underlying the specific roles histone variants can play in the cell 
from formation of centromeric chromatin (CENP-A) to marking sites of DNA double- 
strand breaks (γ-H2A.X) (Henikoff and Ahmad, 2005; Talbert and Henikoff, 2010).  
The N-terminal tails of histone proteins are also important regulatory modules. 
While the histone globular core domains contribute predominantly to the stable 
framework of the NCP, the N-terminal tails for all four of the core histones are highly 
basic and flexible and protrude through DNA grooves on the sides of the nucleosome 
(Figure 1.4B-C). Because of the mobility of histone tails, they are often highly 
disordered in crystal structures of the NCP and not visible unless stabilized by contacts 
with a neighboring NCP in the crystal lattice. Tail lengths can differ greatly from ~15 
(H2A) to 40 amino acids (H3) (Luger et al., 1997). Specific amino acid side chains on 
the histone tails have been found to be covalently altered via the post-translational 
addition of small, chemical modifications (Luger et al., 2012; Strahl and Allis, 2000), 
revealing these histone tails have important roles in higher-order chromatin packaging 
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1.1.2. Post-Translational Modification of Histones 
Post-translational modifications (PTMs) on amino acid residues in the histone 
tails and/or in the histone core can affect chromatin compaction and cellular processes. 
This has led to the proposal of a histone code: signals that can be read by effector 
proteins to serve downstream applications (Strahl and Allis, 2000; Jenuwein and Allis, 
2001; Fischle et al., 2003). PTMs such as methylation or acetylation can alter the 
charge of histone residues, affecting internucleosome interactions with significant 
impacts on higher order chromatin structure (Jenuwein and Allis, 2000; Berger, 2002; 
Peterson and Laniel, 2004; Iizuka and Smith, 2003; Turner, 2000; Gardner et al., 2011). 
For instance, the positively charged H4 tail has been observed to mediate nucleosome-
nucleosome interactions by binding to a negatively charged acidic patch on the H2A-
H2B dimer surface (Schalch et al., 2005; Luger et al., 2012; Luger et al., 1997; White et 
al., 2001). Acetylation of basic residues on the H4 tail hinders formation of higher-order 
chromatin structures (Dorigo et al., 2004; Shogren-Knaak et al., 2006; Allahverdi et al., 
2011). Similarly, neutralization of the acidic patch on H2A-H2B disrupts inter-
nucleosome interactions and inhibits formation of the 30 nm fiber in vitro (Zhou et al., 
2007). These changes can be used to make chromatin more or less accessible to 
macromolecular machineries that carry out transcription (Jenuwein and Allis, 2001; 
Berger, 2002; Peterson and Laniel, 2004; Iizuka and Smith, 2003; Turner, 2000; 
Gardner et al., 2011) or to those that are needed for the repair of DNA damage 
(Smeenk and van Attikum, 2013; Altmeyer and Lukas, 2013).  
Histone PTMs can also serve as scaffolds for the recruitment of molecular 
machineries to genomic loci (Strahl and Allis, 2000; Jenuwein and Allis, 2001; Fischle et 
	   13 
al., 2003). Protein domains with the capacity to bind specific PTMs on histone tails have 
been identified (Jenuwein and Allis, 2001). The bromodomain, for instance, binds 
acetylated histone tail lysines (Dhalluin et al., 1999; Winston and Allis, 1999; Jacobson 
et al., 2000; Owen et al., 2000). Acetylated lysines have been associated with more 
actively transcribed chromatin (Brownell et al., 1996; Brownell and Allis, 1996; Wade 
and Wolffe, 1997) and accordingly, bromodomains have been found in many 
transcriptional co-regulators and chromatin-modifying enzymes (Jenuwein and Allis, 
2001; Jacobson et al., 2000; Owen et al., 2000; Brownell et al., 1996; Haynes et al., 
1992; Filippakopoulos and Knapp, 2012). Another type of domain, the chromodomain, 
recognizes methylated lysine residues (Koonin et al., 1995; Eissenberg, 2001; Kim et 
al., 2006). Methylation of lysines 9 or 27 on the N-terminal tail of histone H3 is 
commonly found in repressive chromatin (Zhang and Reinberg, 2001; Nakayama et al., 
2001; Hawkins et al., 2010) so it is not surprising that chromodomains are present in 
heterochromatin-associated proteins like HP1 (Platero et al., 1995; Eissenberg and 
Elgin, 2000; Bannister et al., 2001; Lachner et al., 2001; Jacobs et al., 2001) and the 
Polycomb family of transcriptional repressors (Messmer et al., 1992; Cao et al., 2002; 
Czermin et al., 2002; Kuzmichev et al., 2002; Cao and Zhang, 2004; Boros et al., 2014). 
However, the biological readout of a PTM is very context-dependent – for example, 
while methylated H3 lysine 9 is associated with inactive or silent loci (Nakayama et al., 
2001; Georgopoulos, 2002), methylated H3 lysine 4 is associated with nucleosomes 
found at the promoters of actively transcribed genes (Georgopoulos, 2002; Santos-
Rosa et al., 2002; Schneider et al., 2004; Schübeler et al., 2004; Azuara et al., 2006; 
Bernstein et al., 2006; Pan et al., 2007). Given the number of known types of PTMs and 
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the number of known modification sites, the combinations are endless (Luger et al., 
2012). The recent technological advances in studying nucleosome structure (Chien and 
van Noort, 2009; Ando et al., 2008; Panchenko et al., 2011) and the ability to 
reconstitute NCPs with all kinds of combinations of PTMs, histone variants, and DNA 
sequences in vitro (Muir, 2003; Neumann et al., 2008; Simon et al., 2007; Mahto et al., 
2011) will help with the systematic investigation of biologically relevant NCP 
modifications (Luger et al., 2012).  
Because nucleosomes govern accessibility and processing of DNA sequences, 
the positioning and composition of assembled nucleosomes have a great deal of 
influence on chromatin structure and the correlated functional outcome (Luger et al., 
2012). For instance, genome-wide nucleosome maps for Saccharomyces cerevisiae 
(Albert et al., 2007), Drosophila melanogaster (Mavrich et al., 2008a), Caenorhabditis 
elegans (Valouev et al., 2008), and Homo sapiens (Valouev et al., 2011) have 
converged on a characteristic chromatin structure at gene promoters. Promoter regions 
are depleted in nucleosome binding and the nucleosomes flanking these nucleosome-
depleted regions are highly phased or positionally stable compared to nucleosomes 
across the gene body (Mavrich et al., 2008b). While the genomic DNA sequence 
harbors some information that dictates specific patterns of nucleosome positioning, 
formation of proper gene promoter structure needs ATP-dependent factors (Zhang et 
al., 2011). Though the histone octamer exhibits some mobility in vivo due to diffusion or 
breathing of the nucleosome (Flaus and Richmond, 1998; Meersseman et al., 1992; Li 
and Widom, 2004), coordinated disruption of the highly stable network of histone-DNA 
contacts within the NCP to establish proper positioning requires ATP-dependent 
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molecular machines called chromatin remodelers (Workman and Kingston, 1998; Hota 
and Bartholomew, 2011; Clapier and Cairns, 2009; Bartholomew, 2014).   
 
1.2. ATP-DEPENDENT CHROMATIN REMODELERS 
Chromatin remodelers are evolutionarily conserved molecular machines that use 
the energy from ATP hydrolysis to disrupt histone-DNA contacts in order to catalyze a 
variety of non-covalent rearrangements (remodeling) that affect the inherently stable 
structure of the NCP: these include nucleosome sliding, nucleosome 
disassembly/assembly, nucleosome spacing, and the exchange of histone variants 
(Figure 1.5) (Hota and Bartholomew, 2011; Clapier and Cairns, 2009; Bartholomew, 
2014; Petty and Pillus, 2013). Chromatin remodelers each have a catalytic subunit that 
harbors a central SNF2-like catalytic ATPase domain from the Super-Family 2 (SF2) of 
helicases/translocases (Byrd and Raney, 2012; Hota and Bartholomew, 2011; Clapier 
and Cairns, 2009; Bartholomew, 2014). Though chromatin remodelers are part of the 
SF2 family of helicases/translocases, they lack the wedge domain that enables strand-
separating activity found in bona fide helicases (Fairman-Williams et al., 2010). While 
remodelers have not been found to exhibit helicase activity, they are proposed to modify 
nucleosome structure via ATP-dependent translocation along DNA, breaking histone-
DNA contacts in order to carry out the desired remodeling outcome (Saha et al., 2002; 
Ryan and Owen-Hughes, 2011; Clapier and Cairns, 2009; Bartholomew, 2014). The 
catalytic subunit harbors additional domains flanking the SNF2-like ATPase that serve 
as the basis for the categorization of chromatin remodelers into four main umbrella 
families: SWI/SNF, INO80/SWR1, ISWI, and CHD (Clapier and Cairns, 2009; 
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Bartholomew, 2014). The remodeling factors from each family are highly conserved 




Figure 1.5. Types of nucleosome remodeling outcomes. Chromatin remodeling 
factors have been observed to carry out several types of nucleosome remodeling 
activities. These include sliding the nucleosome or disassembling/ejecting the 
histone octamer. This action can be used to reveal a previously blocked DNA 
sequence (i.e. so that a specific DNA-binding factor may bind) or create nucleosome-
depleted regions such as those found near active gene promoters. Remodelers can 
also assemble nucleosomes, properly space irregular nucleosome arrays, or carry 
out histone exchange reactions. Adapted from Petty and Pillus, 2013.  




Table 1.1. Composition of chromatin remodelers and their paralogs/homologs. 
Adapted from Clapier and Cairns, 2009. 
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Studying ATP-dependent chromatin remodeling complexes in the context of 
human disease has highlighted that they are important at every level of differentiation 
and in preventing oncogenesis (Ho and Crabtree, 2010; Wang et al., 2007; de la Serna 
et al., 2006). In order to understand the role of chromatin remodelers in maintaining 
proper cellular function, much work has gone into identifying the activities of remodeling 
complexes in the cell and into characterizing the molecular mechanisms through which 
they act (Clapier and Cairns, 2009; Hargreaves and Crabtree, 2011; Bartholomew, 
2014). Approximately 25 genetically non-redundant SNF2-like homologs have been 
identified in humans, suggesting each remodeler has evolved specialized functions in 
the cell (Hargreaves and Crabtree, 2011).  
The first remodeling complex to be described and purified was SWI/SNF from 
Saccharomyces cerevisiae (ySWI/SNF) (Cairns et al., 1994; Côté et al., 1994; Peterson 
et al., 1994; reviewed in Clapier and Cairns, 2009; Mohrmann and Verrijzer, 2005). 
Genes encoding the ySWI/SNF subunits were originally identified in a genetic screen 
looking for mutations affecting either mating-type SWItching or growth on sucrose 
(Sucrose Non-Fermenting) and thus the name SWI/SNF (Cairns et al., 1994; Côté et al., 
1994; Peterson et al., 1994). Members of the SWI/SNF remodeling family have been 
found to be composed of eight to fourteen subunits (Mohrmann and Verrijzer, 2005; 
Clapier and Cairns, 2009). SWI/SNF complexes increase accessibility to nucleosomal 
DNA by sliding nucleosomes, displacing H2A-H2B dimers and/or completely 
disassembling the nucleosome in an ATP-dependent manner (Whitehouse et al., 1999; 
Lorch et al., 1999, 2006; Narlikar et al., 2001; Kassabov et al., 2003; Bruno et al., 2003; 
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Dechassa et al., 2010). These activities are thought to aid in transcription activation 
(Workman and Kingston, 1998; Sudarsanam and Winston, 2000).  
Initial members of the INO80/SWR1 remodeling family were also purified from 
Saccharomyces cerevisiae (Shen et al., 2000, Mizuguchi et al., 2004; reviewed in 
Clapier and Cairns, 2009; Bao and Shen, 2007). INO80 was first identified in yeast as a 
paralogue of SWI/SNF that regulates INOsitol-dependent gene activation (Ebbert et al., 
1999). In a similar vein, yeast genetic screens searching for mutants with defects in 
chromatin modification and transcriptional elongation by RNA Polymerase II identified 
the SWR1 complex (SWI/SNF-Related) as another SWI/SNF paralogue (Krogan et al., 
2003). INO80 and SWR1 are both macromolecular complexes composed of more than 
ten subunits with the ability to catalyze histone exchange reactions (Shen et al., 2000; 
Mizuguchi et al., 2004; Clapier and Cairns, 2009). While SWR1 catalyzes the 
incorporation of histone variant H2A.Z at specific genomic loci (Mizuguchi et al., 2004; 
Kobor et al., 2004; Gévry et al., 2007), INO80 catalyzes the reverse reaction 
(Papamichos-Chronakis et al., 2011). INO80 has been implicated in transcriptional 
regulation (Bao and Shen, 2007) and DNA double-strand break repair processes 
(Morrison et al., 2004; van Attikum et al., 2004; Downs et al., 2004) while SWR1 has the 
ability to exchange canonical H2A-H2B dimers for H2A.Z-H2B; this activity has been 
shown to be important for establishing H2A.Z-containing NCPs flanking nucleosome-
depleted regions at gene promoters (Kobor et al., 2004; Krogan et al., 2003; Mizuguchi 
et al., 2004).  
The first ISWI remodeling complexes (reviewed in Corona and Tamkun, 2004; 
Clapier and Cairns, 2009) were purified from D. melanogaster embryo extracts in a 
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search for factors that would allow transcription factors to access nucleosomal DNA 
(Tsukiyama and Wu, 1995a; Tsukiyama et al., 1995b; Varga-Weisz et al., 1997). In 
parallel, an ATP-dependent nucleosome spacing factor containing ISWI was identified 
from D. melanogaster embryo extracts as well (Ito et al., 1997a). ISWI was so named 
because of its sequence similarity to ySWI/SNF (Imitation SWItch or ISWI) (Elfring et 
al., 1994). ISWI-containing remodeling complexes typically contain two to four subunits, 
and can assemble periodic nucleosomal arrays/slide nucleosomes to alter nucleosome 
spacing; these remodeling activities are important for proper chromatin assembly in vivo 
and the formation of higher-order chromatin structures (Deuring et al., 2000; Corona et 
al., 2007; Vincent et al., 2008; Sala et al., 2011).  
The founding member of the CHD family, CHD1, was identified as a murine 
nuclear protein that bound immunoglobulin promoter DNA sequences (Delmas et al., 
1993). CHD remodeling factors can be composed of one to ten subunits (Clapier and 
Cairns, 2009; Woodage et al., 1997; Hall and Georgel, 2007; Marfella and Imbalzano, 
2007) and are so named Chromodomain Helicase DNA-binding (CHD) proteins 
because of the presence of tandem chromodomains N-terminal to the central SNF2-like 
ATPase of the catalytic subunit (Delmas et al., 1993; Woodage et al., 1997; Hall and 
Georgel, 2007; Marfella and Imbalzano, 2007). Vertebrates have nine CHD proteins and 
their variability is thought in part to be due to diversification of their chromodomains 
(Flanagan et al., 2007) along with the presence of additional auxiliary domains 
(Woodage et al., 1997; Hall and Georgel, 2007; Marfella and Imbalzano, 2007). Only 
CHD1 from S. cerevisiae (Chd1p = yCHD1) and D. melanogaster (Chd1 = dCHD1) has 
been found to possess the ability to assemble periodic nucleosomal arrays thus far 
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(Robinson and Schultz, 2003; Lusser et al., 2005). Mammalian CHD2 is most closely 
related to CHD1 as both share a C-terminal putative DNA-binding domain not as well 
conserved in other CHD proteins (Woodage et al., 1997; Hall and Georgel, 2007; 
Marfella and Imbalzano, 2007). The CHD family is thought to be involved in 
transcriptional regulation and maintenance of proper developmental pathways 
(Woodage et al., 1997; Marfella and Imbalzano, 2007). Loss or mutation of genes 
coding for CHD proteins has been linked to various developmental disorders and 
several types of cancers (Marfella and Imbalzano, 2007). While significant progress has 
been made toward delineating the in vivo roles of various chromatin remodeling factors, 
less is understood regarding how the enzymatic activity of each remodeler differs from 
one another (Hota and Bartholomew, 2011). 
 
1.3. THE CORE ATPASE SUBUNIT 
Recent work in the last two decades has shed light into how several core 
ATPases from each of the remodeling families carries out substrate recognition and 
subsequent ATP hydrolysis and remodeling activity (reviewed in Clapier and Cairns, 
2009; Hota and Bartholomew, 2011; Becker and Hörz, 2002). While the number of 
subunits found in remodeling complexes can range from one to fifteen, all remodelers 
contain a unique catalytic subunit from the SNF2-like family (Clapier and Cairns, 2009, 
Hota and Bartholomew, 2011; Gorbalenya et al., 1988; Gorbalenya and Koonin, 1993). 
SNF2-like members have been classified based on the presence of a series of short 
ordered motifs numbered I, Ia, II, III, IV, V, and VI typically located in the core of the 
protein sequence (Gorbalenya et al., 1988; Gorbalenya and Koonin, 1993; Flaus et al., 
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2006). Crystal structures of the core ATPase domain from SNF2-like proteins Rad54 
and CHD1 reveal the presence of two RecA-like lobes separated by a central linker of 
variable lengths (Thomä et al., 2005; Dürr et al., 2005; Sengoku et al., 2006; Hauk et 
al., 2010), suggesting this is a common core structural fold of chromatin remodelers in 
the SNF2-like family and that remodelers possess DNA translocase activity (Hauk and 
Bowman, 2011).  
DNA cross-linking studies show that the catalytic subunits of ISWI and SWI/SNF 
remodeling complexes make significant contacts with the nucleosome, suggesting the 
catalytic subunits from all the remodeling families utilize direct contacts with the DNA 
and histones to carry out remodeling via their proposed DNA translocase activity (Saha 
et al., 2002; Ryan and Owen-Hughes, 2011; Clapier and Cairns, 2009; Bartholomew, 
2014). Contacts made between the core ATPase subunit and the nucleosome have 
been observed to occur within three main regions: the nucleosomal DNA, the non-
bound open histone octamer face, and the linker DNA (Hota and Bartholomew, 2011). It 
is becoming clear that beyond the conserved helicase motifs, the ATPase domain has 
evolved regions that play key roles in modulating not only recruitment to the 
nucleosome but also efficiency of remodeling as well (Flaus et al., 2006). Determining 
the region of the catalytic subunit responsible for making contacts to each of these 
regions, where on the nucleosome contacts are made, and how these contacts change 
throughout the remodeling reaction will provide significant insight into how remodelers 
with similar ATPase domains can have vastly different remodeling outcomes (Hota and 
Bartholomew, 2011).  
 Each remodeling family has a set of distinct regulatory features (Figure 1.6). 
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The catalytic subunit of SWI/SNF remodelers has several functional domains: a central 
ATPase domain, a helicase-SANT-associated or HSA domain, and a distinguishing 
bromodomain that binds acetylated histone tails (Figure 1.6) (Clapier and Cairns, 2009). 
The HSA domain interacts with nuclear actin-related proteins (Arps) and serves 
 
 
Figure 1.6. Domain architecture of regulatory modules found in core catalytic 
subunit making up SNF2-like chromatin remodeling families. SNF2-like 
ATPases contain a central domain made up of two RecA-like lobes (RecA-1 and 
RecA-2, blue) separated by a central linker (L, light blue). Members of the 
INO80/SWR1 family are characterized as having an extra-long linker (XL, light blue). 
Core ATPases of the SWI/SNF and INO80/SWR1 families have an N-terminal 
helicase-SANT-associated domain at the N-terminus (HSA, light orange). Catalytic 
core subunit of the SWI/SNF remodeling complex is distinguished by a C-terminal 
bromodomain (green). The core ATPase for the ISWI family possesses two auto-
inhibitory motifs called AutoN and NegC (brown). This core ATPase also possesses 
a histone-interacting HAND domain (orange). Directly adjacent to the HAND domain 
is a single DNA-binding module made up of SANT and SLIDE domains (red) also 
found in CHD1 and CHD2 of the CHD family. CHD family members are defined by 
the presence of N-terminal tandem chromodomains (yellow). The functional roles of 
these domains are discussed in the text. Adapted from Bartholomew, 2014. 
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important structural and regulatory roles (Trotter et al., 2008; Szerlong et al., 2008). 
Recently, a motif coupling ATPase activity to remodeling has been identified C-terminal 
to the central ATPase domain and named Snf2 ATP Coupling or SnAC (Figure 1.6) 
(Sen et al., 2011). DNA and nucleosomal substrates stimulate the ATPase activity of 
SWI/SNF remodelers equally (Phelan et al., 1999) although DNA cross-linking data 
show the region of the catalytic subunit contacting DNA changes depending on whether 
the substrate is naked DNA or nucleosomal DNA (Dechassa et al., 2012). Removal of 
histone tails by limited trypsinization of the NCP does not affect the remodeling activity 
(Guyon et al., 1999) but the presence of an acetylated H3 tail can increase SWI/SNF 
affinity for the nucleosome (Chatterjee et al., 2011). 
 ATPases from the INO80/SWR1 family are characterized by an extra-long ~400 
amino acid insert separating the two RecA-like lobes (Clapier and Cairns, 2009). This 
insert is important for complex formation and recruitment of AAA+ helicase subunits 
Rvb1/2 (Shen et al., 2000; Mizuguchi et al., 2004; Wu et al., 2009). The N-terminal 
region also contains an HSA domain (Figure 1.6), which binds actin and actin-related 
proteins and is needed for complex assembly (Trotter et al., 2008; Szerlong et al., 2008; 
Wu et al., 2009). The N-terminus also serves as a histone-binding site for the H2A.Z-
H2B dimer in the case of SWR1 (Wu et al., 2009).  
Studies on ISWI have revealed significant insight into how accessory domains 
modulate the way the ATPase interacts and senses both nucleosomal and extra-
nucleosomal DNA. The N terminus of ISWI was found to contain a region called AutoN 
with high homology to the histone H4 tail (Clapier and Cairns, 2012). This correlates 
well with the observation that ISWI remodelers need the H4 tail to remodel 
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nucleosomes (Georgel et al., 1997; Hamiche et al., 2001; Clapier et al., 2002; Fazzio et 
al., 2005) and with DNA cross-linking studies that show ISWI remodelers bind to the 
nucleosome at ~SHL 2, which is near where the histone H4 N-terminal tail protrudes 
(Figure 1.4) (Schwanbeck et al., 2004; Zofall et al., 2006). A motif directly C-terminal to 
the ATPase domain called NegC regulates the coupling of ATP hydrolysis to DNA 
translocation (Clapier and Cairns, 2012). These types of regulatory mechanisms have 
also been observed for Rad54 DNA translocases (Alexiadis et al., 2004). Moreover, 
kinetic studies on ATP hydrolysis and substrate recognition by ISWI revealed that the 
core ATPase domain is an autonomous remodeling machine and that the C-terminal 
DNA-binding domain is not necessary for remodeling but instead enhances both the 
efficiency and processivity of remodeling activity (Mueller-Planitz et al., 2013).  
Recent single molecule and structural studies are starting to elucidate the 
mechanism through which ISWI heterodimer and chromatin assembly factor in D. 
melanogaster ACF (henceforth dACF) translocates along the DNA. Furthermore, dACF 
can bind to the nucleosome as a dimer, providing a model through which dACF centers 
the nucleosome by sensing linker DNA flanking either side through its SANT-SLIDE 
DNA-binding domains (Racki et al., 2009). Fluorescence resonance energy transfer 
(FRET) studies show dACF translocates along the DNA with several pauses (Blosser et 
al., 2009). The initial pause always occurs after a step-size of seven base pairs (bp) 
while subsequent pauses occur after three to four bp of translocation (Blosser et al., 
2009). This mechanism is conserved in other ISWI-containing complexes as well 
(Deindl et al., 2013). Single-molecule studies of DNA translocation by other remodeling 
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families on nucleosomal substrates would establish whether this type of DNA-
translocating activity is unique to the ISWI family.   
 Much of what is known about the biochemical properties of CHD remodelers 
comes from studying yCHD1 or dCHD1 from S. cerevisiae or D. melanogaster, 
respectively. In the crystal structure of the yCHD1 ATPase domain with the N-terminal 
chromodomains, the two RecA-like lobes appear to be oriented in an inactive 
conformation with the chromodomains bound to a putative DNA binding site on the core 
ATPase domain. This orientation suggests the N-terminal tandem chromodomains block 
DNA access to the catalytic center, representing another example of an auto-inhibitory 
mechanism utilized by remodelers (Hauk et al., 2010). A motif directly C-terminal to the 
ATPase domain bridging the two RecA-like lobes is highly conserved between ISWI and 
CHD1 (Clapier and Cairns, 2012); this motif has been shown to couple ATP hydrolysis 
to nucleosome remodeling (Patel et al., 2011; Torigoe et al., 2013). While structural and 
biochemical data reveal key insights into how the chromdomains and ATPase interact, 
they leave open the question of how the C-terminal DNA-binding domain interacts with 
the chromodomains and ATPase domain to achieve nucleosome remodeling and 
chromatin assembly by CHD1. All members of the CHD family possess N-terminal 
tandem chromodomains; the chromodomains likely provide an additional level of 
regulation by targeting CHD proteins to loci with specific histone modifications 
(Woodage et al., 1997; Hall and Georgel, 2007; Marfella and Imbalzano, 2007; 
Flanagan et al., 2005, 2007; Sims et al., 2005). Study of these accessory domains have 
revealed that they play key roles in remodeler activity on the nucleosomal substrate.    
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 ISWI-containing and CHD1 remodelers are unique in that they are also ATP-
dependent chromatin assembly factors (Ito et al., 1997a; Robinson and Schultz, 2003; 
Lusser et al., 2005). Chromatin assembly factors are important not only for the basic 
packaging of DNA into nucleosomes but also for the proper maintenance of genome 
structure and integrity (Tyler, 2002; Haushalter and Kadonaga, 2003). For instance, 
when enzymes such as the DNA polymerase or the transcription machinery travel 
through a specific region, nucleosomes must be re-assembled behind in order to 
maintain genomic stability (Krude and Keller, 2001; Groth et al., 2007). The same is true 
for processes that repair DNA damage (Groth et al., 2007). In each of these contexts it 
is necessary to know which chromatin assembly factors are being utilized and how the 
cell decides when and where to assemble chromatin.  
 
1.4. CHROMATIN / NUCLEOSOME ASSEMBLY  
Because chromatin assembly influences a broad range of nuclear processes, it is 
important to understand the various contexts in which chromatin assembly occurs and 
the key players involved. In the cell, chromatin assembly can occur in a replication-
coupled manner during S phase or in a replication-independent manner at other points 
in the cell cycle (Polo and Almouzni, 2006). Replication-dependent assembly occurs 
behind the replication fork, where the newly synthesized DNA must be reassembled into 
chromatin (Krude, 1999; Annunziato, 2005, 2013). To accommodate replication-
dependent assembly, new core histones are expressed and synthesized during S phase 
in a tightly regulated system (Polo and Almouzni, 2006; Gunjan and Verreault, 2003; 
Gunjan et al., 2005, 2006; Marzluff et al., 2008). Nucleosome assembly that is not 
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coupled to replication often involves the incorporation of histone variants and can occur 
in conjunction with transcription, DNA repair, or homologous recombination or during 
normal histone exchange/turnover (Groth et al., 2007; Annunziato, 2013; Kadam and 
Emerson, 2002; Das and Tyler, 2013; Ahmad and Henikoff, 2002). Replication-
dependent assembly has been observed to occur in a stepwise manner (Smith and 
Stillman, 1991). Newly synthesized H3 and H4 associate and are initially acetylated on 
various lysines in their amino-terminal domains (Verreault, 2000). The acetylated (H3-
H4)2 heterotetramer is then deposited onto the DNA to form the “tetrasome” and two 
H2A-H2B dimers subsequently incorporated to form the core histone octamer (Polo and 
Almouzni, 2006; Smith and Stillman, 1991; Kleinschmidt et al., 1990; Akey and Luger, 
2003; Torigoe et al., 2011). Shortly after H3 and H4 are packaged into the histone 
octamer, removal of the acetyl groups occurs (Jackson et al., 1976). Lastly, nucleosome 
maturation requires an ATP-dependent motor protein for proper supercoiling of the DNA 
around the histone octamer and spacing of the nucleosomes along the DNA (Torigoe et 
al., 2011; Glikin et al., 1984; Nakagawa et al., 2001). Stepwise assembly is supported 
by studies of the chromatin assembly process in vitro (Torigoe et al., 2011); the 
following sections outline details of the chromatin assembly process. 
Early in vitro chromatin assembly experiments that mixed histones and DNA at 
physiological salt concentrations found they formed an insoluble aggregate because the 
highly basic histones (~20% lysine and arginine) would interact non-specifically with the 
DNA (Wilhelm et al., 1978; Ito et al., 1997b). However, if the histones and DNA were 
mixed at 2 M sodium chloride (NaCl) and the salt concentration gradually lowered by 
dialysis or dilution, this allowed for specific histone-DNA interactions to be made and 
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nucleosomes to be properly assembled (Wilhelm et al., 1978; Germond et al., 1976; 
Camerini-Otero et al., 1976). Gradually lowering the salt concentration from 2 M NaCl is 
frequently used for the formation of salt-dialyzed chromatin and takes advantage of the 
fact that the (H3-H4)2 tetramer associates with DNA at a higher ionic strength than the 
H2A-H2B dimer (Wilhelm et al., 1978; Germond et al., 1976; Camerini-Otero et al., 
1976). This led to the identification of certain anionic compounds that could act as 
histone transfer vehicles that bind to the core histones and mediate their deposition onto 
naked DNA (reviewed in Ito et al.,1997b).  
A host of factors can act as histone transfer vehicles in vitro. Histone transfer 
vehicles are typically negatively charged or acidic in nature and bind histones, shielding 
their positive charge and allowing for the ordered stepwise assembly of nucleosomes 
(Ito et al., 1997b). In addition to NaCl, these include polyanions such as bulk RNA 
(Nelson et al., 1981) and polyglutamic acid (Stein et al., 1979). In the cell, histone 
transfer vehicles are acidic proteins that are referred to as histone chaperones or 
histone carriers (reviewed in Polo and Almouzni, 2006; Tyler, 2002; Krude and Keller, 
2001; Loyola and Almouzni, 2004; Burgess and Zhang, 2013).  
 
1.4.1. Histone Chaperones 
The discovery of the first histone chaperone, nucleoplasmin (Laskey et al., 1978), 
laid the foundation for a family of proteins that have important roles in histone dynamics 
and the regulation of chromatin assembly (reviewed in Polo and Almouzni, 2006; Tyler, 
2002; Krude and Keller, 2001; Loyola and Almouzni, 2004; Burgess and Zhang, 2013). 
Because the core histone proteins H2A, H2B, H3, and H4 are highly basic, histone 
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chaperones are needed to prevent the formation of non-specific ionic interactions and to 
ensure the proper deposition of the core histones onto DNA (Loyola and Almouzni, 
2004). Moreover, there are unique histone chaperones that bind histone variants and 
ensure their proper spatial and temporal incorporation into the genome (Henikoff and 
Ahmad, 2005).  
Though initially discovered as having a direct role in nucleosome assembly, 
histone chaperones have also been found to play roles in regulating transcription and 
the cell cycle, providing increasing evidence that histones are far more than just 
packaging proteins. Some histone chaperones are important for regulating histone 
protein levels, as too many histones can be toxic to the cell (Gunjan et al., 2005). Still 
other histone chaperones are needed to regulate the import of histones from the 
cytoplasm into the nucleus (Mosammaparast et al., 2002). The histone chaperone, 
nucleosome assembly protein 1 (NAP-1), plays multiple roles in histone dynamics and 
has been frequently used in in vitro chromatin assembly assays.  
In the cell, NAP-1 has multiple functions. While NAP-1 binds both to H2A-H2B 
and H3-H4 heterodimers in vitro (Andrews et al., 2008), it prefers to bind to H2A-H2B 
dimers in vivo (Park et al., 2005). NAP-1 acts as an H2A-H2B shuttle protein, 
transporting newly synthesized histones from the cytoplasm into the nucleus (Park et 
al., 2005). In vitro, NAP-1 aids in nucleosome formation by disrupting nonnucleosomal 
histone-DNA contacts (Andrews et al., 2010). NAP-1 also has the ability to form a pre-
nucleosome substrate that can then be rapidly converted into the canonical nucleosome 
by an ATP-dependent chromatin assembly factor (Nakagawa et al., 2001; Torigoe et al., 
2011). 
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While histone chaperones can deposit histones onto DNA, proper maturation of 
nucleosome arrays is an ATP-dependent process (Haushalter and Kadonaga, 2003; 
Glikin et al., 1984; Ruberti and Worcel, 1986). The use of histone chaperones to 
assemble chromatin in vitro yields nucleosomal arrays that do not have any of the 
regularity or periodicity found in bulk chromatin and cannot account for all of chromatin 
assembly in vivo (Glikin et al., 1984; Ruberti and Worcel, 1986). Experiments conducted 
in Xenopus laevis oocyte extracts first showed the assembly of periodic nucleosomes 
requires ATP and Mg++ (Glikin et al., 1984; Ruberti and Worcel, 1986). Identifying and 
characterizing these ATP-dependent assembly factors will serve an important step 
towards understanding the formation and regulation of chromatin structure and 
accessibility in the cell.  
 
1.4.2. ATP-Utilizing Chromatin Assembly Factors 
We now know that ATP-dependent chromatin assembly occurs as a coordinated 
effort between histone chaperones and chromatin assembly motor proteins (Figure 1.7) 
(Polo and Almouzni, 2006; Tyler, 2002; Haushalter and Kadonaga, 2003; Ito et al., 
1997b; Nakagawa et al., 2001; Torigoe et al., 2011). While several groups had detected 
ATP-dependent chromatin assembly in extracts from X. laevis (Glikin et al., 1984; 
Ruberti and Worcel, 1986) and D. melanogaster (Becker and Wu, 1992; Kamakaka et 
al., 1993), it was the fractionation of D. melanogaster extracts that ultimately led to 
identification of the first ATP-dependent chromatin assembly factor (Ito et al.,1997a).  
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1.4.2.1. ISWI-Containing Chromatin Assembly Factors 
The first ATP-dependent chromatin assembly factor identified was called ATP-
utilizing chromatin assembly and remodeling factor or ACF (Ito et al., 1997a). ACF is a 
heterodimer of the core ATPase ISWI and the regulatory subunit Acf1, and can catalyze 




Figure 1.7. Stepwise assembly of periodic nucleosomal arrays. The assembly of 
periodic nucleosome arrays is thought to occur in a stepwise manner as a 
coordinated effort between histone chaperones and ATP-utilizing chromatin 
assembly factors. 1. Histone chaperones (orange) are needed for the ordered 
formation of the histone octamer (yellow) on the DNA. 2. Nucleosome maturation 
requires ATP and ATP-dependent chromatin assembly factors (blue) for proper 
supercoiling of the DNA around the histone octamer and spacing of nucleosomes 
along the DNA. Adapted from Nakagawa et al., 2001 and Torigoe et al., 2011. 
	   33 
2005; Fyodorov et al., 2004). ACF from D. melanogaster also has the ability to 
assemble nucleosomes containing the linker histone H1 (Lusser et al., 2005). Linker 
histones like H1 bind to the linker DNA between nucleosomes, aiding in the formation of 
higher-order chromatin structures (Thoma et al., 1979; Misteli et al., 2000). Other ISWI-
containing complexes have also been found to have chromatin assembly activities, 
suggesting the core ATPase ISWI dictates the ability to assemble periodic nucleosomal 
arrays (Varga-Weisz et al., 1997; LeRoy et al., 2000). Interestingly one ISWI-containing 
complex, RSF, does not require an external histone chaperone (Loyola and Almouzni, 
2004; LeRoy et al., 2000; Loyola et al., 2001) providing an example in which auxiliary 
domains of the core ATPase have important roles in regulating the assembly function. 
Moreover, the assembly function of ISWI-containing remodelers is important for 
chromosome organization (Corona and Tamkun, 2004). For instance, loss of ISWI in D. 
melanogaster leads to global decondensation of the male X chromosome (Deuring et 
al., 2000) and a decrease in the periodicity of nucleosome arrays in bulk chromatin 
(Fyodorov et al., 2004). ACF has also been implicated in regulation of the formation of 
chromatin loop domains (Yasui et al., 2002). 
 
1.4.2.2. Chromatin Assembly Factor CHD1 
Besides members of the ISWI family, only one other remodeler, CHD1 from both 
S. cerevisiae and D. melanogaster (yCHD1 and dCHD1, respectively), has been found 
to possess chromatin assembly activity thus far (Robinson and Schultz, 2003; Lusser et 
al., 2005). Despite yeast and fly CHD1 exhibiting remodeling activities in vitro as a 
monomer (Tran et al., 2000; Lusser et al., 2005), CHD1 from yeast and humans has 
	   34 
been observed to associate with multi-subunit complexes in vivo (Krogan et al., 2002; 
Pray-Grant et al., 2005; Lin et al., 2011). In yeast cells, yCHD1 interacts with the 
SAGA/SLIK histone acetylation complex (Pray-Grant et al., 2005) while human CHD1 
interacts with the Mediator complex in assembly of the pre-initiation complex and might 
be needed to establish nucleosome structure at active gene promoters (Lin et al., 2011). 
It is possible CHD1 exists as part of distinct complexes depending on the species, 
tissue type, or developmental window. These point toward a likely role for the 
remodeling activity of CHD1 in regulating transcription and gene expression (Krogan et 
al., 2003; Alén et al., 2002; Hennig et al., 2012; Radman-Livaja et al., 2012). CHD1 is 
also needed to maintain pluripotency of mouse embryonic stem cells, suggesting its 
chromatin assembly activity is important for establishing appropriate chromatin structure 
for global gene expression (Gaspar-Maia et al., 2009).  
The chromodomains are also likely to play a role in targeting the assembly 
activity of human CHD1. Human but not yeast CHD1 is able to recognize modified 
histone tails (Sims et al., 2005). Human CHD1 binds methylated histone tails via the N-
terminal tandem chromodomains, suggesting human CHD1 has evolved to carry out 
fine-tuning of gene regulation in higher organisms (Sims et al., 2005; Flanagan et al., 
2005). Further, CHD1 localization to chromatin is dependent on the chromodomains 
(Kelley et al., 1999; Morettini et al., 2011). While yCHD1 and dCHD1 assemble 
chromatin in vitro (Robinson and Schultz, 2003; Lusser et al., 2005), chromatin 
assembly activity by human CHD1 has yet to be shown.  
My dissertation work has delineated the biochemical properties of two CHD 
remodelers from humans, CHD1 and CHD2 (hCHD1 and hCHD2), which have been 
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implicated in gene regulation and development. While hCHD2 has been found to 
associate with chromatin in vivo (Harada et al., 2012), its biochemical properties have 
not been well characterized thus far. I have demonstrated hCHD2 possesses ATP-
dependent chromatin assembly activity and can remodel nucleosomes in vitro. In order 
to provide a foundation for delineating the molecular mechanisms for CHD remodelers, I 
have dissected the domain architecture of hCHD2 in the context of its ATP-dependent 
activities. These results will be the focus of Chapter 2. I have also shown that while 
hCHD1 can assemble and remodel nucleosomes, it does so inefficiently. Furthermore, I 
went on to dissect the ATPase activities of hCHD1 as well. These findings will be 
outlined in Chapter 3. In the last chapter, I will discuss conclusions made from the 
findings outlined in chapters 2 and 3, how they relate to each other, discuss models for 
how human CHD1 and CHD2 could be recruited in vivo, and propose future 











	   36 
1.5. REFERENCES 
Ahmad, K., & Henikoff, S. (2002). Epigenetic consequences of nucleosome dynamics. 
Cell, 111(3), 281-284. 
 
Akey, C.W., & Luger, K. (2003). Histone chaperones and nucleosome assembly. Curr. 
Opin. Struct. Biol., 13(1), 6-14.  
 
Albert, I., Mavrich, T.N., Tomsho, L.P., Qi, J., Zanton, S.J., Schuster, S.C., & Pugh, B.F. 
(2007). Translational and rotational settings of H2A.Z nucleosomes across the 
Saccharomyces cerevisiae genome. Nature, 446(7135), 572-576. 
 
Alén, C., Kent, N.A., Jones, H.S., O’Sullivan, J., Aranda, A., & Proudfoot, N.J. (2002). A 
role for chromatin remodeling in transcriptional termination by RNA polymerase II. Mol. 
Cell, 10(6), 1441-1452. 
 
Alexiadis, V., Lusser, A., & Kadonaga, J.T. (2004). A conserved N-terminal motif in 
Rad54 is important for chromatin remodeling and homologous strand pairing. J. Biol. 
Chem., 279(26), 27824-27829. 
 
Allahverdi, A., Yang, R., Korolev, N., Fan, Y., Davey, C.A., Liu, C.F., & Nordenskiöld, L. 
(2011). The effects of histone H4 tail acetylations on cation-induced chromatin folding 
and self-association. Nucleic Acids Res., 39(5), 1680-1691. 
 
Altmeyer, M., & Lukas, J. (2013). To spread or not to spread—chromatin modifications 
in response to DNA damage. Curr. Opin. Genet. Dev., 23(2), 156-165. 
 
Altshuler, D., Daly, M.J., & Lander, E.S. (2008). Genetic mapping in human disease. 
Science, 322(5903), 881-888. 
 
Ando, T., Uchihashi, T., Kodera, N., Yamamoto, D., Miyagi, A., Taniguchi, M., 
Yamashita, H. (2008). High-speed AFM and nano-visualization of biomolecular 
processes. Pflugers Arch., 456(1), 211-225. 
 
Andrews, A.J., & Luger, K. (2011). Nucleosome structure(s) and stability: variations on a 
theme. Annu. Rev. Biophys., 40, 99-117. 
 
Andrews, A.J., Chen, X., Zevin, A., Stargell, L.A., & Luger, K. (2010). The histone 
chaperone Nap1 promotes nucleosome assembly by eliminating nonnucleosomal 
histone DNA interactions. Mol. Cell, 37(6), 834-842. 
 
Andrews, A.J., Downing, G., Brown, K., Park, Y.J., & Luger, K. (2008). A 
thermodynamic model for Nap1-histone interactions. J. Biol. Chem., 283(47), 32412-
32418. 
 
	   37 
Annunziato, A.T. (2005). Split decision: what happens to nucleosomes during DNA 
replication? J. Biol. Chem., 280(13), 12065-12068. 
 
Annunziato, A.T. (2013). Assembling chromatin: the long and winding road. Biochim. 
Biophys. Acta, 1819(3-4), 196-210. 
 
Azuara, V., Perry, P., Sauer, S., Spivakov, M., Jørgensen, H.F., John, R.M., Gouti, M., 
Casanova, M., Warnes, G., Merkenschlager, M., & Fisher, A.G. (2006). Chromatin 
signatures of pluripotent cell lines. Nat. Cell Biol., 8(5), 532-538. 
 
Bannister, A.J., Zegerman, P., Partridge, J.F., Miska, E.A., Thomas, J.O., Allshire, R.C., 
Kouzarides, T. (2001). Selective recognition of methylated lysine 9 on histone H3 by the 
HP1 chromo domain. Nature, 410(6824), 120-124. 
 
Bao, Y., & Shen, X. (2007). INO80 subfamily of chromatin remodeling complexes. 
Mutat. Res., 618(1-2), 18-29. 
 
Bartholomew, B. (2014). Regulating the chromatin landscape: structural and 
mechanistic perspectives. Annu. Rev. Biochem., 83, 671-696. 
 
Becker, P.B., & Hörz, W. (2002). ATP-dependent nucleosome remodeling. Annu. Rev. 
Biochem., 71, 247-273. 
 
Becker, P.B., & Wu, C. (1992). Cell-free system for assembly of transcriptionally 
repressed chromatin from Drosophila embryos. Mol. Cell. Biol., 12(5), 2241-2249. 
 
Belmont, A.S., & Bruce, K. (1994). Visualization of G1 chromosomes: a folded, twisted, 
supercoiled chromonema model of interphase chromatid structure. J. Cell Biol., 127(2), 
287-302. 
 
Berger, S.L. (2000). Gene regulation. Local or global? Nature, 408(6811), 412-413, 415. 
 
Berger, S.L. (2002). Histone modifications in transcriptional regulation. Curr. Opin. 
Genet. Dev., 12(2), 142-148. 
 
Berger, S.L., & Felsenfeld, G. (2001). Chromatin goes global. Mol. Cell, 8(2), 263-268. 
 
Bernstein, B.E., Mikkelsen, T.S., Xie, X., Kamal, M., Huebert, D.J., Cuff, J., Fry, B., 
Meissner, A., Wernig, M., Plath, K., Jaenisch, R., Wagschal, A., Feil, R., Schreiber, S.L., 
& Lander, E.S. (2006). A bivalent chromatin structure marks key developmental genes 
in embryonic stem cells. Cell, 125(2), 315-326. 
 
Blosser, T.R., Yang, J.G., Stone, M.D., Narlikar, G.J., & Zhuang, X. (2009). Dynamics of 
nucleosome remodelling by individual ACF complexes. Nature, 462(7276), 1022-1027. 
 
	   38 
Boros, J., Arnoult, N., Stroobant, V., Collet, J.F., & Decottignies, A. (2014). Polycomb 
repressive complex 2 and H3K27me3 cooperate with H3K9 methylation to maintain 
heterochromatin protein 1α at chromatin. Mol. Cell. Biol., 34(19), 3662-3674. 
 
Boveri, T. (1909). Die Blastomerenkerne von Ascaris megalocephala und die Theorie 
der Chromosomenindividualität. Arch. Zellforsch., 3, 181-268. 
 
Brown, S.W. (1966). Heterochromatin. Science, 151(3709), 417-425. 
 
Brownell, J.E., & Allis, C.D. (1996). Special HATs for special occasions: linking histone 
acetylation to chromatin assembly and gene activation. Curr. Opin. Genet. Dev., 6(2), 
176-184. 
 
Brownell, J.E., Zhou, J., Ranalli, T., Kobayashi, R., Edmondson, D.G., Roth, S.Y., & 
Allis, C.D. (1996). Tetrahymena histone acetyltransferase A: a homolog to yeast Gcn5p 
linking histone acetylation to gene activation. Cell, 84(6), 843-851. 
 
Bruno, M., Flaus, A., Stockdale, C., Rencurel, C., Ferriera, H., & Owen-Hughes, T. 
(2003). Histone H2A/H2B dimer exchange by ATP-dependent chromatin remodeling 
activities. Mol. Cell, 12(6), 1599-1606. 
 
Burgess, R.J., & Zhang, Z. (2013). Histone chaperones in nucleosome assembly and 
human disease. Nat. Struct. Mol. Biol., 20(1), 14-22. 
 
Byrd, A.K., & Raney, K.D. (2012). Superfamily 2 helicases. Front Biosci. (Landmark Ed), 
17, 2070-2088. 
 
Cairns, B.R., Kim, Y.J., Sayre, M.H., Laurent, B.C., & Kornberg, R.D. (1994). A 
multisubunit complex containing the SWI1/ADR6, SWI2/SNF2, SWI3, SNF5, and SNF6 
gene products isolated from yeast. Proc. Natl. Acad. Sci. USA, 91(5), 1950-1954. 
 
Camerini-Otero, R.D., Sollner-Webb, B., & Felsenfeld, G. (1976). The organization of 
histones and DNA in chromatin: evidence for an arginine-rich histone kernel. Cell, 8(3), 
333-347. 
 
Cao, R., & Zhang, Y. (2004). The functions of E(Z)/EZH2-mediated methylation of lysine 
27 in histone H3. Curr. Opin. Genet. Dev., 14(2), 155-164. 
 
Cao, R., Wang, L., Wang, H., Xia, L., Erdjument-Gromage, H., Tempst, P., Jones, R.S., 
& Zhang, Y. (2002). Role of histone H3 lysine 27 methylation in Polycomb-group 
silencing. Science, 298(5595), 1039-1043. 
 
Caous, C.A., Smith, R.L., Haapalainen, E.F., & Lindsey, C.J. (2013). Ultrastructural 
transneuronal degeneration study of axonal elements within the paratrigeminal nucleus 
in sinoaortic deafferented rats. Einstein (Sao Paolo), 10(2), 145-150. 
 
	   39 
Chakravarthy, S., Gundimella, S.K., Caron, C., Perche, P.Y., Pehrson, J.R., Khochbin, 
S., & Luger, K. (2005). Structural characterization of the histone variant macroH2A. Mol. 
Cell. Biol., 25(17), 7616-7624. 
 
Chakravarthy, S., Park, Y.J., Chodaparambil, J., Edayathumangalam, R.S., & Luger, K. 
(2005). Structure and dynamic properties of nucleosome core particles. FEBS Lett., 
579(4), 895-898. 
 
Chatterjee, N., Sinha, D., Lemma-Dechassa, M., Tan, S., Shogren-Knaak, M.A., & 
Bartholomew, B. (2011). Histone H3 tail acetylation modulates ATP-dependent 
remodeling through multiple mechanisms. Nucleic Acid Res., 39(19), 8378-8391. 
 
Chien, F.T., & van Noort, J. (2009). 10 years of tension on chromatin: results from 
single molecule force spectroscopy. Curr. Pharm. Biotechnol., 10(5), 474-485. 
 
Cirulli, E.T., & Goldstein, D.B. (2010). Uncovering the roles of rare variants in common 
disease through whole-genome sequencing. Nat. Rev. Genet., 11(6), 415-425. 
 
Clapier, C.R., & Cairns, B.R. (2009). The biology of chromatin remodeling complexes. 
Annu. Rev. Biochem., 78, 273-304. 
 
Clapier, C.R., & Cairns, B.R. (2012). Regulation of ISWI involves inhibitory modules 
antagonized by nucleosomal epitopes. Nature, 492(7428), 280-284. 
 
Clapier, C.R., Chakravarthy, S., Petosa, C., Fernández-Tornero, C., Luger, K., & Müller, 
C.W. (2008). Structure of the Drosophila nucleosome core particle highlights 
evolutionary constraints on the H2A-H2B histone dimer. Proteins, 71(1), 1-7. 
 
Clapier, C.R., Nightingale, K.P., & Becker, P.B. (2002). A critical epitope for substrate 
recognition by the nucleosome remodeling ATPase ISWI. Nucleic Acids Res., 30(3), 
649-655. 
 
Corona, D.F., & Tamkun, J.W. (2004). Multiple roles for ISWI in transcription, 
chromosome organization and DNA replication. Biochim. Biophys. Acta, 1677(1-3), 113-
119. 
 
Corona, D.F., Siriaco, G., Armstrong, J.A., Snarskaya, N., McClymont, S.A., Scott, M.P., 
& Tamkun, J.W. (2007). ISWI regulates higher-order chromatin structure and histone H1 
assembly in vivo. PLoS Biol., 5(9), 2011-2021. 
 
Côté, J., Quinn, J., Workman, J.L., & Peterson, C.L. (1994). Stimulation of GAL4 
derivative binding to nucleosomal DNA by the yeast SWI/SNF complex. Science, 
265(5168), 53-60. 
 
Cremer, T. & Cremer, C. (2001). Chromosome Territories: Nuclear Architecture and 
Gene Regulation in Mammalian Cells. Nat. Rev. Genet., 2(4), 292-301. 
	   40 
Cremer, T., & Cremer, M., Dietzel, S., Müller, S., Solovei, I., & Fakan, S. (2006). 
Chromosome territories – a functional nuclear landscape. Curr. Opin. Cell. Biol., 18(3), 
307-316. 
 
Cremer, T., Cremer, C., Schneider, T., Baumann, H., Hens, L., & Kirsch-Volders, M. 
(1982). Analysis of Chromosome Positions in the Interphase Nucleus of Chinese 
Hamster Cells by Laser-UV-Microirradiation Experiments. Hum. Genet., 62(3), 201-209. 
 
Czermin, B., Melfi, R., McCabe, D., Seitz, V., Imhof, A., & Pirotta, V. (2002). Drosophila 
Enhancer of Zeste/ESC Complexes Have a Histone H3 Methyltransferase Activity that 
Marks Chromosomal Polycomb Sites. Cell, 111(2), 185-196.  
 
Dagliesh, G.L., Furge, K., Greenman, C., Chen, L., Bignell, G., Butler, A., … Futreal, 
P.A. (2010). Systematic sequencing of renal carcinoma reveals inactivation of histone 
modifying genes. Nature, 463(7279), 360-363. 
 
Das, C., & Tyler, J.K. (2013). Histone exchange and histone modifications during 
transcription and aging. Biochim. Biophys. Acta, 1819(3-4), 332-342. 
 
Davey, C.A., Sargent, D.F., Luger, K., Maeder, A.W., & Richmond, T.J. (2002). Solvent 
Mediated Interactions in the Structure of the Nucleosome Core Particle at 1.9 Å 
Resolution. J. Mol. Biol., 319(5), 1097-1113. 
 
de la Serna, I.L., Ohkawa, Y., & Imbalzano, A.N. (2006). Chromatin remodelling in 
mammalian differentiation: lessons from ATP-dependent remodellers. Nat. Rev. Genet., 
7(6), 461-473. 
 
Dechassa, M.L., Hota, S.K., Sen, P., Chatterjee, N., Prasad, P., & Bartholomew, B. 
(2012). Disparity in the DNA translocase domains of SWI/SNF and ISW2. Nucleic Acids 
Res., 40(10), 4412-4421. 
 
Dechassa, M.L., Sabri, A., Pondugula, S., Kassabov, S.R., Chatterjee, N., Kladde, M.P., 
& Bartholomew, B. (2010). SWI/SNF has intrinsic nucleosome disassembly activity that 
is dependent on adjacent nucleosomes. Mol. Cell, 38(4), 590-602. 
 
Deindl, S., Hwang, W.L., Hota, S.K., Blosser, T.R., Prasad, P., Bartholomew, B., & 
Zhuang, X. (2013). ISWI remodelers slide nucleosomes with coordinated multi-base-
pair entry steps and single-base-pair exit steps. Cell, 152(3), 442-452. 
 
Dekker, J., Marti-Renom, M.A., & Mirny, L.A. (2013). Exploring the three-dimensional 
organization of genomes: interpreting chromatin interaction data. Nat. Rev. Genet., 
14(6), 390-403. 
 
Dekker, J., Rippe, K., Dekker, M., & Kleckner, N. (2002). Capturing chromosome 
conformation. Science, 295(5558), 1306-1311. 
	   41 
Delmas, V., Stokes, D.G., & Perry, R.P. (1993). A mammalian DNA-binding protein that 
contains a chromodomain and an SNF2/SWI2-like helicase domain. Proc. Natl. Acad. 
Sci. USA, 90(6), 2414-2418. 
 
Deuring, R., Fanti, L., Armstrong, J.A., Sarte, M., Papoulas, O., Prestel, M., Daubresse, 
G., Verardo, M., Moseley, S.L., Berloco, M., Tsukiyama, T., Wu, C., Pimpinelli, S., & 
Tamkun, J.W. (2000). The ISWI chromatin-remodeling protein is required for gene 
expression and the maintenance of higher order chromatin structures. Mol. Cell, 5(2), 
355-365. 
 
Dhalluin, C., Carlson, J.E., Zeng, L., He, C., Aggarwal, A.K., & Zhou, M.M. (1999). 
Structure and ligand of a histone acetyltransferase bromodomain. Nature, 399(6735), 
491-496. 
 
Dorigo, B., Schalch, T., Kulangara, A., Duda, S., Schroeder, R.R., & Richmond, T.J. 
(2004). Nucleosome Arrays Reveal the Two-Start Organization of the Chromatin Fiber. 
Science, 306(5701), 1571-1573. 
 
Downs, J.A., Allard, S., Jobin-Robitaille, O., Javaheri, A., Auger, A., Bouchard, N., Kron, 
S.J., Jackson, S.P., & Côté, J. (2004). Binding of chromatin-modifying activities to 
phosphorylated histone H2A at DNA damage sites. Mol. Cell, 16(6), 979-990. 
 
Dulbecco, R.A. (1986). A turning point in cancer research: sequencing the human 
genome. Science, 231(4742), 1055-1056. 
 
Dürr, H., Körner, C., Müller, M., Hickmann, V., & Hopfner, K.P. (2005). X-ray structures 
of the Sulfolobus solfataricus SWI2/SNF2 ATPase core and its complex with DNA. Cell, 
121(3), 363-373. 
 
Ebbert, R., Birkmann, A., & Schüller, H.J. (1999). The product of the SNF2/SWI2 
paralogue INO80 of Saccharomyces cerevisiae required for various yeast structural 
genes is part of a high-molecular-weight protein complex. Mol. Microbiol., 32(4), 741-
751. 
 
Eissenberg, J.C. (2001). Molecular biology of the chromo domain: an ancient chromatin 
module comes of age. Gene, 275(1), 19-29. 
 
Eissenberg, J.C., & Elgin, S.C. (2000). The HP1 protein family: getting a grip on 
chromatin. Curr. Opin. Genet. Dev., 10(2), 204-210. 
 
Elfring, L.K., Deuring, R., McCallum, C.M., Peterson, C.L., & Tamkun, J.W. (1994). 
Identification and characterization of Drosophila relatives of the yeast transcriptional 
activator SNF2/SWI2. Mol. Cell. Biol., 14(4), 2225-2234. 
 
Elgin, S.C. (1996). Heterochromatin and gene regulation in Drosophila. Curr. Opin. 
Genet. Dev., 6(2), 193-202. 
	   42 
Fairman-Williams, M.E., Guenther, U.P., & Jankowsky, E. (2010). SF1 and SF2 
helicases: family matters. Curr. Opin. Struct. Biol., 20(3), 313-324. 
 
Fawcett, D.W. (1966). An Atlas of Fine Structure: The Cell, Its Organelles, and 
Inclusions. Philadelphia, PA: W.B. Saunders Company.  
 
Fazzio, T.G., Gelbart, M.E., & Tsukiyama, T. (2005). Two distinct mechanisms of 
chromatin interaction by the Isw2 chromatin remodeling complex in vivo. Mol. Cell. Biol., 
25(21), 9165-9174. 
 
Felsenfeld, G., & Groudine, M. (2003). Controlling the double helix. Nature, 421(6921), 
448-453. 
 
Filippakopoulos, P., & Knapp, S. (2012). The bromodomain interaction module. FEBS 
Lett., 586(17), 2692-2704. 
 
Finch, J.T., & Klug, A. (1976). Solenoidal model for superstructure in chromatin. Proc. 
Natl. Acad. Sci. USA, 73(6), 1897-1901. 
 
Finch, J.T., Noll, M., & Kornberg, R.D. (1975). Electron microscopy of defined lengths of 
chromatin. Proc. Natl. Acad. Sci. USA, 72(9), 3320-3322. 
 
Fischle, W., Wang, Y., & Allis, C.D. (2003). Binary switches and modification cassettes 
in histone biology and beyond. Nature, 425(6957), 475-479. 
 
Flanagan, J.F., Blus, B.J., Kim, D., Clines, K.L., Rastinejad, F., & Khorasanizadeh, S. 
(2007). Molecular implications of evolutionary differences in CHD double 
chromodomains. J. Mol. Biol., 369(2), 334-342. 
 
Flanagan, J.F., Mi, L.Z., Chruszcz, M., Cymborowski, M., Clines, K.L., Kim, Y., Minor, 
W., Rastinejad, F., & Khorasanizadeh, S. (2005). Double chromodomains cooperate to 
recognize the methylated histone H3 tail. Nature, 438(7071), 1181-1185. 
 
Flaus, A., & Richmond, T.J. (1998). Positioning and stability of nucleosome on MMTV 
3’LTR sequences. J. Mol. Biol., 275(3), 427-441. 
 
Flaus, A., Martin, D.M., Barton, G.J., & Owen-Hughes, T. (2006). Identification of 
multiple distinct Snf2 subfamilies with conserved structural motifs. Nucleic Acids Res., 
34(10), 2887-2905. 
 
Flemming, W. (1882). Zellsubstanz, Kern und Zelltheilung (Cell Substance, Nucleus and 
Cell Division). Leipzig, Germany: F.C.W. Vogel. 
 
Foster, H.A., & Bridger J.M. (2005). The genome and the nucleus: a marriage made by 
evolution. Genome organization and nuclear architecture. Chromosoma, 114(4), 212-
229. 
	   43 
Fraser, P. (2006). Transcriptional control thrown for a loop. Curr. Opin. Genet. Dev., 
16(5), 490-495. 
 
Fujimoto, A., Totoki, Y., Abe, T., Boroevich, K.A., Hosoda, F., Nguyen, H.H., … 
Nakagawa, H. (2012). Whole-genome sequencing of liver cancers identifies etiological 
influences on mutation patterns and recurrent mutations in chromatin regulators. Nat. 
Genet., 44(7), 760-764. 
 
Fyodorov, D.V., Blower, M.D., Karpen, G.H., & Kadonaga, J.T. (2004). Acf1 confers 
unique activities to ACF/CHRAC and promotes the formation rather than disruption of 
chromatin in vivo. Genes Dev., 18(2), 170-183. 
 
Gardner, K.E., Allis, C.D., & Strahl, B.D. (2011). Operating on chromatin, a colorful 
language where context matters. J. Mol. Biol., 409(1), 36-46. 
 
Gaspar-Maia, A., Alajem, A., Polesso, F., Sridharan, R., Mason, M.J., Heidersbach, A., 
Ramalho-Santos, J., McManus, M.T., Plath, K., Meshorer, E., & Ramalho-Santos, M. 
(2009). Chd1 regulates open chromatin and pluripotency of embryonic stem cells. 
Nature, 460(7257), 863-868. 
 
Georgel, P.T., Tsukiyama, T., & Wu, C. (1997). Role for histone tails in nucleosome 
remodeling by Drosophila NURF. EMBO J., 16(15), 4717-4726. 
 
Georgopoulos, K. (2002). Haematopoietic cell-fate decisions, chromatin regulation and 
ikaros. Nat. Rev. Immunol., 2(3), 162-174. 
 
Germond, J.E., Bellard, M., Oudet, P., & Chambon, P. (1976). Stability of nucleosomes 
in native and reconstituted chromatins. Nucleic Acids Res., 3(11), 3173-3192. 
 
Gévry, N., Chan, H.M., Laflamme, L., Livingston, D.M., & Gaudreau, L. (2007). p21 
transcription is regulated by differential localization of histone H2A.Z. Genes Dev., 
21(15), 1869-1881. 
 
Ghirlando, R., & Felsenfeld, G. (2013). Chromatin structure outside and inside the 
nucleus. Biopolymers, 99(4), 225-232. 
 
Glikin, G.C., Ruberti, I., & Worcel, A. (1984). Chromatin assembly in Xenopus oocytes: 
in vitro studies. Cell, 37(1), 33-41. 
 
Gorbalenya, A.E., & Koonin, E.V. (1993). Helicases: amino acid sequence comparisons 
and structure–function relationships. Curr. Opin. Struct. Biol., 3(3), 419-429. 
 
Gorbalenya, A.E., Koonin, E.V., Donchenko, A.P., & Blinov, V.M. (1988). A novel 
superfamily of nucleoside triphosphate-binding motif containing proteins which are 
probably involved in duplex unwinding in DNA and RNA replication and recombination. 
FEBS Lett., 235(1-2), 16-24. 
	   44 
Groth, A., Rocha, W., Verreault, A., & Almouzni, G. (2007). Chromatin challenges 
during DNA replication and repair. Cell, 128(4), 721-733. 
 
Gui, Y., Guo, G., Huang, Y., Hu, X., Tang, A., Gao, S., … Cai, Z. (2011). Frequent 
mutations of chromatin remodeling genes in transitional cell carcinoma of the bladder. 
Nat. Genet., 43(9), 875-878. 
 
Gunjan, A., & Verreault, A. (2003). A Rad53 kinase-dependent surveillance mechanism 
that regulates histone protein levels in S. cerevisiae. Cell, 115(5), 537-549. 
 
Gunjan, A., Paik, J., & Verreault, A. (2005). Regulation of histone synthesis and 
nucleosome assembly. Biochimie, 87(7), 625-635. 
 
Gunjan, A., Paik J., & Verreault A. (2006). The emergence of regulated histone 
proteolysis. Curr. Opin. Genet. Dev., 16(2), 112-118. 
 
Guyon, J.R., Narlikar, G.J., Sif, S., & Kingston, R.E. (1999). Stable remodeling of 
tailless nucleosomes by the human SWI-SNF complex. Mol. Cell. Biol., 19(3), 2088-
2097. 
 
Hall, J.A., & Georgel, P.T. (2007). CHD proteins: a diverse family with strong ties. 
Biochem. Cell Biol., 85(4), 463-476. 
 
Hall, M.A., Shundrovsky, A., Bai, L., Fulbright, R.M., Lis, J.T., & Wang, M.D. (2009). 
High-resolution dynamic mapping of histone-DNA interactions in a nucleosome. Nat. 
Struct. Mol. Biol., 16(2), 124-129. 
 
Hamiche, A., Kang, J.G., Dennis, C. Xiao, H., & Wu, C. (2001). Histone tails modulate 
nucleosome mobility and regulate ATP-dependent nucleosome sliding by NURF. Proc. 
Natl. Acad. Sci. USA, 98(25), 14316-14321. 
 
Hanahan, D., & Weinberg, R.A. (2000). The hallmarks of cancer. Cell, 100(1), 57-70. 
 
Hansen, J.C., & Turgeon, C.L. (1999). Analytical centrifugation of chromatin. Methods 
Mol. Biol., 119, 127-141. 
 
Harada, A., Okada, S., Konno, D., Odawara, J., Yoshimi, T., Yoshimura, S., Kumamaru, 
H., Saiwai, H., Tsubota, T., Kurumizaka, H., Akashi, K., Tachibana, T., Imbalzano, A.N., 
& Ohkawa, Y. (2012). Chd2 interacts with H3.3 to determine myogenic cell fate. EMBO 
J., 31(13), 2994-3007. 
 
Hargreaves, D.C., & Crabtree, G.R. (2011). ATP-dependent chromatin remodeling: 
genetics, genomics and mechanisms. Cell Res., 21(3), 396-420. 
 
Hauk, G., & Bowman, G.D. (2011). Structural insights into regulation and action of 
SWI2/SNF2 ATPases. Curr. Opin. Struct. Biol., 21(6), 719-727. 
	   45 
Hauk, G., McKnight, J.N., Nodelman, I.M., & Bowman, G.D. (2010). The 
chromodomains of the Chd1 chromatin remodeler regulate DNA access to the ATPase 
motor. Mol. Cell, 39(5), 711-723. 
 
Haushalter, K.A., & Kadonaga, J.T. (2003). Chromatin assembly by DNA-translocating 
motors. Nat. Rev. Mol. Cell Biol., 4(8), 613-620. 
 
Hawkins, R.D., Hon, G.C., Lee, L.K., Ngo, Q., Lister, R., Pelizzola, M., … Ren, B. 
(2010). Distinct epigenomic landscapes of pluripotent and lineage-committed human 
cells. Cell Stem Cell, 6(5), 479-491. 
 
Haynes, S.R., Dollard, C., Winston, F., Beck, S., Trowsdale, J., & Dawid, I.B. (1992). 
The bromodomain: a conserved sequence found in human, Drosophila and yeast 
proteins. Nucleic Acids Res., 20(10), 2603. 
 
Heitz, E. (1928). Das Heterochromatin der Moose, 1. Jahrb. Wiss. Bot., 69, 762-818. 
 
Heitz, E. (1929). Heterochromatin, Chromocentren, Chromomeren (Vorlaufige 
Mitteilung). Ber. Dtsch. Bot. Ges., 47, 274-284. 
 
Henikoff, S., & Ahmad, K. (2005). Assembly of variant histones into chromatin. Annu. 
Rev. Cell Dev. Biol., 21, 133-153. 
 
Hennig, B.P., Bendrin, K., Zhou, Y., & Fischer, T. (2012). Chd1 chromatin remodelers 
maintain nucleosome organization and repress cryptic transcription. EMBO Rep., 
13(11), 997-1003. 
 
Ho, L., & Crabtree, G.R. (2010). Chromatin remodelling during development. Nature, 
463(7280), 474-484. 
 
Hota, S.K., & Bartholomew, B. (2011). Diversity of operation in ATP-dependent 
chromatin remodelers. Biochim. Biophys. Acta, 1809(9), 476-487. 
 
Huang, C., Sloan, E.A., & Boerkoel, C.F. (2003). Chromatin remodeling and human 
disease. Curr. Opin. Genet. Dev., 13(3), 246-252. 
 
Iizuka, M., & Smith, M.M. (2003). Functional consequences of histone modifications. 
Curr. Opin. Genet. Dev., 13(2), 154-160. 
 
Ito, T., Bulger, M., Pazin, M.J., Kobayashi, R., & Kadonaga, J.T. (1997a). ACF, an ISWI-
containing and ATP-utilizing chromatin assembly and remodeling factor. Cell, 90(1), 
145-155. 
 
Ito, T., Tyler, J.K., & Kadonaga, J.T. (1997b). Chromatin assembly factors: a dual 
function in nucleosome formation and mobilization? Genes Cells, 2(10), 593-600. 
 
	   46 
Jackson, V., Shires, A., Tanphaichitr, N., & Chalkley, R. (1976). Modifications to 
histones immediately after synthesis. J. Mol. Biol., 104(2), 471-483. 
 
Jacobs, S.A., Taverna, S.D., Zhang, Y., Briggs, S.D., Li, J., Eissenberg, J.C., Allis, C.D., 
& Khorasanizadeh, S. (2001). Specificity of the HP1 chromo domain for the methylated 
N-terminus of histone H3. EMBO J., 20(18), 5232-5241. 
 
Jacobson, R.H., Ladurner, A.G., King, D.S., & Tijan, R. (2000). Structure and function of 
a human TAFII250 double bromodomain module. Science, 288(5470), 1422-1425. 
 
Jenuwein, T., & Allis, C.D. (2001). Translating the histone code. Science, 293(5532), 
1074-1080. 
 
Kadam, S., & Emerson, B.M. (2002). Mechanisms of chromatin assembly and 
transcription. Curr. Opin. Cell Biol., 14(3), 262-268. 
 
Kadoch, C., Hargreaves, D.C., Hodges, C., Elias, L., Ho, L. Ranish, J., & Crabtree, G.R. 
(2013). Proteomic and bioinformatics analysis of mammalian SWI/SNF complexes 
identifies extensive roles in human malignancy. Nat. Genet., 45(6), 592-601. 
 
Kamakaka, R.T., Bulger, M., & Kadonaga, J.T. (1993). Potentiation of RNA polymerase 
II transcription by Gal4-VP16 during but not after DNA replication and chromatin 
assembly. Genes Dev., 7(9), 1779-1795. 
 
Kaplan, N., Moore, I.K., Fondufe-Mittendorf, Y., Gossett, A.J., Tillo, D., Field, Y., 
LeProust, E.M., Hughes, T.R., Lieb, J.D., Widom, J., & Segal, E. (2009). The DNA-
encoded nucleosome organization of a eukaryotic genome. Nature, 458(7236), 362-
366. 
 
Kassabov, S.R., Zhang, B., Persinger, J., & Bartholomew, B. (2003). SWI/SNF 
unwraps, slides, and rewraps the nucleosome. Mol. Cell, 11(2), 391-403. 
 
Kelley, D.E., Stokes, D.G., & Perry, R.P. (1999). CHD1 interacts with SSRP1 and 
depends on both its chromodomain and its ATPase/helicase-like domain for proper 
association with chromatin. Chromosoma, 108(1), 10-25. 
 
Kim, J., Daniel, J., Espejo, A., Lake, A., Krishna, M., Xia, L., Zhang, Y., & Bedford, M.T. 
(2006). Tudor, MBT and chromo domains gauge the degree of lysine methylation. 
EMBO Rep., 7(4), 397-403. 
 
Kleinschmidt, J.A., Seiter, A., & Zentgraf, H. (1990). Nucleosome assembly in vitro: 
separate histone transfer and synergistic interaction of native histone complexes 
purified from nuclei of Xenopus laevis ooctyes. EMBO J., 9(4), 1309-1318. 
 
 
	   47 
Kobor, M.S., Venkatasubrahmanyam, S., Meneghini, M.D., Gin, J.W., Jennings, J.L., 
Link, A.J., Madhani, H.D., & Rine, J. (2004). A protein complex containing the 
conserved Swi2/Snf2-related ATPase Swr1p deposits histone variant H2A.Z into 
euchromatin. PLoS Biol., 2(5), 587-599. 
 
Koonin, E.V., Zhou, S., & Lucchesi, J.C. (1995). The chromo superfamily: new 
members, duplication of the chromo domain and possible role in delivering transcription 
regulators to chromatin. Nucleic Acids Res., 23(21), 4229-4233. 
 
Kornberg, R.D. (1974). Chromatin structure: a repeating unit of histones and DNA. 
Science, 184(4139), 868-871. 
 
Kornberg, R.D. (1977). Structure of Chromatin. Annu. Rev. Biochem., 46, 931-954. 
 
Kornberg, R.D., & Thomas, J.O. (1974). Chromatin structure; oligomers of the histones. 
Science, 184(4139), 865-868. 
 
Krogan, N.J., Keogh, M.C., Datta, N., Sawa, C., Ryan, O.W., Ding, H., Haw, R.A., 
Pootoolal, J., Tong, A., Canadien, V., Richards, D.P., Wu, X., Emili, A., Hughes, T.R., 
Buratowski, S., & Greenblatt, J.F. (2003). A Snf2 family ATPase complex required for 
recruitment of the histone H2A variant Htz1. Mol. Cell, 12(6), 1565-1576. 
 
Krogan, N.J., Kim, M., Ahn, S.H., Zhong, G., Kobor, M.S., Cagney, G., Emili, A., 
Shilatifard, A., Buratowski, S., & Greenblatt, J.F. (2002). RNA polymerase II elongation 
factors of Saccharomyces cerevisiae: A targeted proteomics approach. Mol. Cell. Biol., 
22(20), 6979-6992. 
 
Krude, T. (1999). Chromatin assembly during DNA replication in somatic cells. Eur. J. 
Biochem., 263(1), 1-5. 
 
Krude, T., & Keller, C. (2001). Chromatin assembly during S phase: contributions from 
histone deposition, DNA replication and the cell division cycle. Cell. Mol. Life. Sci., 58(5-
6), 665-672. 
 
Kuzmichev, A., Nishioka, K., Erdjument-Bromage, H., Tempst, P., & Reinberg, D. 
(2002). Histone methyltransferase activity associated with a human multiprotein 
complex containing the Enhancer of Zeste protein. Genes Dev., 16(22), 2893-2905. 
 
Lachner, M., O’Carroll, D., Rea, S., Mechtler, K., & Jenuwein, T. (2001). Methylation of 
histone H3 lysine 9 creates a binding site for HP1 proteins. Nature, 410(6824), 116-120. 
 
Lamond, A.I., & Earnshaw, W.C. (1998). Structure and function in the nucleus. Science, 
280(5363), 547-553. 
 
Lander, E.S. (2011). Initial impact of the sequencing of the human genome. Nature, 
470(7333), 187-197. 
	   48 
Lander, E.S., Linton, L.M., Birren, B., Nusbaum, C., Zody, M.C., Baldwin, J., … Chen, 
Y.J.; International Human Genome Sequencing Consortium. (2001). Initial sequencing 
and analysis of the human genome. Nature, 409(6822), 860-921. 
 
Laskey, R.A., Honda, B.M., Mills, A.D., & Finch, J.T. (1978). Nucleosomes are 
assembled by an acidic protein which binds histones and transfers them to DNA. 
Nature, 275(5679), 416-420. 
 
LeRoy, G., Loyola, A., Lane, W.S., & Reinberg, D. (2000). Purification and 
characterization of a human factor that assembles and remodels chromatin. J. Biol. 
Chem., 275(20), 14787-14790. 
 
Li, G., & Widom, J. (2004). Nucleosomes facilitate their own invasion. Nat. Struc. Mol. 
Biol., 11(8), 763-769. 
 
Lin, J.J., Lehmann, L.W., Bonora, G., Sridharan, R., Vashisht, A.A., Tran, N., Plath, K., 
Wohlschlegel, J.A., & Carey, M. (2011). Mediator coordinates PIC assembly with 
recruitment of CHD1. Genes Dev., 25(20), 2198-2209. 
 
Lorch, Y., Maier-Davis, B., & Kornberg, R.D. (2006). Chromatin remodeling by 
nucleosome disassembly in vitro. Proc. Natl. Acad. Sci. USA, 103(9), 3090-3093. 
 
Lorch, Y., Zhang, M., & Kornberg, R.D. (1999). Histone octamer transfer by a 
chromatin-remodeling complex. Cell, 96(3), 389-392. 
 
Loyola, A., & Almouzni, G. (2004). Histone chaperones, a supporting role in the 
limelight. Biochim. Biophys. Acta, 1677(1-3), 3-11. 
 
Loyola, A., LeRoy, G., Wang, Y.H., & Reinberg, D. (2001). Reconstitution of 
recombinant chromatin establishes a requirement for histone-tail modifications during 
chromatin assembly and transcription. Genes Dev., 15(21), 2837-2851. 
 
Luger, K., & Richmond, T.J. (1998). The histone tails of the nucleosome. Curr. Opin. 
Genet. Dev., 8(2), 140-146. 
 
Luger, K., Dechassa, M.L., & Tremethick, D.J. (2012). New insights into nucleosome 
and chromatin structure: an ordered state or a disordered affair? Nat. Rev. Mol. Cell. 
Biol., 13(7), 436-447. 
 
Luger, K., Mäder, A.W., Richmond, R.K., Sargent, D.F., & Richmond, T.J. (1997). 
Crystal structure of the nucleosome core particle at 2.8 Å resolution. Nature, 389(6648), 
251-260. 
 
Lusser, A., Urwin, D.L., & Kadonaga, J.T. (2005). Distinct activities of CHD1 and ACF in 
ATP-dependent chromatin assembly. Nat. Struct. Mol. Biol., 12(2), 160-166. 
	   49 
Mahto, S.K., Howard, C.J., Shimko, J.C., & Ottesen, J.J. (2011). A reversible protection 
strategy to improve Fmoc-SPPS of peptide thioesters by the N-Acylurea approach. 
Chembiochem., 12(16), 2488-2494. 
 
Manuelidis, L. (1985). Individual interphase chromosome domains revealed by in situ 
hybridization. Hum. Genet., 71(4), 288-293. 
 
Marfella, C.G., & Imbalzano, A.N. (2007). The Chd family of chromatin remodelers. 
Mutat. Res., 618(1-2), 30-40.  
 
Marzluff, W.F., Wagner, E.J., & Duronio, R.J. (2008). Metabolism and regulation of 
canonical histone mRNAs: life without a poly(A) tail. Nat. Rev. Genet., 9(11), 843-854. 
 
Mavrich, T.N., Jiang, C., Ioshikhes, I.P., Li, X., Venters, B.J., Zanton, S.J., Tomsho, 
L.P., Qi, J., Glaser, R.L., Schuster, S.C., Gilmour, D.S., Albert, I., & Pugh, B.F. (2008a). 
Nucleosome organization in the Drosophila genome. Nature, 453(7193), 358-362. 
 
Mavrich, T.N., Ioshikhes, I.P., Venters, B.J., Jiang, C., Tomsho, L.P., Qi, J., Schuster, 
S.C., Albert, I., & Pugh, B.F. (2008b). A barrier nucleosome model for statistical 
positioning of nucleosomes throughout the yeast genome. Genome Res., 18(7), 1073-
1083. 
 
McGhee, J.D., Nickol, J.M., Felsenfeld, G., & Rau, D.C. (1983). Higher Order Structure 
of Chromatin: Orientation of Nucleosomes within the 30 nm Chromatin Solenoid is 
Independent of Species and Spacer Length. Cell, 33(3), 831-841. 
 
Meersseman, G., Pennings, S., & Bradbury, E.M. (1992). Mobile nucleosomes—a 
general behavior. EMBO J., 11(8), 2951-2959. 
 
Messmer, S., Franke, A., & Paro, R. (1992). Analysis of the functional role of the 
Polycomb chromo domain in Drosophila melanogaster. Genes Dev., 6(7), 1241-1254. 
 
Misteli, T., Gunjan., A., Hock, R., Bustin, M., & Brown, D.T. (2000). Dynamic binding of 
histone H1 to chromatin in living cells. Nature, 408(6814), 877-881. 
 
Mizuguchi, G., Shen, X., Landry, J., Wu, W.H., Sen, S., & Wu, C. (2004). ATP-driven 
exchange of histone H2AZ variant catalyzed by SWR1 chromatin remodeling complex. 
Science, 303(5656), 343-348. 
 
Mohrmann, L., & Verrijzer, C.P. (2005). Composition and functional specificity of 





	   50 
Morettini, S., Tribus, M., Zeilner, A., Sebald, J., Campo-Fernandez, B., Scheran, G., 
Wörle, H., Podhraski, V., Fyodorov, D.V., & Lusser, A. (2011). The chromodomains of 
CHD1 are critical for enzymatic activity but less important for chromatin localization. 
Nucleic Acids Res., 39(8), 3103-3115. 
 
Morin, R.D., Mendez-Lago, M., Mungall, A.J., Goya, R., Mungall, K.L., Corbett, R.D., … 
Marra, M.A. (2011). Frequent mutation of histone-modifying genes in non-Hodgkin 
lymphoma. Nature, 476(7360), 298-303. 
 
Morrison, A.J., Highland, J., Krogan, N.J., Arbel-Eden, A., Greenblatt, J.F., Haber, J.E., 
& Shen, X. (2004). INO80 and gamma-H2AX interaction links ATP-dependent 
chromatin remodeling to DNA damage repair. Cell, 119(6), 767-775. 
 
Mosammaparast, N., Ewart, C.S., & Pemberton, L.F. (2002). A role for nucleosome 
assembly protein 1 in the nuclear transport of histones H2A and H2B. EMBO J., 21(23), 
6527-6538. 
 
Mueller-Planitz, F., Klinker, H., Ludwigsen, J., & Becker, P.B. (2013). The ATPase 
domain of ISWI is an autonomous nucleosome remodeling machine. Nat. Struct. Mol. 
Biol., 20(1), 82-89. 
 
Muir, T.W. (2003). Semisynthesis of proteins by expressed protein ligation. Annu. Rev. 
Biochem., 72, 249-289. 
 
Muthurajan, U.M., Bao, Y., Forsberg, L.J., Edayathumangalam, R.S., Dyer, P.N., White, 
C.L., & Luger, K. (2004). Crystal structures of histone Sin mutant nucleosomes reveal 
altered protein-DNA interactions. EMBO J., 23(2), 260-271. 
 
Nakagawa, T., Bulger, M., Muramatsu, M., & Ito, T. (2001). Multistep chromatin 
assembly on supercoiled plasmid DNA by nucleosome assembly protein-1 and ATP-
utilizing chromatin assembly and remodeling factor. J. Biol. Chem., 276(29), 27384-
27391. 
 
Nakayama, J., Rice, J.C., Strahl, B.D., Allis, C.D., & Grewal, S.I. (2001). Role of histone 
H3 lysine 9 methylation in epigenetic control of heterochromatin assembly. Science, 
292(5514), 110-113. 
 
Narlikar, G.J., Phelan, M.L., & Kingston, R.E. (2001). Generation and interconversion of 
multiple distinct nucleosomal states as a mechanism for catalyzing chromatin fluidity. 
Mol. Cell, 8(6), 1219-1230. 
 
Nelson, T., Wiegand, R., & Brutlag, D. (1981). Ribonucleic acid and other polyanions 
facilitate chromatin assembly in vitro. Biochemistry, 20(9), 2594-2601. 
 
Neumann, H., Peak-Chew, S.Y., & Chin, J.W. (2008). Genetically encoding N(epsilon)-
acetyllysine in recombinant proteins. Nat. Chem. Biol., 4(4), 232-234. 
	   51 
Olins, A.L., & Olins, D.E. (1974). Spheroid Chromatin Units (ν Bodies). Science, 
183(4122), 330-332. 
 
Olins, D.E., & Olins, A.L. (2003). Chromatin history: our view from the bridge. Nat. Rev. 
Mol. Cell. Biol., 4(10), 809-814. 
 
Olson, M.O., Dunder, M., & Szebeni, A. (2000). The nucleolus: an old factory with 
unexpected capabilities. Trends Cell Biol., 10(5), 189-196. 
 
Oudet, P., Gross-Bellard, M., & Chambon, P. (1975). Electron Microscopic and 
Biochemical Evidence that Chromatin Structure Is a Repeating Unit. Cell, 4(4), 281-300. 
 
Owen, D.J., Ornaghi, P., Yang, J.C., Lowe, N., Evans, P.R., Ballario, P., Neuhaus, D., 
Filetici, P., & Travers, A.A. (2000). The structural basis for the recognition of acetylated 
histone H4 by the bromodomain of histone acetyltransferase Gcn5p. EMBO J., 19(22), 
6141-6149. 
 
Pan, G., Tian, S., Nie, J., Yang, C., Ruotti, V., Wei, H., Jonsdottir, G.A., Stewart, R., & 
Thomson, J.A. (2007). Whole-genome analysis of histone H3 lysine 4 and lysine 27 
methylation in human embryonic stem cells. Cell Stem Cell, 1(3), 299-312. 
 
Panchenko, T., Sorensen, T.C., Woodcock, C.L., Kan, Z.Y., Wood, S., Resch, M.G., 
Luger, K., Englander, S.W., Hansen, J.C., & Black, B.E. (2011). Replacement of histone 
H3 with CENP-A directs global nucleosome array condensation and loosening of 
nucleosome superhelical termini. Proc. Natl. Acad. Sci. USA, 108(40), 16588-16593. 
 
Papamichos-Chronakis, M., Watanabe, S., Rando, O.J., & Peterson, C.L. (2011). 
Global regulation of H2A.Z localization by the INO80 chromatin-remodeling enzyme is 
essential for genome integrity. Cell, 144(2), 200-213. 
 
Parada, L.A., Sotiriou, S., & Misteli, T. (2004). Spatial genome organization. Exp. Cell 
Res., 296(1), 64-70.  
 
Park, Y.J., Chodaparambil, J.V., Bao, Y., McBryant, S. J., & Luger, K. (2005). 
Nucleosome assembly protein 1 exchanges histone H2A-H2B dimers and assists 
nucleosome sliding. J. Biol. Chem., 280(3), 1817-1825. 
 
Patel, A., McKnight, J.N., Genzor, P., & Bowman, G.D. (2011). Identification of residues 
in chromodomain helicase DNA-binding protein 1 (Chd1) required for coupling ATP 
hydrolysis to nucleosome sliding. J. Biol. Chem., 286(51), 43984-43993. 
 
Peterson, C.L., & Laniel, M.A. (2004). Histones and histone modifications. Curr. Biol., 
14(14), R546-R551. 
 
	   52 
Peterson, C.L., Dingwall, A., & Scott, M.P. (1994). Five SWI/SNF gene products are 
components of a large multisubunit complex required for transcriptional enhancement. 
Proc. Natl. Acad. Sci. USA, 91(8), 2905-2908.  
 
Petty, E., & Pillus, L. (2013). Balancing chromatin remodeling and histone modifications 
in transcription. Trends Genet., 29(11), 621-629. 
 
Phelan, M.L., Sif, S., Narlikar, G.J., & Kingston, R.E. (1999). Reconstitution of a core 
chromatin remodeling complex from SWI/SNF subunits. Mol. Cell, 3(2), 247-253. 
 
Platero, J.S., Hartnett, T., & Eissenberg, J.C. (1995). Functional analysis of the chromo 
domain of HP1. EMBO J., 14(16), 3977-3986. 
 
Politz, J.C., Scalzo, D., & Groudine, M. (2013). Something silent this way forms: the 
functional organization of the repressive nuclear compartment. Annu. Rev. Cell Dev. 
Biol., 29, 241-270.   
 
Polo, S.E., & Almouzni, G. (2006). Chromatin assembly: a basic recipe with various 
flavours. Curr. Opin. Genet. Dev., 16(2), 104-111. 
 
Pray-Grant, M.G., Daniel, J.A., Schieltz, D., Yates, J.R., III., & Grant, P.A. (2005). Chd1 
chromodomain links histone H3 methylation with SAGA- and SLIK-dependent 
acetylation. Nature, 433(7024), 434-438. 
 
Rabl, C. (1885). Über Zelltheilung. Morph. Jb., 10, 214-330. 
 
Racki, L.R., Yang, J.G., Naber, N., Partensky, P.D., Acevedo, A., Purcell, T.J., Cooke, 
R., Cheng, Y., & Narlikar, G.J. (2009). The chromatin remodeller ACF acts as a dimeric 
motor to space nucleosomes. Nature, 462(7276), 1016-1021. 
 
Radman-Livaja, M., Quan, T.K., Valenzuela, L., Armstrong, J.A., van Welsem, T., Kim, 
T., Lee, L.J., Buratowski, S., van Leeuwen, F., Rando, O.J., & Hartozog, G.A. (2012). A 
key role for Chd1 in histone H3 dynamics at the 3’ ends of long genes in yeast. PLoS 
Genet., 8(7), 1-10. 
 
Richmond, T.J., Finch, J.T., Rushton, B., Rhodes, D., & Klug, A. (1984). Structure of the 
nucleosome core particle at 7 Å resolution. Nature, 311(5986), 532-537. 
 
Robinson, K.M., & Schultz, M.C. (2003). Replication-independent assembly of 
nucleosome arrays in a novel yeast chromatin reconstitution system involves 
antisilencing factor Asf1p and chromodomain protein Chd1p. Mol. Cell. Biol., 23(22), 
7937-7946. 
 
Ruberti, I., & Worcel, A. (1986). Mechanism of chromatin assembly in Xenopus oocytes. 
J. Mol. Biol., 189(3), 457-476. 
 
	   53 
Ryan, D.P., & Owen-Hughes, T. (2011). Snf2-family proteins: chromatin remodellers for 
any occasion. Curr. Opin. Chem. Biol., 15(5), 649-656. 
 
Saha, A., Wittmeyer, J., & Cairns, B.R. (2002). Chromatin remodeling by RSC involves 
ATP-dependent DNA translocation. Genes Dev., 16(16), 2120-2134. 
 
Sala, A., Toto, M., Pinello, L., Gabriele, A., Di Benedetto, V., Ingrassia, A.M., Lo Bosco, 
G., Di Gesù, V., Giancarlo, R., & Corona, D.F. (2011). Genome-wide characterization of 
chromatin binding and nucleosome spacing activity of the nucleosome remodeling 
ATPase ISWI. EMBO J., 30(9), 1766-1777. 
 
Santos-Rosa, H., Schneider, R., Bannister, A.J., Sherriff, J., Bernstein, B.E., Emre, 
N.C., Schreiber, S.L., Mellor, J., & Kouzarides, T. (2002). Active genes are tri-
methylated at K4 of histone H3. Nature, 419(6905), 407-411. 
 
Schalch, T., Duda, S., Sargent, D.F., & Richmond, T.J. (2005). X-ray structure of a 
tetranucleosome and its implications for the chromatin fibre. Nature, 436(7047), 138-
141. 
 
Schneider, R., Bannister, A.J., Myers, F.A., Thorne, A.W., Crane-Robinson, C., & 
Kouzarides, T. (2004). Histone H3 lysine 4 methylation patterns in higher eukaryotic 
genes. Nat. Cell Biol., 6(1), 73-77. 
 
Schübeler, D., MacAlpine, D.M., Scalzo, D., Wirbelauer, C., Kooperberg, C., van 
Leeuwen, F., Gottschling, D.E., O’Neill, L.P., Turner, B.M., Delrow, J., Bell, S.P., & 
Groudine, M. (2004). The histone modification pattern of active genes revealed through 
genome-wide chromatin analysis of a higher eukaryote. Genes Dev., 18(11), 1263-
1271. 
 
Schwanbeck, R., Xiao, H., & Wu, C. (2004). Spatial contacts and nucleosome step 
movements induced by the NURF chromatin remodeling complex. J. Biol. Chem., 
279(38), 39933-39941. 
 
Sen, P., Ghosh, S., Pugh, B.F., & Bartholomew, B. (2011). A new, highly conserved 
domain in Swi2/Snf2 is required for SWI/SNF remodeling. Nucleic Acids Res., 39(21), 
9155-9166. 
 
Sengoku, T., Nureki, O., Nakamura, A., Kobayashi, S., & Yokoyama, S. (2006). 
Structural basis for RNA unwinding by the DEAD-box protein Drosophila Vasa. Cell, 
125(2), 287-300. 
 
Sexton, T., Schober, H., Fraser, P., & Gasser, S.M. (2007). Gene regulation through 
nuclear organization. Nat. Struct. Mol. Biol., 14(11), 1049-1055. 
 
Shain, A.H., & Pollack, J.R. (2013). The spectrum of SWI/SNF mutations, ubiquitous in 
human cancers. PLoS One, 8(1), 1-11. doi: 10.1371/journal.pone.0055119 
	   54 
Shen, X., Mizuguchi, G., Hamiche, A., & Wu, C. (2000). A chromatin remodelling 
complex involved in transcription and DNA processing. Nature, 406(6795), 541-544. 
 
Shogren-Knaak, M., Ishii, H., Sun, J.M., Pazin, M.J., Davie, J.R., & Peterson, C.L. 
(2006). Histone H4-K16 acetylation controls chromatin structure and protein 
interactions. Science, 311(5762), 844-847. 
 
Simon, M.D., Chu, F., Racki, L.R., de la Cruz, C.C., Burlingame, A.L., Panning, B., 
Narlikar, G.J., & Shokat, K.M. (2007). The site-specific installation of methyl-lysine 
analogs into recombinant histones. Cell, 128(5), 1003-1012. 
 
Simonis, M., Klous, P., Splinter, E., Moshkin, Y., Willemsen, R., de Wit, E., van 
Steensel, B., & de Laat, W. (2006). Nuclear organization of active and inactive 
chromatin domains uncovered by chromosome conformation capture-on-chip (4C). Nat. 
Genet., 38(11), 1348-1354. 
 
Sims, R.J., III., Chen, C.F., Santos-Rosa, H., Kouzarides, T., Patel, S.S., & Reinberg, D. 
(2005). Human but not yeast CHD1 binds directly and selectively to histone H3 
methylated at lysine 4 via its tandem chromodomains. J. Biol. Chem., 280(51), 41789-
41792. 
 
Skowronek, F., Casanova, G., Alciaturi, J., Capurro, A., Cantu, L., Montes, J.M., & 
Sapiro, R. (2012). DNA sperm damage correlates with nuclear ultrastructural sperm 
defects in teratozoospermic men. Andrologia, 44(1), 59-65. 
 
Smeenk, G., & van Attikum, H. (2013). The chromatin response to DNA breaks: leaving 
a mark on genome integrity. Annu. Rev. Biochem., 82, 55-80. 
 
Smith, M.F., Athey, B.D., Williams, S.P., & Langmore, J.P. (1990). Radial Density 
Distribution of Chromatin: Evidence that Chromatin Fibers have Solid Centers. J. Cell 
Biol., 110(2), 245-254. 
 
Smith, S., & Stillman, B. (1991). Stepwise assembly of chromatin during DNA replication 
in vitro. EMBO J., 10(4), 971-980. 
 
Song, F., Chen, P., Sun, D., Wang, M., Dong, L., Liang, D., Xu, R.M., Zhu, P., & Li, G. 
(2014). Cryo-EM study of the chromatin fiber reveals a double helix twisted by 
tetranucleosomal units. Science, 344(6182), 376-380. 
 
Stankiewicz, P., & Lupski, J.R. (2010). Structural variation in the human genome and its 
role in disease. Annu. Rev. Med., 61, 437-455. 
 
Stein, A., Whitlock, J.P., Jr., & Bina, M. (1979). Acidic polypeptides can assemble both 
histones and chromatin in vitro at physiological ionic strength. Proc. Natl. Acad. Sci. 
USA, 76(10), 5000-5004. 
 
	   55 
Strahl, B.D., & Allis, C.D. (2000). The language of covalent histone modifications. 
Nature, 403(6765), 41-45. 
 
Stratton, M.R., Campbell, P.J., & Futreal, P.A. (2009). The cancer genome. Nature, 
458(7239), 719-724. 
 
Sudarsanam, P., & Winston, F. (2000). The Swi/Snf family nucleosome-remodeling 
complexes and transcriptional control. Trends Genet., 16(8), 345-351. 
 
Suto, R.K., Clarkson, M.J., Tremethick, D.J., & Luger, K. (2000). Crystal structure of a 
nucleosome core particle containing the variant histone H2A.Z. Nat. Struct. Biol., 7(12), 
1121-1124. 
 
Szerlong, H., Hinata, K., Viswanathan, R., Erdjument-Bromage, H., Tempst, P. & 
Cairns, B.R. (2008). The HSA domain binds nuclear actin-related proteins to regulate 
chromatin-remodeling ATPases. Nat. Struct. Mol. Biol., 15(5), 469-476. 
 
Tachiwana, H., Osakabe, A., Shiga, T., Miya, Y., Kimura, H., Kagawa, W., & 
Kurumizaka, H. (2011). Structures of human nucleosomes containing major histone H3 
variants. Acta Crystallogr. D Biol. Crystallogr., 67(Pt 6), 578-583. 
 
Talbert, P.B., & Henikoff, S. (2010). Histone variants—ancient wrap artists of the 
epigenome. Nat. Rev. Mol. Cell Biol., 11(4), 264-275. 
 
Thoma, F., Koller, T., & Klug, A. (1979). Involvement of histone H1 in the organization of 
the nucleosome and the salt-dependent superstructure of chromatin. J. Cell Biol., 83(2 
Pt 1), 403-427. 
 
Thomä, N.H., Czyzewski, B.K., Alexeev, A.A., Mazin, A.V., Kowalczykowski, S.C., & 
Pavletich, N.P. (2005). Structure of the SWI2/SNF2 chromatin-remodeling domain of 
eukaryotic Rad54. Nat. Struct. Mol. Biol., 12(4), 350-356. 
 
Tolhuis, B., Palstra, R.J., Splinter, E., Grosveld, F., & de Laat, W. (2002). Looping and 
interaction between hypersensitive sites in the active beta-globin locus. Mol. Cell, 10(6), 
1453-1465. 
 
Torigoe, S.E., Patel, A., Khuong, M.T., Bowman, G.D., & Kadonaga, J.T. (2013). ATP-
dependent chromatin assembly is functionally distinct from chromatin remodeling. Elife, 
2, e00863. doi: 10.7554/eLife.00863 
 
Torigoe, S.E., Urwin, D.L., Ishii, H., Smith, D.E., & Kadonaga, J.T. (2011). Identification 
of a rapidly formed nonnucleosomal histone-DNA intermediate that is converted into 
chromatin by ACF. Mol. Cell, 43(4), 638-648. 
 
	   56 
Tran, H.G., Steger, D.J., Iyer, V.R., & Johnson, A.D. (2000). The chromo domain protein 
chd1p from budding yeast is an ATP-dependent chromatin-modifying factor. EMBO J., 
19(10), 2323-2331. 
 
Travers, A. (2014). Structural biology. The 30-nm fiber redux. Science, 344(6182), 370-
372. 
 
Travers, A.A. (1987). DNA bending and nucleosome positioning. Trends Biochem. Sci., 
12, 108-112. 
 
Tremethick, D.J. (2007). Higher-order structures of chromatin: the elusive 30 nm fiber. 
Cell, 128(4), 651-654. 
 
Trojer, P., & Reinberg, D. (2007). Facultative heterochromatin: is there a distinctive 
molecular signature? Mol. Cell, 28(1), 1-13. 
 
Trotter, K.W., Fan, H.Y., Ivey, M.L., Kingston, R.E., & Archer, T.K. (2008). The HSA 
domain of BRG1 mediates critical interactions required for glucocorticoid receptor-
dependent transcriptional activation in vivo. Mol. Cell. Biol., 28(4), 1413-1426. 
 
Tsukiyama, T., & Wu, C. (1995a). Purification and properties of an ATP-dependent 
nucleosome remodeling factor. Cell, 83(6), 1011-1020. 
 
Tsukiyama, T., Daniel, C., Tamkun, J., & Wu, C. (1995b). ISWI, a member of the 
SWI2/SNF2 ATPase family, encodes the 140 kDa subunit of the nucleosome 
remodeling factor. Cell, 83(6), 1021-1026. 
 
Tsunaka, Y., Kajimura, N., Tate, S., & Morikawa, K. (2005). Alteration of the 
nucleosomal DNA path in the crystal structure of a human nucleosome core particle. 
Nucleic Acids Res., 33(10), 3424-3434. 
 
Turner, B.M. (2000). Histone acetylation and an epigenetic code. Bioessays, 22(9), 836-
845. 
 
Tyler, J.K. (2002). Chromatin assembly: Cooperation between histone chaperones and 
ATP-dependent nucleosome remodeling machines. Eur. J. Biochem., 269(9), 2268-
2274. 
 
Valouev, A., Ichikawa, J., Tonthat, T., Stuart, J., Ranade, S., Peckham, H., Zeng, K., 
Malek, J.A., Costa, G., McKernan, K., Sidow, A., Fire, A., & Johnson, S.M. (2008). A 
high-resolution, nucleosome position map of C. elegans reveals a lack of universal 
sequence-dictated positioning. Genome Res., 18(7), 1051-1063. 
 
Valouev, A., Johnson, S.M., Boyd, S.D., Smith, C.L., Fire, A.Z., & Sidow, A. (2011). 
Determinants of nucleosome organization in primary human cells. Nature, 474(7352), 
516-520. 
	   57 
van Attikum, H., Fritsch, O., Hohn, B., & Gasser, S.M. (2004). Recruitment of the INO80 
complex by H2A phosphorylation links ATP-dependent chromatin remodeling with DNA 
double-strand break repair. Cell, 119(6), 777-788. 
 
Varga-Weisz, P.D., Wilm, M., Bonte, E., Dumas, K., Mann, M., & Becker, P.B. (1997). 
Chromatin-remodelling factor CHRAC contains the ATPases ISWI and topoisomerase 
II. Nature, 388(6642), 598-602. 
 
Venter, J.C., Adams, M.D., Myers, E.W., Li, P.W., Mural, R.J., Sutton, G.G., … Zhu, X. 
(2001). The sequence of the human genome. Science, 291(5507), 1304-1351. 
 
Verreault, A. (2000). De novo nucleosome assembly: new pieces in an old puzzle. 
Genes Dev., 14(12), 1430-1438. 
 
Vincent, J.A., Kwong, T.J., & Tsukiyama, T. (2008). ATP-dependent chromatin 
remodeling shapes the DNA replication landscape. Nat. Struct. Mol. Biol., 15(5), 477-
484. 
 
Wade, P.A., & Kikyo, N. (2002). Chromatin remodeling in nuclear cloning. Eur. J. 
Biochem., 269(9), 2284-2287. 
 
Wade, P.A., & Wolffe, A.P. (1997). Histone acetyltransferases in control. Curr. Biol., 
7(2), R82-R84. 
 
Wang, G.G., Allis, C.D., & Chi, P. (2007). Chromatin remodeling and cancer, Part II: 
ATP-dependent chromatin remodeling. Trends Mol. Med., 13(9), 373-380. 
 
Wasylyk, B., & Chambon, P. (1979). Transcription by eukaryotic RNA polymerases A 
and B of chromatin assembled in vitro. Eur. J. Biochem., 98(2), 317-327. 
 
White, C.L., Suto, R.K., & Luger, K. (2001). Structure of the yeast nucleosome core 
particle reveals fundamental changes in internucleosome interactions. EMBO J., 20(18), 
5207-5218. 
 
Whitehouse, I., Flaus, A., Cairns, B.R., White, M.F., Workman, J.L., & Owen-Hughes, T. 
(1999). Nucleosome mobilization catalyzed by the yeast SWI/SNF complex. Nature, 
400(6746), 784-787. 
 
Wilhelm, F.X., Wilhelm, M.L., Erard, M., & Duane, M.P. (1978). Reconstitution of 
chromatin: assembly of the nucleosome. Nucleic Acids Res., 5(2), 505-521. 
 
Williams, S.P., Athey, B.D., Muglia, L.J., Schappe, R.S., Gough, A.H., & Langmore, J.P. 
(1986). Chromatin Fibers are Left-Handed Double Helices with Diameter and Mass Per 
Unit Length that Depend on Linker Length. Biophys. J., 49(1), 233-248. 
 
	   58 
Winston, F., & Allis, C.D. (1999). The bromodomain: a chromatin-targeting module? 
Nat. Struct. Biol., 6(7), 601-604. 
 
Woodage, T., Basrai, M.A., Baxevanis, A.D., Hieter, P., & Collins, F.S. (1997). 
Characterization of the CHD family of proteins. Proc. Natl. Acad. Sci. USA, 94(21), 
11472-11477. 
 
Woodcock, C.L. (1980). Nucleus-associated intermediate filaments from chicken 
erythrocytes. J. Cell Biol., 85(3), 881-889. 
 
Woodcock, C.L. (2006). Chromatin architecture. Curr. Opin. Struct. Biol., 16(2), 213-
220. 
 
Woodcock, C.L., & Dimitrov, S. (2001). Higher-order structure of chromatin and 
chromosomes. Curr. Opin. Genet. Dev., 11(2), 130-135. 
 
Woodcock, C.L., Frado, L.L., & Rattner, J.B. (1984). The Higher-order Structure of 
Chromatin: Evidence for a Helical Ribbon Arrangement. J. Cell Biol., 99(1 Pt 1), 42-52. 
 
Worcel, A., Strogatz, S., & Riley, D. (1981). Structure of chromatin and the linking 
number of DNA. Proc. Natl. Acad. Sci. USA, 78(3), 1461-1465. 
 
Workman, J.L., & Kingston, R.E. (1998). Alteration of nucleosome structure as a 
mechanism of transcriptional regulation. Annu. Rev. Biochem., 67, 545-579. 
 
Wu, W.H., Wu, C.H., Ladurner, A., Mizuguchi, G., Wei, D., Xiao, H., Luk, E., Ranjan, A., 
& Wu, C. (2009). N terminus of Swr1 binds to histone H2AZ and provides a platform for 
subunit assembly in the chromatin remodeling complex. J. Biol. Chem., 284(10), 6200-
6207. 
 
Yasui, D., Miyano, M., Cai, S., Varga-Weisz, P., & Kohwi-Shigematsu, T. (2002). 
SATB1 targets chromatin remodeling to regulate genes over long distances. Nature, 
419(6907), 641-645. 
 
Zang, Z.J., Cutcutache, I., Poon, S.L., Zhang, S.L., McPherson, J.R., Tao, J., … Tan, P. 
(2012). Exome sequencing of gastric adenocarcinoma identifies recurrent somatic 
mutations in cell adhesion and chromatin remodeling genes. Nat. Genet., 44(5), 570-
574. 
 
Zhang, Y., & Reinberg, D. (2001). Transcription regulation by histone methylation: 
interplay between different covalent modification of the core histone tails. Genes Dev., 
15(18), 2343-2360. 
 
Zhang, Z., Wippo, C.J., Wal, M., Ward, E., Korber, P., & Pugh, B.F. (2011). A Packing 
Mechanism for Nucleosome Organization Reconstituted Across a Eukaryotic Genome. 
Science, 332(6032), 977-980. 
	   59 
Zhou, J., Fan, J.Y., Rangasamy, D., & Tremethick, D.J. (2007). The nucleosome 
surface regulates chromatin compaction and couples it with transcriptional repression. 
Nat. Struct. Mol. Biol., 14(11), 1070-1076. 
 
Zofall, M., Persinger, J., Kassabov, S.R., & Bartholomew, B. (2006). Chromatin 
remodeling by ISW2 and SWI/SNF requires DNA translocation inside the nucleosome. 
Nat. Struct. Mol. Biol., 13(4), 339-346.  
 
Zorn, C., Cremer, C., Cremer, T., & Zimmer, J. (1979). Unscheduled DNA Synthesis 















Human CHD2 Is a Chromatin Assembly ATPase Regulated by 
Its Chromo- and DNA-Binding Domains 
 
 
This work was originally published in Journal of Biological Chemistry. Liu JC, Ferreira 
CG, and Yusufzai T. Human CHD2 is a Chromatin Assembly ATPase Regulated by Its 
Chromo- and DNA-Binding Domains. Journal of Biological Chemistry. 2014; 290. © the 









Part of this work was completed with the help of Catarina G. Ferreira (Yusufzai 
Laboratory). C.G.F. performed some of the electrophoretic mobility shift assays for the 
CHD2 truncation proteins. 
 61 
2.1. ABSTRACT 
Chromodomain Helicase DNA-binding protein 2 (CHD2) is an ATPase and a 
member of the SNF2-like family of helicase-related enzymes. Although deletions of 
CHD2 have been linked to developmental defects in mice and epileptic disorders in 
humans, little is known about its biochemical and cellular activities. In this study, we 
investigate the ATP-dependent activity of human CHD2 (hCHD2) and show that hCHD2 
catalyzes the assembly of chromatin into periodic arrays. We also show that the N-
terminal region of hCHD2, which contains tandem chromodomains, serves an auto-
inhibitory role in both the DNA-binding and ATPase activities of hCHD2. While loss of 
the N-terminal region enhances chromatin-stimulated ATPase activity, the N-terminal 
region is required for ATP-dependent chromatin remodeling by hCHD2. In contrast, the 
C-terminal region, which contains a putative DNA-binding domain, senses double-
stranded DNA of at least 40 base pairs in length and enhances the ATPase and 
chromatin remodeling activities of hCHD2. Our study shows that the accessory domains 
of hCHD2 play central roles in both regulating the ATPase domain and conferring 
selectivity for chromatin substrates.   
 
2.2. INTRODUCTION 
Chromodomain Helicase DNA-binding protein 2 (CHD2) is a member of the 
SNF2-like family of helicase-related enzymes, which includes all known ATP-dependent 
chromatin remodeling factors (Gorbalenya and Koonin, 1993; Eisen et al., 1995; Flaus 
et al., 2006). In general, chromatin remodeling enzymes catalyze non-covalent changes 
in histone-DNA contacts leading to alterations in the structure of nucleosomes. Distinct 
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groups of chromatin remodeling enzymes have been shown to act on chromatin in 
different ways (reviewed in Clapier and Cairns, 2009). For example, ISWI-containing 
and CHD1 remodelers can catalyze the assembly of periodic nucleosome arrays (Ito et 
al., 1997; Robinson and Schultz, 2003; Lusser et al., 2005), whereas SWI/SNF 
remodeling factors have been linked to the disruption and disassembly of nucleosomes 
(Whitehouse et al., 1999; Lorch et al., 1999, 2006; Narlikar et al., 2001; Kassabov et al., 
2003; Bruno et al., 2003; Dechassa et al., 2010). Finally, the INO80 family of chromatin 
remodelers has been shown to exchange histones into, or out of, nucleosomes (Shen et 
al., 2000; Mizuguchi et al., 2004).     
The mechanisms through which chromatin remodelers couple ATP hydrolysis to 
a particular remodeling activity are not well understood. While all remodeling enzymes 
contain a conserved ATPase domain, they also possess accessory domains that likely 
regulate the activity of the ATPase domain and confer distinct remodeling activities 
(reviewed in Clapier and Cairns, 2009). CHD2 is part of the CHD family of chromatin 
remodelers that possess tandem chromodomains (CDs) on the N-terminal side of the 
core ATPase domain (Woodage et al., 1997). While only one CHD protein is expressed 
in yeast (Chd1p), flies express four (Chd1, 3, 4, and 7), and vertebrates express nine 
(CHD1 through 9). Members of the CHD family have been further categorized into 
subgroups, based on the presence of additional accessory domains. For example, 
CHD2 is grouped with CHD1 because both contain a putative SANT-SLIDE-like DNA-
binding domain (DBD) near their C termini that is not as well conserved in the other 
seven CHD proteins (Woodage et al., 1997).   
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While little is known about the biochemical and cellular activities of CHD2, 
several studies have shown that CHD2 is required for proper development. 
Homozygous mice containing a C-terminal truncation of the CHD2 protein are not 
viable, while the heterozygous mice exhibit decreased survival rates (Marfella et al., 
2006). In humans, a variety of developmental defects were observed in a heterozygous 
patient with one CHD2 allele disrupted by a translocation (Kulkarni et al., 2008). More 
recently, a number of chromosome deletions and somatic nonsense, frameshift, splice-
site, and missense mutations that prematurely truncate or mutate CHD2 have been 
linked to epileptic encephalopathies in humans (Carvill et al., 2013; Suls et al., 2013; 
Lund et al., 2014; Courage et al., 2014; Chénier et al., 2014). Similarly, heterozygous 
knockdown of CHD2 in zebrafish leads to increased epileptic seizures and stunted 
growth and development when compared to controls (Suls et al., 2013). A study of 
CHD2 in myoblasts reported that loss of the chromodomains from CHD2 leads to 
decreased expression of muscle-specific genes and lower rates of differentiation of the 
myoblasts into muscle cells (Harada et al., 2012), suggesting CHD2 may be required for 
the expression of tissue-specific genes. Together, these findings point toward CHD2 
playing an integral role in specific developmental pathways. However, our 
understanding of how CHD2 functions in development is limited by the lack of insight 
into its biochemical activity. 
 In the present study, we purified hCHD2 and characterized its remodeling 
activity. We also dissected the roles of its accessory domains to determine how the 
ATPase and chromatin remodeling activities of hCHD2 are regulated. Our study, which 
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is the first to investigate the biochemical activity of full-length hCHD2, helps shed light 
on the potential role of this protein in cells.  
 
2.3. EXPERIMENTAL PROCEDURES 
Purification of Recombinant Human CHD2  
 In this study, we cloned and purified wild-type hCHD2 (WT) and a mutant version 
of hCHD2 (Mut), which contains a two-amino acid alanine substitution of the catalytic 
residues D617 and E618 in the Walker B motif that were introduced by site-directed 
mutagenesis. We also cloned and purified three hCHD2 proteins with systematic 
truncations: central core ATPase consisting of amino acid residues 450-1129 (Core); 
DNA-binding truncation consisting of amino acid residues 1-1129 (Core+CD); and 
chromodomain truncation consisting of amino acid residues 450-1828 (Core+DBD). The 
hCHD2 proteins were cloned and expressed as N-terminal FLAG-fusion proteins in Sf9 
cells using the Bac-to-Bac baculovirus expression system (Life Technologies). Of note, 
the Core+DBD protein also contained a 6XHis-tag at the C terminus that helped 
stabilize the protein against proteolysis. All plasmid constructs were verified by 
sequencing. The hCHD2 proteins were purified from infected Sf9 cells by immunoaffinity 
purification, as previously described for other ATPases (Yusufzai and Kadonaga, 2008). 
Briefly, infected Sf9 cells were suspended in cold Lysis Buffer [20 mM Tris-Cl, pH 7.6, 
500 mM NaCl, 1.5 mM MgCl2, 0.2 mM EDTA, 20% glycerol, 0.01% NP-40, 1 mM DTT 
supplemented with the following protease inhibitors: 0.5 mM benzamidine, 1 µg/ml of 
leupeptin, aprotinin, pepstatin A, bestatin, 5 µg/ml caspase-1 inhibitor I (EMD 
Biochemicals), and 10 µg/ml E-64]. The cells were lysed by 30 strokes of a Dounce 
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homogenizer on ice and immediately centrifuged at 48,384 x g for 10 minutes at 4°C. 
The supernatant was centrifuged a second time for an additional 5 minutes at 4°C to 
remove any residual insoluble material. The cleared cell lysate was then incubated with 
anti-FLAG resin (Sigma; pre-washed with Lysis Buffer) for 2-4 hours at 4°C, with 
rotation. The resin was pelleted by centrifugation, transferred to a 1.7 ml microcentrifuge 
tube, and washed two times with Lysis Buffer, and two times with Wash Buffer [Lysis 
Buffer containing only 100 mM NaCl]. The hCHD2 proteins were eluted with 8 
sequential incubations of the resin with an equal volume of Elution Buffer [Wash Buffer 
containing 0.2 mg/ml FLAG peptide; Sigma]. For the purification of the Core+DBD 
protein, all of the wash and elution steps were performed using Lysis Buffer, as the 
Core+DBD protein had a tendency to precipitate in the Wash Buffer containing less salt. 
Bradford assay and SDS-PAGE/Coomassie staining were used to assess the 
concentration and quality of the purified hCHD2 proteins. The purest fractions were 
pooled, flash-frozen with liquid nitrogen, and stored at -80°C for subsequent 
biochemical experiments. 
 
In Vitro Chromatin Assembly 
The in vitro chromatin assembly assay was performed essentially as described 
(Fyodorov and Kadonaga, 2003) with minor modifications. Native Drosophila 
melanogaster core histones (used throughout this study), the catalytic domain of 
topoisomerase I (Topo I), NAP-1 and ACF from Drosophila melanogaster (dNAP-1, 
dACF, respectively) were purified as described (Fyodorov and Kadonaga, 2003). 
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Micrococcal Nuclease (MNase) Analysis A standard 70 µl assembly reaction 
contained purified core histones (1.4 µg), plasmid DNA (1.4 µg; 3.2 kilobases (kb); 
pGIE-0), Topo I, dNAP-1 (13 µg), recombinant hCHD2 (100 nM final concentration), and 
an ATP regeneration system [3 mM ATP, 5 mM MgCl2, 30 mM phosphocreatine, and 5 
ng/µl creatine phosphokinase]. Briefly, the core histones were incubated first with the 
histone chaperone dNAP-1 for 20 minutes on ice. In parallel, the plasmid DNA/Topo I 
reaction was set up for 10 minutes at 30 °C and kept at room temperature until use. 
After 20 minutes, the ATP regeneration system, relaxed plasmid DNA (with Topo I still 
present), and hCHD2 were added to the histone/chaperone mixture. For minus ATP 
reactions, only ATP was left out; all other components of the regeneration system were 
included. The reaction was allowed to proceed for 1 hour at room temperature and then 
partially digested by adding 2 mM CaCl2 and MNase (Worthington; low concentration = 
7 mU µl-1, high concentration = 28 mU µl-1). After 4 minutes at room temperature, the 
reactions were stopped with the addition of 125 µl of Stop Buffer [1% (w/v) SDS, 200 
mM NaCl, 250 µg/ml glycogen, 20 mM EDTA, pH 8.0] and proteinase K (Worthington) 
at a final concentration of 50 µg/ml. The DNA was then extracted with 
phenol:chloroform, precipitated with ethanol, resolved by agarose gel electrophoresis, 
and visualized by staining with ethidium bromide. The marker is a 123-base-pair (bp) 
repeat ladder (Life Technologies).  
Supercoiling Analysis A standard 70 µl assembly reaction contained core 
histones (0.35 µg), plasmid DNA (0.35 µg; 3.2 kb; pGIE-0), Topo I, dNAP-1 (2 µg), 
recombinant, purified dACF or hCHD2 (20 nM final concentration), and an ATP 
regeneration system [3 mM ATP, 5 mM MgCl2, 30 mM phosphocreatine, and 5 ng/µl 
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creatine phosphokinase]. Briefly, the core histones were incubated first with the histone 
chaperone dNAP-1 for 30 minutes on ice. In parallel, the plasmid DNA/Topo I reaction 
was set up for 10 minutes at 30 °C and kept at room temperature until use. After 30 
minutes, the ATP regeneration system, relaxed plasmid DNA (with Topo I still present), 
and hCHD2 were added to the histone/chaperone mixture. For minus ATP reactions, 
AMP-PNP was used instead of ATP. The reaction was allowed to proceed for 1 hour at 
room temperature and then the reactions were stopped with the addition of 125 µl of 
Stop Buffer and proteinase K at a final concentration of 50 µg/ml. The DNA was then 
extracted with phenol:chloroform, precipitated with ethanol, resolved by agarose gel 
electrophoresis, and visualized by staining with ethidium bromide. Plasmid DNA or DNA 
extracted from the plasmid DNA/Topo I mixture was used to assess where supercoiled 
(sc) and relaxed (rel) DNA run for comparison in agarose gel electrophoresis.  
 
Radiometric ATPase Assay 
 Each ATPase reaction (10 µl) contained 500 nM ATP in Reaction Buffer [10 mM 
HEPES-K+, pH 7.6, 50 mM KCl, 5 mM MgCl2, 0.1 µg/µl BSA] and 5 µCi of [γ-32P]-ATP 
as a tracer.  Where indicated, reactions also contained 50 ng/µl of short, double-
stranded DNAs (dsDNAs) 15, 20, 30, 40, 50, or 60 bp in length, plasmid DNA (3.2 kb), 
or plasmid that had been pre-assembled into chromatin by salt dialysis (final 
concentration 50 ng/µl). Human CHD2 was then added to a final concentration of 100 
nM to start the ATPase reaction. Aliquots (1 µl) of the reaction were removed and added 
to 4 µl of 125 mM EDTA, pH 8.0 at the selected time points (0, 0.5, 1, 5, 15, 30, 60, and 
90 minutes). From each stopped reaction, 0.5 µl was spotted onto a PEI-cellulose plate 
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(Sigma), air-dried, and resolved by thin-layer chromatography (TLC) with 1 M acetic 
acid, 0.25 M lithium chloride. The TLC plate was then air-dried and exposed to a 
storage phosphor screen.   
 Quantification of the [γ-32P]-ATP and the released inorganic phosphate (32Pi) 
was performed using ImageLab software. After background subtraction, the fraction of 
hydrolyzed ATP was calculated for each time point and plotted versus time (min). Curve 
fitting was done with the Prism software (GraphPad) using the Michaelis-Menten model. 
Error bars representing standard deviations from the mean (SD) were calculated from at 
least three experiments. The Student’s t-test was used to calculate P values and 
statistical significance. 
 
Restriction Endonuclease Accessibility (REA) Assay 
 The REA assay was performed essentially as described (Alexiadis and 
Kadonaga, 2002). A standard 20 µl REA reaction contained 1 µg of plasmid DNA (3.2 
kb; pGIE-0) or plasmid pre-assembled into chromatin by salt dialysis, 5 units of HaeIII 
(NEB) in Reaction Buffer [20 mM Tris-acetate, 10 mM magnesium acetate, 50 mM 
potassium acetate, 1 mM DTT, pH 7.9] and either 3 mM AMP-PNP (as a minus ATP 
control) or ATP. Human CHD2 (100 nM) or the chromatin-remodeling and assembly 
factor dACF (100 nM) was included, where indicated.  After 2 hours in a 30°C water 
bath, the reactions were stopped by the addition of 125 µl of Stop Buffer and proteinase 
K at a final concentration of 50 µg/ml. The DNA was then extracted with 
phenol:chloroform, precipitated with ethanol, resolved by agarose gel electrophoresis, 
and visualized by staining with ethidium bromide.      
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 The DNA signal in each lane was quantified using the QuantityOne (Bio-Rad) 
software.  To facilitate the comparison of the amount of DNA digested in each lane, 
which indirectly measures chromatin remodeling, we created a Digestion Index (DI). 
The DI is calculated from the difference between the amount of DNA fragments smaller 
than 1 kb (Y) and the amount of DNA fragments larger than 1 kb (X), divided by the total 
amount of DNA in each lane [DI = (Y-X) / (Y+X)].  Bar graphs of the calculated DI values 
for each condition represent mean and SD [n=3].  The Student’s t-test was used to 
calculate P values and statistical significance.  
 
Electrophoretic Mobility Gel Shift Assay (EMSA) 
 Each 10 µl gel shift reaction included hCHD2 (0, 10, 20, 50, 100, 200, or 400 nM) 
and a dsDNA probe in Binding Buffer [20 mM HEPES-K+, pH 7.6, 50 mM KCl, 5 mM 
magnesium acetate, 0.1 µg/µl BSA, 5% glycerol, 1 mM DTT, 0.2 mM EDTA, and 0.01% 
NP-40]. The dsDNA probes were generated by annealing an oligonucleotide that was 5’ 
fluorescently-labeled with IRDye-700 (IDT) to its complement. The short, dsDNA probes 
used are the same as those used in the radiometric ATPase assays and were 15, 20, 
30, 40, 50, and 60 bp in length at a final concentration of 5 nM. The samples were 
incubated for 1 hour on ice and resolved on a 5% polyacrylamide/0.5X TBE gel at 4°C. 
The gel was then scanned using a fluorescent imager (Li-Cor).          
     Using the QuantityOne software (BioRad), we quantified the intensity of the free 
and bound DNA bands. We then adjusted for background and used these values to 
calculate the fraction of DNA bound for each lane. Curve fitting was done with the Prism 
software (GraphPad) using the Allosteric Sigmoidal model and an estimated Kd 
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calculated. The graphed data represent mean and SD [n=3]. The Student’s t-test was 
used to calculate P values and statistical significance.  
 
2.4. RESULTS 
Human CHD2 Is an ATP-dependent Chromatin Assembly Factor 
Despite the knowledge that human CHD2 (hCHD2) targets chromatin in vivo 
(Harada et al., 2012), little is known about the ATP-dependent activity of hCHD2 and 
whether hCHD2 possesses chromatin remodeling activity. Sequence alignments with 
other remodeling factors (Woodage et al., 1997) have highlighted conserved domains 
within hCHD2 (Figure 2.1A): a central core SNF2-like ATPase domain (Core) flanked by 
tandem chromodomains (CDs) on the N-terminal side and a DNA-binding domain 
(DBD) on the C-terminal side.  
To investigate the ATP-dependent activity of hCHD2, we first cloned and purified 
the full-length wild-type hCHD2 protein (WT hCHD2) and a catalytically-dead mutant 
version of hCHD2 (Mut hCHD2), which carries a two-amino acid substitution (D617A 






We then evaluated whether purified WT hCHD2 is able to hydrolyze ATP. For this 
analysis, we used a radiometric ATPase assay in which we resolved the amount of 
 
 
Figure 2.1. Wild-type human CHD2 (WT hCHD2) is a chromatin-stimulated 
ATPase. (A) Top, WT hCHD2 protein contains a central SNF2-like ATPase domain 
(Core) flanked by tandem chromodomains (CDs) and a putative DNA-binding domain 
(DBD). Bottom, site-directed mutagenesis was used to clone a mutant version of 
hCHD2 (Mut), which contains a two amino-acid alanine substitution of the catalytic 
D617 and E618 residues (red) in the conserved DExH (Walker B) motif. (B) WT and 
Mut hCHD2 were purified from baculovirus-infected cells and analyzed by SDS-
PAGE and Coomassie staining. (C) Representative raw data from radiometric 
ATPase assays. ATPase reactions with WT hCHD2 alone (Basal) or containing DNA 
or chromatin were incubated for 0, 0.5, 1, 5, 15, 30, 60 or 90 minutes, stopped by the 
addition of EDTA, and resolved by thin-layer chromatography (TLC) on plates coated 
with PEI-cellulose. (D) Quantification of the ATPase assays with WT hCHD2 
stimulated by core histones, DNA, or chromatin from 0 to 90 minutes. (E) 
Quantification of the radiometric ATPase assays at 90 minutes with purified WT or 
Mut hCHD2 protein alone (Basal) or in the presence of DNA or chromatin. For (D) 
and (E), the values shown are mean and SD [n=3]. In (E), Student’s t-test used to 
calculate statistical significance; *** = extremely statistically significant (P < 0.0001), 
** = very statistically significant (P < 0.001).  
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unhydrolyzed [γ-32P]-ATP and released inorganic phosphate (32Pi) on PEI-cellulose 
TLC plates (a representative TLC plate is shown in Figure 2.1C). Because hCHD2 
contains tandem chromodomains, which are predicted to interact with histones (Brehm 
et al., 2004), and a putative DNA-binding domain (Marfella et al., 2006), we measured 
the effects of adding core histones, plasmid DNA, or pre-assembled, salt-dialyzed 
chromatin on the ATPase activity of hCHD2. The fraction of ATP hydrolyzed was 
measured over a time course spanning 90 minutes. Using this assay, we found WT 
hCHD2 exhibits nearly undetectable ATPase activity alone (Figure 2.1D, Basal) or in the 
presence of core histones (Figure 2.1D, Histones). In contrast, both plasmid DNA and 
plasmid pre-assembled into chromatin by salt dialysis stimulate the ATPase activity of 
hCHD2, with chromatin providing the most stimulation (Figure 2.1D, DNA and 
Chromatin). To confirm Mut hCHD2 is catalytically inactive, we measured the fraction of 
ATP hydrolyzed in the absence or presence of DNA or chromatin. Under basal 
conditions, both WT and Mut hCHD2 exhibit low levels of ATP hydrolysis (Figure 2.1E). 
In contrast, under conditions where WT hCHD2 is active, Mut hCHD2 remains inactive 
(Figure 2.1E). There was no detectable ATPase activity with the addition of plasmid or 
chromatin to the ATPase reaction in the absence of WT hCHD2 (data not shown).    
The sequence similarity of hCHD2 to other remodeling enzymes and the fact that 
hCHD2 is preferentially stimulated by chromatin (Figure 2.1E) suggest hCHD2 is also 
capable of remodeling chromatin. Chromatin remodeling factors have been shown to 
exhibit distinct remodeling activities (reviewed in Clapier and Cairns, 2009); these 
include nucleosome assembly, disassembly, sliding, unwrapping, and histone 
exchange. So far, only the remodeling factors ISWI-containing ACF and CHD1 from 
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Saccharomyces cerevisiae and Drosophila melanogaster have been shown to catalyze 
the ATP-dependent assembly of periodic nucleosomes (Ito et al., 1997; Robinson and 
Schultz, 2003; Lusser et al., 2005).  Because hCHD2 is approximately 60% identical 
and 80% similar to CHD1 we considered the possibility that hCHD2 can also catalyze 
nucleosome assembly. To test this, we used an established in vitro chromatin assembly 
assay, which relies on purified components to generate regularly spaced nucleosome 
arrays (Fyodorov and Kadonaga, 2003; Ito et al., 1997). We pre-incubated purified core 
histones with the histone chaperone NAP-1 from Drosophila melanogaster (dNAP-1), 
and then added pre-relaxed (with Topo I) plasmid DNA, and an ATP regeneration 
system (Figure 2.2A, Left). Assembly of plasmid DNA into periodic nucleosomal arrays 
was first analyzed by partial micrococcal nuclease (MNase) digestion. In the absence of 
an ATP-dependent assembly factor and ATP, a limited amount of mono- and di-
nucleosomes were observed, as previously reported (Figure 2.2A, Right, None) (Ito et 
al., 1997; Torigoe et al., 2011). In contrast, reactions that contained hCHD2 and ATP 
yield periodic arrays of nucleosomes, as indicated by the extended DNA ladder formed 
following partial MNase digestion (Figure 2.2A, Right, WT hCHD2 and ATP). 
Nucleosome assembly does not occur in reactions that lack ATP or when Mut hCHD2 is 
used, demonstrating chromatin assembly by hCHD2 depends both on the presence of 
ATP and on a functional ATPase domain.  
We next used DNA supercoiling to monitor the assembly of plasmid DNA into 
chromatin (Figure 2.2B, Left). Nucleosome assembly on pre-relaxed DNA introduces 
supercoils. Thus, plasmid DNA that has been assembled into chromatin will retain 
supercoiling after extraction from the stopped reactions (Fyodorov and Kadonaga, 
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2003) while unassembled plasmid DNA will remain in a relaxed state. Using the amount 
of supercoiled DNA as an assessment of chromatin assembly, hCHD2 catalyzes the 
efficient ATP-dependent assembly of plasmid DNA into chromatin at levels comparable 
to that of Drosophila ACF (dACF), a factor previously shown to assemble nucleosomes 
(Figure 2.2B, Right, compare lane 6 with lane 5) (Ito et al., 1997; Lusser et al., 2005).  
Both dACF and hCHD2 require ATP and NAP-1 for efficient chromatin assembly, as 
significantly less supercoiling was detected in reactions containing the non-hydrolyzable 
ATP analog AMP-PNP (Figure 2.2B, Right, lanes 5 and 9), or in reactions lacking the 
histone chaperone dNAP-1 (Figure 2.2B, Right, lanes 7 and 8 and 11 and 12). 
Previous reports showed chromatin assembly occurs in at least two steps (Ito et 
al., 1997; Lusser et al., 2005; Torigoe et al., 2011; Nakagawa et al., 2001). The first step 
involves the deposition of histones onto DNA by NAP-1 and leads to the formation of an 
intermediate species termed pre-nucleosomes (Torigoe et al., 2011).  The second step 
involves rapid conversion of the pre-nucleosomes into canonical nucleosomes by an 
ATP-dependent chromatin assembly motor protein (Torigoe et al., 2011). In the 
absence of an assembly motor protein, a fraction of the histones deposited by NAP-1 
may spontaneously fold into canonical nucleosomes (Torigoe et al., 2011; Nakagawa et 
al., 2001). In our reactions lacking a chromatin assembly motor protein or ATP, we also 
observe the formation of a limited amount of canonical mono- and di-nucleosomes that 
can be converted into extensive nucleosome arrays by hCHD2 and ATP (Figure 2.2A, 
Right) and see a low, but detectable, amount of supercoiling (Figure 2.2B, Right, lanes 




Conversion of the pre-nucleosomes generated by dNAP-1 into an extended array of 
canonical nucleosomes only occurs with the addition of an ATP-utilizing chromatin 
 
 
Figure 2.2. The assembly of periodic nucleosome arrays by hCHD2. (A) Left, 
nucleosome assembly reactions were performed to determine whether CHD2 
assembles periodic nucleosome arrays. Core histones (1.4 µg) were pre-incubated 
with the histone chaperone NAP-1 (dNAP-1; 13 µg). Naked plasmid DNA (1.4 µg), 
Topo I, and WT or Mut hCHD2 (100 nM) was then added in the presence or absence 
of ATP. The reactions were then partially digested with a low (left-hand lane) or a 
high (right-hand lane) concentration of MNase. A 123-bp repeat marker (M) was run 
between each pair of samples. Right, a representative agarose gel showing the 
presence of a DNA ladder formed upon assembly of nucleosomes by hCHD2 and 
ATP. (B) Left, chromatin assembly in vitro assay. Core histones (0.35 µg) were pre-
incubated with the histone chaperone dNAP-1 (2 µg). Naked plasmid DNA (0.35 µg), 
Topo I, and dACF (20 nM) or WT hCHD2 (20 nM) was then added in the presence or 
absence of ATP (AMP-PNP used as negative ATP control). Right, supercoiling 
analysis of chromatin assembly reactions. sc, supercoiled; rel, relaxed. 
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assembly motor protein such as dACF or hCHD2 and ATP to the reactions containing 
dNAP-1, histones, and DNA (Figure 2.2A, Right; Figure 2.2B, Right, lanes 6 and 10). 
Together, these results show that at least three distinct ATP-dependent chromatin 
assembly enzymes exist: ISWI (ACF), CHD1 and CHD2. 
 
The CDs and DBD Regulate the Activity and Substrate Specificity of Human CHD2 
Recent studies of other chromatin remodeling factors have shown that accessory 
domains outside of the core ATPase domain often play important roles in regulating the 
biochemical activity of the factor (Alexiadis et al., 2004; Lake et al., 2010; Hauk et al., 
2010; Clapier and Cairns, 2012; Mueller-Planitz et al., 2013). To understand the role 
that the CDs and DBD play in the regulation of hCHD2 activity, we cloned, expressed, 
and purified a series of hCHD2 truncation proteins missing either the DBD-containing C-
terminal region (Core+CD) or the CD-containing N-terminal region (Core+DBD), or both, 
leaving the conserved ATPase domain (Core) (Figure 2.3A).   
To study how the accessory domains regulate the activity of hCHD2, we first 
measured the ability of the hCHD2 truncation proteins to hydrolyze ATP in the absence 
of DNA or chromatin.  As observed with WT hCHD2, all of the deletion proteins exhibit 
little to no activity in the absence of DNA or chromatin (Figure 2.3B, Basal; Figure 2.3C, 
bars 1, 7, 10, and 13). We then examined the ability of the deletion proteins to hydrolyze 
ATP in the presence of DNA or chromatin. We found the core ATPase domain of 
hCHD2 is stimulated by DNA to levels similar to WT hCHD2, but is poorly stimulated by 
chromatin (Figure 2.3B, DNA and Chromatin; Figure 2.3C, bars 8 and 9). This finding is 
consistent with the prediction that SNF2-like ATPases are DNA-dependent (Eisen et al., 
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1995; Henikoff, 1993), suggesting other regions of hCHD2 are responsible for 
conferring selectivity for chromatin. 
 
 
Figure 2.3. The accessory domains of hCHD2 regulate the core ATPase 
domain. (A) Left, systematic truncation of hCHD2 which removed C-terminal region 
containing putative DNA-binding domain (Core+CD), removed chromodomain-
containing N-terminal region (Core+DBD), or removed both regions (Core). Right, the 
truncation proteins were purified from baculovirus-infected cells and analyzed by 
SDS-PAGE and Coomassie staining. (B) Fraction of ATP hydrolyzed by WT, Mut 
hCHD2, and truncation proteins (100 nM) in the presence of 50 ng/µl of DNA or in 
vitro salt-dialyzed, pre-assembled chromatin. The reactions were stopped at various 
time points (0, 0.5, 1, 5, 15, 30, 60, and 90 minutes) and resolved by thin-layer 
chromatography (TLC). (C) For comparison, the fraction of ATP hydrolyzed at the 15-
minute time point from experiments shown in (B) were graphed. All values are mean 
and SD [n=3]. Student’s t-test was used to calculate statistical significance; *** = 
extremely statistically significant (P < 0.0001), ** = very statistically significant (P < 
0.001), * = statistically significant (P < 0.01), and n.s. = not significant. 
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We next examined the Core+CD protein, which contains the core ATPase 
domain and the tandem CDs but lacks the DBD (Figure 2.3A). The Core+CD protein 
shows modest chromatin-stimulated ATPase activity but almost no DNA-stimulated 
ATPase activity (Figure 2.3B, DNA and Chromatin; Figure 2.3C, bars 11 and 12). Thus, 
the presence of the N-terminal region and CDs confers chromatin selectivity to the 
ATPase domain, which alone is preferentially stimulated by DNA. This finding also 
suggests that the N terminus negatively regulates the ATPase domain, possibly by 
limiting access of the ATPase domain to DNA.    
We then examined the Core+DBD protein, which contains the core ATPase 
domain and the C-terminal DNA-binding domain (Figure 2.3A). Unlike WT hCHD2 and 
the Core+CD, which are preferentially stimulated by chromatin, the Core+DBD is 
stimulated almost equally by both DNA and chromatin, and the levels of stimulation are 
significantly higher than those observed with WT hCHD2 (Figure 2.3B, DNA and 
Chromatin; Figure 2.3C, bars 14 and 15). This finding further implicates the N terminus 
and CDs in both providing the selectivity of hCHD2 for chromatin substrates and in 
repressing the ATPase activity of the core ATPase domain. The inhibition of ATPase 
activity by regions such as the CDs, which are able to sense unique features of 
chromatin such as specific histone modification patterns in the histone tails (Brehm et 
al., 2004), is consistent with models proposed for other remodeling enzymes (Alexiadis 
et al., 2004; Lake et al., 2010; Hauk et al., 2010; Clapier and Cairns, 2012). Our results 
also suggest that the DBD acts to increase the affinity of hCHD2 to both naked DNA 
and DNA present in the context of chromatin, leading to an overall increase in ATPase 
activity when compared to the core ATPase domain.   
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The Chromodomain-Containing N Terminus of Human CHD2 Couples ATP Hydrolysis 
to Chromatin Remodeling  
After examining the differences in substrate-stimulated ATPase activity between 
WT hCHD2 and the hCHD2 truncation proteins, we assessed how removal of the 
accessory domains affects the chromatin remodeling activity of hCHD2. Because it is 
difficult to quantify the assembly of nucleosomal arrays, we used a restriction 
endonuclease accessibility (REA) assay to measure the extent of chromatin remodeling 
by hCHD2. REA assays have been used successfully to investigate the remodeling 
activity of other enzymes including the chromatin assembly factors Drosophila ACF 
(dACF, a heterodimer that contains the ISWI ATPase) and Drosophila CHD1 (dCHD1) 
(Alexiadis and Kadonaga, 2002; Torigoe et al., 2013). This assay relies on the principle 
that when a plasmid is reconstituted into chromatin via salt dialysis, specific restriction 
sites are occluded by the presence of nucleosomes, which are made accessible by 
remodeling (Alexiadis and Kadonaga, 2002; Almer et al., 1986; Varga-Weisz et al., 
1997; Boyer et al., 2000; Fan et al., 2003). For this analysis, we used a 3.2 kb plasmid 
(pGIE-0) that contains 15 HaeIII restriction sites. The plasmid alone is completely 
digested by HaeIII, regardless of the presence of AMP-PNP (minus ATP control) or ATP 
(Figure 2.4A, compare lane 2 with lane 1). Plasmid DNA purified from reactions 
containing plasmid-assembled chromatin is not affected by the presence of AMP-PNP 
or ATP either but is only partial digested due to occlusion of some HaeIII sites (Figure 
2.4A, compare lanes 3 and 4 with lanes 1 and 2). To facilitate the comparison of the 
remodeling activities exhibited by the different proteins, we established a Digestion 
Index (DI) that takes into account the difference between the amount of DNA fragments 
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larger than 1 kb (i.e., less digested) and the amount of DNA smaller than 1 kb (i.e., 
more digested) relative to the total amount of DNA in each lane (see Experimental 
Procedures for formula).  
Using the REA assay, we observed a significant ATP-dependent increase in 
HaeIII accessibility in reactions containing WT hCHD2 (Figure 2.4A, compare lanes 7 
and 8) or our positive control, dACF (Figure 2.4A, compare lanes 5 and 6). The 
catalytically-inactive Mut hCHD2 does not exhibit any detectable remodeling activity, 
consistent with its lack of ATPase and chromatin assembly activities (Figure 2.4A, 
compare lanes 9 and 10). Similarly, the core ATPase domain did not show any 
detectable remodeling activity during the two-hour incubation with chromatin and HaeIII 
(Figure 2.4A, compare lanes 11 and 12). The Core+DBD deletion did not show any 
detectable remodeling activity during this two-hour incubation as well (Figure 2.4A, 
compare lanes 15 and 16), despite having robust chromatin-stimulated ATPase activity 
(Figure 2.3C, bar 15). This result suggests the N terminus helps couple ATP hydrolysis 
to efficient chromatin remodeling and implies that the sustained stimulation of the 
ATPase domain by chromatin does not guarantee chromatin remodeling will occur.       
In contrast to the Core+DBD protein, the Core+CD protein shows low, but 
significant, remodeling activity after the two-hour incubation with chromatin and HaeIII 
(Figure 2.4A, compare lanes 13 and 14). This finding is consistent with the results from 
the ATPase assays, which show the Core+CD protein exhibits chromatin-stimulated 
ATPase activity, albeit at lower levels compared to WT hCHD2 (Figure 2.3C, compare 
bar 12 to bar 3). We extended the incubation time of the REA assay to four hours and 
were still unable to detect any remodeling activity for the core ATPase domain or the 
 81 
Core+DBD protein (data not shown). Our results show the N-terminal region containing 
the CDs with the core ATPase is sufficient for chromatin remodeling (Figure 2.4B, DI of 
Core+CD in the presence of ATP). While the C-terminal region containing the DBD is 
not needed for chromatin remodeling in our assays, its presence enhances the 
remodeling activity (Figure 2.4B, compare the DI of the Core+CD to that of WT hCHD2 
in the presence of ATP). 
 
Double-Stranded DNA Must Be Minimum of 40 bp for Stable Binding by hCHD2 
Thus far, our results have supported the prediction that the C-terminal region of 
hCHD2 contains a DBD. Loss of the DBD (Core+CD) reduces the ability of hCHD2 to be 
stimulated by DNA, whereas addition of the DBD to the core ATPase domain 
 
 
Figure 2.4. The chromodomains of hCHD2 couple ATP hydrolysis to chromatin 
remodeling. (A) A restriction endonuclease accessibility (REA) assay was performed 
to measure the extent of chromatin remodeling by hCHD2. The indicated proteins 
(100 nM) were incubated with the restriction enzyme HaeIII and plasmid chromatin (1 
µg), which has 15 HaeIII restriction sites. AMP-PNP was a minus ATP control. 
Representative agarose gel is shown. (B) Quantification of replicate REA assays. A 
Digestion Index (DI) was calculated as described in the Experimental Procedures. 
Graphed data represent mean and SD [n=3]. Student’s t-test was used to calculate 
statistical significance; *** = extremely statistically significant (P < 0.0001), ** = very 
statistically significant (P < 0.001). 
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(Core+DBD) greatly increases the ability of DNA and chromatin to stimulate the ATPase 
domain (Figures 2.3B-C). To examine the overall DNA-binding properties of hCHD2, we 
performed electrophoretic mobility gel shift assays (EMSAs) using a series of short, 15-
60 bp, dsDNA substrates as probes (Figure 2.5A). We found WT hCHD2 shows weak 
association with 15, 20, or 30 bp probes (Figures 2.5A-B). In contrast, WT hCHD2 
shows stable binding to DNA probes 40 bp or longer in length (Figures 2.5A-B). This 
correlates well with the DNA-stimulated ATPase activity of hCHD2, which is higher for 
dsDNAs greater than 40 bp in length (Figure 2.5C). We did observe low but detectable 
stimulation of the ATPase activity of hCHD2 with dsDNA substrates less than 40 bp, 
and the effect is likely due to direct stimulation of the core ATPase domain.  
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To determine whether the C-terminal region of hCHD2 plays a role in binding 
dsDNA, we performed EMSA with the Core+CD protein and the 40 bp probe. In contrast 
to WT hCHD2 (Figure 2.6A), we were unable to detect significant binding even at high 
concentrations of the Core+CD protein (Figure 2.6B), suggesting the C-terminal region 
of hCHD2 contains a DNA-binding domain. We also examined how loss of the CDs 
affects the binding of hCHD2 to DNA. Results from our ATPase assays show the 
 
 
Figure 2.5. Human CHD2 binds dsDNA substrates that are at least 40 bp in 
length. (A) Electrophoretic mobility gel shift assays (EMSAs) were performed using 
WT hCHD2 and a series of fluorescently-labeled dsDNA probes. Increasing amounts 
of hCHD2 (0, 10, 20, 50, 100, 200, or 400 nM) were incubated with a dsDNA probe 
(final concentration 5 nM) of the indicated length. The samples were then resolved by 
native PAGE and imaged with a fluorescent laser scanner. (B) For comparison, the 
fraction of DNA bound by hCHD2 at 200 nM was quantified. All values are mean and 
SD [n=3]. (C) Quantification of the fraction of ATP hydrolyzed by hCHD2 (100 nM) in 
the presence of the same dsDNA probes (15, 20, 30, 40, 50, 60 bp) used in EMSAs 
after 30 minutes as compared with fraction of ATP hydrolyzed in the presence of 
plasmid DNA (~3 kb). All values are mean and SD [n=3].   
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Core+DBD protein exhibits robust DNA- and chromatin-stimulated ATPase activity 
(Figures 2.3B-C), suggesting the Core+DBD protein is capable of interacting with DNA. 
We then performed EMSA with the Core+DBD and the 40 bp probe (Figure 2.6C) and 
found the Core+DBD binds with significantly higher affinity than that observed for the 
WT hCHD2 (Figure 2.6A). Based on our analyses from a DNA binding curve (Figure 
2.6D), the Core+DBD exhibits approximately 3-fold higher affinity for dsDNA than WT 
hCHD2; the Kd for WT hCHD2 is ~160 nM while the Kd for Core+DBD is ~50 nM. The 
fact that the Core+DBD protein shows enhanced DNA binding (Figure 2.6E) likely 
explains its higher DNA-dependent ATPase activity, as compared to WT hCHD2 (Figure 
2.3C, compare bar 14 with bar 2). This further reinforces the model that the N terminus 
plays an inhibitory role in cis by reducing the affinity of the core ATPase domain and 















 In this study, we identified human CHD2 (hCHD2) as a new ATP-dependent 
chromatin assembly factor. The identification of a new assembly factor suggests 
vertebrate cells have at least three distinct ATP-dependent chromatin assembly factors: 
ISWI, CHD1, and CHD2.  The reason vertebrate cells would need three assembly 
activities is not known, although they all appear to be required for proper development 
 
 
Figure 2.6. The accessory domains of hCHD2 regulate its DNA-binding activities. 
EMSAs were performed using increasing amounts (0, 10, 20, 50, 100, 200, or 400 nM) 
of (A) full-length WT hCHD2, (B) the Core+CD, or (C) the Core+DBD on a 40 bp 
dsDNA probe. (D) DNA binding curve for full-length WT hCHD2, Core+CD, and 
Core+DBD proteins. (E) For comparison, the fraction of DNA bound by WT hCHD2 and 
the two truncation proteins at 100 nM was calculated and graphed. All values are mean 
and SD [n=3]. Student’s t-test was used to calculate statistical significance; *** = 
extremely statistically significant (P < 0.0001). 
 
 86 
(Marfella et al., 2006; Stopka and Skoultchi, 2003; Gaspar-Maia et al., 2009). This 
suggests ISWI, CHD1, and CHD2 play essential, non-overlapping roles in vivo.   
 
The Core ATPase 
In addition to characterizing the remodeling activity of hCHD2, we dissected the 
roles the accessory domains play in regulating both substrate specificity and chromatin 
remodeling activity (summarized in Figure 2.7).  
 
We show the core ATPase domain alone exhibits DNA-stimulated ATPase activity, and 
that the level of stimulation is similar to that observed for WT hCHD2 (Figure 2.3C, 
 
 
Figure 2.7. A schematic summarizing the findings for hCHD2. The CD-containing 
N-terminal region plays an inhibitory role, reducing the overall DNA affinity of hCHD2, 
limiting the DNA-stimulated ATPase activity of the Core, and thereby conferring 
chromatin specificity. This region is also needed to couple ATP hydrolysis to efficient 
chromatin remodeling. In contrast, the DBD-containing C-terminal region is not 
necessary for chromatin remodeling, positively stimulates ATPase activity on DNA 
and chromatin, and enhances both remodeling and binding to dsDNA greater than or 
equal to 40 bp in length. 
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compare bar 8 with bar 2). In contrast, the core ATPase domain is poorly stimulated by 
chromatin (Figure 2.3C, bar 9) and is unable to remodel chromatin (Figure 2.4B), 
suggesting the core ATPase domain requires the accessory domains to be activated by 
chromatin.   
 
The CD-Containing N-terminal Region 
Our findings show the addition of the CD-containing N-terminal region to the 
ATPase domain (Core+CD) abrogates the ability of the core ATPase domain to be 
stimulated by DNA but not chromatin (Figure 2.3C, bars 11 and 12), supporting the idea 
that chromatin relieves the CD-dependent inhibition of the ATPase domain. This finding 
also shows DNA present in the chromatin is not sufficient to stimulate the ATPase 
activity when the CDs are present. It is possible the CDs act to provide specificity for 
chromatin by restricting the ability of naked DNA to stimulate the ATPase activity and by 
increasing the affinity of hCHD2 for the nucleosome, which would otherwise be 
refractory to its core ATPase domain alone.    
Furthermore, the core ATPase domain with the CD-containing N-terminal region 
appears to be sufficient for chromatin-stimulated ATPase (Figure 2.3C, bar 12) and 
chromatin remodeling activities (Figure 2.4B). Though this N-terminal region provides 
selectivity for chromatin, its inhibitory role may limit the overall activity of the protein and 
explain why the ATPase and remodeling activities of the Core+CD protein are lower 
than that of WT hCHD2.     
In addition to providing specificity to chromatin substrates, the CDs are required 
for chromatin remodeling. The fact that the Core+DBD protein does not show detectable 
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remodeling activity (Figure 2.4B) suggests the CDs have a crucial role in coupling ATP 
hydrolysis to efficient remodeling. The question still remains as to how the N terminus 
couples ATP hydrolysis to chromatin remodeling. If the only role of this region is to 
provide selectivity of hCHD2 for chromatin over free DNA, then we would expect the 
Core+DBD protein, which exhibits robust chromatin-stimulated ATPase activity, to also 
possess remodeling activity; however, this is not the case. 
There are several ways the N-terminal region of hCHD2 could act to couple ATP 
hydrolysis with remodeling. The CDs may act to auto-inhibit the ATPase activity until the 
CDs bind histones, after which the auto-inhibition is relieved. Sustained interaction with 
the histones could be required for subsequent remodeling steps. Since remodeling 
factors are thought to disrupt histone-DNA contacts, the interaction with both the 
histones and DNA could be necessary for this disruption to occur efficiently. Another 
possibility is that the remodeling action of hCHD2 may involve cycling through auto-
inhibited and activated states, which are dependent on transient binding of the CDs to 
the histone tails. This cycling would require the continued presence of the CDs, may be 
regulated by ATP hydrolysis, and could ultimately contribute to the translocation force 
needed for remodeling.   
 
The DBD-Containing C-terminal Region 
Our results show that while the N-terminal region containing the tandem CDs 
provides selectivity for chromatin substrates, it also represses the activity of the ATPase 
domain (Figure 2.3C). In contrast, the presence of the C-terminal region containing the 
DBD appears to counteract this inhibitory effect by stimulating the ATPase activity. Our 
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EMSA studies suggest the stimulation likely occurs through an overall increase in the 
affinity of hCHD2 for DNA.    
We also show hCHD2 requires at least 40 bp of dsDNA for high-affinity binding 
(Figures 2.5A-B) and that this correlates with increasing DNA-dependent ATPase 
activity (Figure 2.5C), suggesting the SANT-SLIDE-like DNA-binding domain of hCHD2 
might serve to bind the linker region between nucleosomes. This would be consistent 
with CHD1 and ISWI, which have SANT-SLIDE-like DNA-binding domains that are 
needed to bind extra-nucleosomal DNA (Stockdale et al., 2006; Yang et al., 2006; 
Gangaraju and Bartholomew, 2007; Racki et al., 2009; Ryan et al., 2011). Moreover, the 
40 bp requirement for high-affinity binding is within the estimated range for the linker 
lengths in humans (Widom, 1992; Gaffney et al., 2012). 
Future studies will help shed light on the direct contributions of the CDs and DBD 
to chromatin remodeling and how the assembly activity of hCHD2 complements those 
of the other chromatin assembly factors, ISWI-containing ACF and CHD1. While we do 
not rule out the possibility other motifs of hCHD2 also contribute to the regulation of the 
ATPase domain, it is apparent the CDs and DBD co-evolved to balance the strong auto-
inhibition from the N terminus with the robust DNA-binding activity provided by the C 
terminus. Our studies here have helped elucidate the biochemical properties of hCHD2 
and set the foundation for delineating the mechanisms by which loss of normal hCHD2 
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3.1. ABSTRACT 
Chromodomain Helicase DNA-binding protein 1 (CHD1) is an ATP-dependent 
chromatin remodeling factor with the ability to assemble periodic nucleosomal arrays. 
Although deletions of CHD1 have been linked to prostate cancer and global 
maintenance of chromatin structure in mammalians, most of what is known about the 
biochemical and cellular activities of CHD1 has been determined using yeast, fruit fly, or 
mouse models. Since species-specific differences exist between the various CHD1 
proteins, we investigated the chromatin assembly and remodeling activity of the human 
counterpart using in vitro assembly and remodeling assays. We found that human 
CHD1 is not as robust as its paralogue, CHD2. We also investigated the ATP-
dependent and DNA-binding activities of human CHD1 using radiometric ATPase and 
electrophoretic mobility gel shift assays. We discovered that while CHD1 is a very active 
ATPase in the presence of DNA and chromatin substrates, it does not exhibit any 
specificity for DNA or chromatin nor does it stably bind DNA. Furthermore, we observed 
that the N-terminal region of human CHD1, which contains tandem chromodomains, 
strongly inhibits both the ATPase and DNA-binding activities of CHD1. This study shows 
that human CHD1 is an inefficient remodeling enzyme with distinct in vitro activities from 
human CHD2, suggesting these two serve non-redundant roles in the cell.   
 
3.2. INTRODUCTION 
 Compaction of eukaryotic DNA into chromatin limits accessibility to the 
transcription machinery. The basic structural unit of chromatin, the nucleosome, is a 
highly stable particle consisting of ~147-150 base pairs (bp) of DNA wrapped ~1.65 
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turns in a flat, left-handed superhelix around a core octameric protein complex (Luger et 
al., 1997). This octameric protein complex is typically made up of two copies of the four 
canonical core histones H2A, H2B, H3, and H4. When DNA is wrapped around the 
histone core, this structure is not always amenable for binding by factors that recognize 
specific DNA sequences. Large-scale mapping of nucleosome positions in yeast, flies, 
worms, and humans reveal that genes have a distinct organization of their chromatin 
structure (Albert et al., 2007; Mavrich et al., 2008; Valouev et al., 2008; Valouev et al., 
2011). Despite DNA sequences harboring information for nucleosome binding, 
regulated positioning of nucleosomes requires ATP-dependent protein machineries 
called chromatin remodelers (Zhang et al., 2011).  
 Chromatin remodelers regulate chromatin structure and accessibility by utilizing 
the energy from ATP hydrolysis to disrupt histone-DNA contacts in order to reposition 
(slide), disassemble, or alter the histone composition of nucleosomes (Hota and 
Bartholomew, 2011; Clapier and Cairns, 2009; Bartholomew, 2014; Petty and Pillus, 
2013). Remodelers are often macromolecular complexes, consisting of 1-15 subunits 
(Clapier and Cairns, 2009) and have been found to be important in all stages of 
development from embryogenesis to organogenesis (Ho and Crabtree, 2010). Each 
remodeling complex has a unique catalytic SNF2-like ATPase subunit with presumed 
DNA translocase activity (Clapier and Cairns, 2009; Bartholomew, 2014). While the 
central ATPase region of the catalytic subunit possesses conserved motifs found in all 
SNF2-like family members, unique inserts and/or auxiliary domains are commonly used 
to define four main remodeling families: SWI/SNF, ISWI, INO80, and CHD (Clapier and 
Cairns, 2009; Bartholomew, 2014).  
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 Chromodomain Helicase DNA-binding protein 1 (CHD1) is the founding member 
of the CHD remodeling family (Delmas et al., 1993; Woodage et al., 1997). CHD 
proteins are necessary for normal development but their roles in the cell remain the 
least characterized of all remodeling proteins (Clapier and Cairns, 2009; Woodage et 
al., 1997; Hall and Georgel, 2007; Marfella and Imbalzano, 2007). Like all CHD proteins, 
CHD1 has tandem chromodomains at the N terminus in addition to the central ATPase 
domain (Woodage et al., 1997). In vertebrates, there are nine CHD proteins, which have 
been further categorized into subfamilies based on additional sequences flanking the 
central ATPase domain (Woodage et al., 1997). A conserved SANT-SLIDE-like DNA-
binding domain at the C terminus characterizes the CHD1/CHD2 subfamily (Woodage 
et al., 1997; Hall and Georgel, 2007; Marfella and Imbalzano, 2007).  
 The role of CHD1 in cells is diverse and has slight variations depending on 
species and cell type, but all point toward a general role for CHD1 in regulating gene 
expression. In yeast, Chd1p (hereafter referred to as yCHD1) localizes to transcribed 
genes (Simic et al., 2003) and is needed for the maintenance of nucleosome structures 
across the gene body (Cheung et al., 2008; Radman-Livaja et al., 2012; Smolle et al., 
2012; Zentner et al., 2013). Yeast CHD1 is also part of the SAGA/SLIK histone 
acetylation complex involved in transcriptional activation (Pray-Grant et al., 2005). Chd1 
in Drosophila melanogaster (dCHD1) has been found to localize to transcriptionally 
active interband regions of chromosomes (Stokes et al., 1996). In mammalians, CHD1 
is needed to preserve euchromatic regions in establishing the pluripotency of embryonic 
stem cells (Gaspar-Maia et al., 2009). Human CHD1 (hCHD1) has also been found to 
associate with the Mediator complex during formation of the transcription pre-initiation 
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complex (Lin et al., 2011). Consistent with the observed roles for CHD1 in transcription, 
histone modifications associated with actively transcribed genes such as H2B mono-
ubiquitination and tri-methyation of H3 lysine 4 (H3K4me3) are recognized by CHD1 
(Quan and Hartzog, 2010; Lee et al., 2012; Sims et al., 2005; Flanagan et al., 2005; 
Sims et al., 2007; Stein and Wang, 2011). Moreover, CHD1 from yeast and flies can 
assemble periodic nucleosomal arrays (Robinson and Schultz, 2003; Lusser et al., 
2005), which might be needed for establishing proper chromatin structure such as that 
found at gene promoter regions (Albert et al., 2007; Mavrich et al., 2008; Valouev et al., 
2008; Valouev et al., 2011) or for maintaining nucleosomes positioned over the gene 
body in order to prevent cryptic transcription (Smolle et al., 2012; Cheung et al., 2008; 
Pointner et al., 2012; Hennig, et al., 2012).   
   Moreover, the domains of CHD1 confer specific regulatory functions. The N-
terminal chromodomains of hCHD1 preferentially bind methylated H3 lysines while the 
chromodomains of yCHD1 do not (Sims et al., 2005, 2007; Flanagan et al., 2005; Stein 
and Wang, 2011; Santos-Rosa et al., 2003), suggesting CHD1 has evolved to perform 
more complicated fine-tuning of gene regulation in higher eukaryotes, which have a 
more complex genome than yeast (Cooper, 2000). The crystal structure of the N-
terminal chromodomains and the ATPase domain from yCHD1 show the 
chromodomains are bound to the ATPase motor region in such a way that the catalytic 
residues are not positioned properly for activation of ATP hydrolysis to occur (Hauk et 
al., 2010). The interface between the chromodomains and the ATPase is electrostatic in 
nature, suggesting DNA is needed to release the proposed inhibition of ATP hydrolysis 
activity from the chromodomains (Hauk et al., 2010). At the other end of CHD1, the C-
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terminal DNA-binding domain senses extra-nucleosomal DNA (Ryan et al., 2011; 
McKnight et al., 2011). While the enzymatic activities of yCHD1 and dCHD1 have been 
well characterized, the same cannot be said for the human counterpart. Since species-
specific differences in activity have been observed for CHD1, we set out to characterize 
the biochemical properties of human CHD1.  
 
3.3. EXPERIMENTAL PROCEDURES 
Purification of Recombinant Human CHD1  
 In this study, we cloned, expressed, and purified wild-type human CHD1 (WT 
hCHD1) and a mutant version (Mut hCHD1), which contains a two-amino acid alanine 
substitution of the catalytic residues D614 and E615 in the Walker B motif that were 
introduced by site-directed mutagenesis. We also cloned and purified three hCHD1 
proteins with systematic truncations: central core ATPase consisting of amino acid 
residues 446-1124 (Core); C-terminal DNA-binding truncation consisting of amino acid 
residues 1-1124 (Core+CD); and N-terminal chromodomain truncation consisting of 
amino acid residues 446-1710 (Core+DBD). The hCHD1 proteins were cloned and 
expressed as N-terminal FLAG-fusion proteins in Sf9 cells using the Bac-to-Bac 
baculovirus expression system (Life Technologies). Of note, the Core+DBD protein also 
contained a 6XHis-tag at the C terminus that helped stabilize the protein against 
proteolysis. All plasmid constructs were verified by sequencing. The hCHD1 proteins 
were purified from infected Sf9 cells by immunoaffinity purification, as previously 
described for other ATPases (Yusufzai and Kadonaga, 2008; Liu et al., 2014). Briefly, 
infected Sf9 cells were suspended in cold Lysis Buffer [20 mM Tris-Cl, pH 7.6, 500 mM 
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NaCl, 1.5 mM MgCl2, 0.2 mM EDTA, 20% glycerol, 0.01% NP-40, 1 mM DTT 
supplemented with the following protease inhibitors: 0.5 mM benzamidine, 1 µg/ml of 
leupeptin, aprotinin, pepstatin A]. The cells were lysed by 30 strokes of a Dounce 
homogenizer on ice and immediately centrifuged at 48,384 x g for 10 minutes at 4°C. 
The supernatant was centrifuged a second time for an additional 5 minutes at 4°C to 
remove any residual insoluble material. The cleared cell lysate was then incubated with 
anti-FLAG resin (Sigma; pre-washed with Lysis Buffer) for 2-4 hours at 4°C, with 
rotation. The resin was pelleted by centrifugation, transferred to a 1.7 ml microcentrifuge 
tube, and washed two times with Lysis Buffer, and two times with Wash Buffer [Lysis 
Buffer containing only 100 mM NaCl). The hCHD1 proteins were eluted with 4-5 
sequential incubations of the resin with an equal volume of Elution Buffer [Wash Buffer 
containing 0.2 mg/ml FLAG peptide; Sigma]. For the purification of the Core+DBD 
protein, all of the wash and elution steps were performed using Lysis Buffer, as the 
Core+DBD protein had a tendency to precipitate in the Wash Buffer containing less salt. 
Bradford assay and SDS-PAGE/Coomassie staining were used to assess the 
concentration and quality of the purified hCHD1 proteins. The purest fractions were 
pooled, flash-frozen with liquid nitrogen, and stored at -80°C for subsequent 
biochemical experiments. Human CHD2 (hCHD2) and Drosophila ACF (dACF) were 
purified as previously described (Fyodorov and Kadonaga, 2003; Liu et al., 2014). 
 
In Vitro Chromatin Assembly 
The in vitro chromatin assembly assay was performed essentially as described 
(Fyodorov and Kadonaga, 2003; Liu et al., 2014) with minor modifications. Native 
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Drosophila core histones (used throughout this study), the catalytic domain of 
topoisomerase I (Topo I), Drosophila NAP-1 (dNAP-1), and hCHD2 were purified as 
previously described (Fyodorov and Kadonaga, 2003; Liu et al., 2014). 
Micrococcal Nuclease (MNase) Analysis A standard 70 µl assembly reaction 
contained purified core histones (1.4 µg), plasmid DNA (1.4 µg; 3.2 kilobases (kb); 
pGIE-0), Topo I, dNAP-1 (13 µg), recombinant hCHD1 or hCHD2 (100 nM final 
concentration), and an ATP regeneration system [3 mM ATP, 5 mM MgCl2, 30 mM 
phosphocreatine, and 5 ng/µl creatine phosphokinase]. Briefly, the core histones were 
incubated first with the histone chaperone dNAP-1 for 20 minutes on ice. In parallel, the 
plasmid DNA/Topo I reaction was set up for 10 minutes at 30 °C and kept at room 
temperature until use. After 20 minutes, the ATP regeneration system, relaxed plasmid 
DNA (with Topo I still present), and hCHD1 or hCHD2 were added to the 
histone/chaperone mixture. For minus ATP reactions, only ATP was left out; all other 
components of the regeneration system were included. The reaction was allowed to 
proceed for 1 hour at room temperature and then partially digested by adding 2 mM 
CaCl2 and MNase (Worthington; low concentration = 7 mU µl
-1, high concentration = 28 
mU µl-1). After 4 minutes at room temperature, the reactions were stopped with the 
addition of 125 µl of Stop Buffer [1% (w/v) SDS, 200 mM NaCl, 250 µg/ml glycogen, 20 
mM EDTA, pH 8.0] and proteinase K (Worthington) at a final concentration of 50 µg/ml. 
The DNA was then extracted with phenol:chloroform, precipitated with ethanol, resolved 
by agarose gel electrophoresis, and visualized by staining with ethidium bromide. The 
marker is a 123-base-pair (bp) repeat ladder (Life Technologies).  
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Radiometric ATPase Assay 
 Each ATPase reaction (10 µl) contained  500 nM ATP in Reaction Buffer [10 mM 
HEPES-K+, pH 7.6, 50 mM KCl, 5 mM MgCl2, 0.1 µg/µl BSA] and 5 µCi of [γ-32P]-ATP 
as a tracer.  Where indicated, reactions also contained 50 ng/µl of plasmid DNA (3.2 
kb), or plasmid that had been pre-assembled into chromatin by salt dialysis (final 
concentration 50 ng/µl). Recombinant hCHD1 was then added at a final concentration of 
100 nM to start the ATPase reaction. Aliquots (1 µl) of the reaction were removed and 
added to 4 µl of 125 mM EDTA, pH 8.0 at the selected time points (0, 0.5, 1, 5, 15, 30, 
60, and 90 minutes). From each stopped reaction, 0.5 µl was spotted onto a PEI-
cellulose plate (Sigma), air-dried, and resolved by thin-layer chromatography (TLC) with 
1 M acetic acid, 0.25 M lithium chloride. The TLC plate was then air-dried and exposed 
to a storage phosphor screen.   
 Quantification of the [γ-32P]-ATP and the released inorganic phosphate (32Pi) 
was performed using ImageLab software. After background subtraction, the fraction of 
hydrolyzed ATP was calculated for each time point and plotted versus time (min). Curve 
fitting was done with the Prism software (GraphPad) using the Michaelis-Menten model. 
Error bars representing standard deviations from the mean (SD) were calculated from at 
least three experiments. The Student’s t-test was used to calculate P values and 
statistical significance. 
 
Restriction Endonuclease Accessibility (REA) Assay 
 The REA assay was performed essentially as described (Alexiadis and 
Kadonaga, 2002; Liu et al., JBC). A standard 20 µl REA reaction contained 1 µg of 
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plasmid DNA (3.2 kb; pGIE-0) or plasmid pre-assembled into chromatin by salt dialysis, 
5 units of HaeIII (NEB) in Reaction Buffer [20 mM Tris-acetate, 10 mM magnesium 
acetate, 50 mM potassium acetate, 1 mM DTT, pH 7.9] and/or 3 mM ATP. Recombinant 
hCHD1 (100 nM) or the chromatin remodeling and assembly factor dACF (100 nM) was 
included, where indicated.  After 2 hours in a 30°C water bath, the reactions were 
stopped by the addition of 125 µl of Stop Buffer and proteinase K at a final 
concentration of 50 µg/ml. The DNA was then extracted with phenol:chloroform, 
precipitated with ethanol, resolved by agarose gel electrophoresis, and visualized by 
staining with ethidium bromide.      
 The DNA signal in each lane was quantified using the QuantityOne (Bio-Rad) 
software.  To facilitate the comparison of the amount of DNA digested in each lane, 
which indirectly measures chromatin remodeling, we created a Digestion Index (DI). 
The DI is calculated from the difference between the amount of DNA fragments smaller 
than 1 kb (Y) and the amount of DNA fragments larger than 1 kb (X), divided by the total 
amount of DNA in each lane [DI = (Y-X) / (Y+X)].  Bar graphs of the calculated DI values 
for each condition represent mean and SD [n=3]. The Student’s t-test was used to 
calculate P values and statistical significance. 
 
Electrophoretic Mobility Gel Shift Assay (EMSA) 
 Each 10 µl gel shift reaction included hCHD1 (0, 10, 20, 50, 100, or 200 nM) and 
a dsDNA probe in Binding Buffer [20 mM HEPES-K+, pH 7.6, 50 mM KCl, 5 mM 
magnesium acetate, 0.1 µg/µl BSA, 5% glycerol, 1 mM DTT, 0.2 mM EDTA, and 0.01% 
NP-40]. The dsDNA probe was generated by annealing an oligonucleotide that was 5’ 
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fluorescently-labeled with IRDye-700 (IDT) to its complement. The short, dsDNA probe 
used is 40 bp in length at a final concentration of 5 nM. The samples were incubated for 
1 hour on ice and resolved on a 5% polyacrylamide/0.5X TBE gel at 4°C. The gel was 
then scanned using a fluorescent imager (Li-Cor).          
     Using the QuantityOne software (BioRad), we quantified the intensity of the free 
and bound DNA bands. We then adjusted for background and used these values to 
calculate the fraction of DNA bound for each lane. Curve fitting was done with the Prism 
software (GraphPad) using the Allosteric Sigmoidal model and an estimated Kd 
calculated. The graphed data represent mean and SD [n=3]. The Student’s t-test was 
used to calculate P values and statistical significance. 
 
3.4. RESULTS 
Human CHD1 Does Not Distinguish Between DNA and Chromatin Substrates 
To investigate the ATP-dependent activity of human CHD1 (hCHD1), we first 
cloned and purified the full-length wild-type hCHD1 protein (WT hCHD1) and a 
catalytically-dead mutant version (Mut hCHD1), which carries a two-amino acid 
substitution (D614A and E615A) in the Walker B motif, from insect Sf9 cells (Figures 
3.1A-B). We then evaluated whether our purified, recombinant WT hCHD1 is 
catalytically active. For this analysis, we used a radiometric ATPase assay in which we 
resolved the amount of unhydrolyzed [γ-32P]-ATP and released inorganic phosphate 
(32Pi) on PEI-cellulose TLC plates (a representative TLC plate is shown in Figure 
3.1C). Because hCHD1 contains tandem chromodomains (CDs), which have been 
observed to bind methylated histone tails (Sims et al., 2005, 2007; Flanagan et al., 
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2005; Stein and Wang, 2011), and a conserved DNA-binding domain (DBD) (Woodage 
et al., 1997; Ryan et al., 2011; Sharma et al., 2011), we measured the effects of adding 
plasmid DNA or plasmid pre-assembled into salt-dialyzed chromatin on the ATPase 
activity of hCHD1. The fraction of ATP hydrolyzed was measured over a time course 
spanning 90 minutes. Using this assay, we found WT hCHD1 exhibits nearly 
undetectable ATPase activity alone (Figure 3.1D, Basal). In contrast, both plasmid DNA 
and plasmid that had been pre-assembled into chromatin by salt dialysis stimulate the 
ATPase activity of CHD1 almost equally (Figure 3.1D, DNA and Chromatin). To confirm 
Mut hCHD1 is catalytically inactive, we measured the fraction of ATP hydrolyzed in the 
absence or presence of stimulating substrates (DNA or chromatin). In the absence of 
DNA or chromatin, both WT and Mut hCHD1 exhibit low levels of ATP hydrolysis 
(Figure 3.1E). In contrast, under conditions where WT hCHD1 is active in the presence 
of DNA or chromatin, Mut hCHD1 remains inactive (Figure 3.1E). There was no 
detectable ATPase activity with the addition of plasmid or chromatin to the ATPase 





Figure 3.1. Wild-type human CHD1 (WT hCHD1) lacks substrate specificity. (A) 
WT hCHD1 has a central SNF2-like ATPase domain (Core) flanked by tandem 
chromodomains (CDs) and a DNA-binding domain (DBD). We used site-directed 
mutagenesis to clone a mutant version of hCHD1 (Mut) containing a two amino-acid 
alanine substitution of catalytic D614 and E615 residues (red) in the conserved DExH 
(Walker B) motif. (B) WT and Mut hCHD1 were purified from baculovirus-infected Sf9 
cells and analyzed by SDS-PAGE and Coomassie staining. (C) Representative raw 
data from radiometric ATPase assays. ATPase reactions with WT hCHD1 alone 
(Basal) or in the presence of DNA or chromatin were incubated for 0, 0.5, 1, 5, 15, 
30, 60 or 90 minutes, stopped by the addition of EDTA, and resolved by thin-layer 
chromatography (TLC) on plates coated with PEI-cellulose. (D) Quantification of the 
ATPase assays with WT hCHD1 stimulated by DNA or chromatin from 0 to 90 
minutes. (E) Quantification of the radiometric ATPase assays at 90 minutes with 
purified WT or Mut hCHD1 protein alone (Basal) or in the presence of DNA or 
chromatin. For (D) and (E), the fraction of ATP hydrolyzed was calculated and the 
values shown are mean and SD [n=3]. In (E), Student’s t-test was used to calculate 




Human CHD1 Is Not a Robust Chromatin Assembly Factor 
Mice experiments suggest hCHD1 and human CHD2 (hCHD2) do not serve 
redundant roles in vivo, so we set out to compare whether any differences in their in 
vitro activities could be detected. Like CHD1 from yeast and flies (yCHD1 and dCHD1, 
respectively) (Robinson and Schultz, 2003; Lusser et al., 2005), hCHD2 is an ATP-
dependent chromatin assembly factor (Liu et al., 2014). To compare the assembly 
activity for hCHD1 and hCHD2, we used an established in vitro chromatin assembly 
assay, which relies on purified components to generate regularly spaced nucleosome 
arrays (Fyodorov and Kadonaga, 2003; Ito et al., 1997). We pre-incubated purified core 
histones with the histone chaperone dNAP-1, and then added pre-relaxed (with Topo I) 
plasmid DNA and an ATP regeneration system (Figure 3.2, Left). The assembly of the 
plasmid DNA into periodic nucleosomal arrays was then analyzed by partial MNase 
digestion followed by agarose gel electrophoresis. In the absence of an ATP-dependent 
assembly factor and ATP, a limited amount of mono- and di-nucleosomes were 
observed, as previously reported (Figure 3.2, Right, None lanes) (Ito et al., 1997; 
Torigoe et al., 2011; Liu et al., 2014). In contrast, the reactions that contain hCHD2 and 
ATP yield periodic arrays of nucleosomes, as indicated by the extended DNA ladder 
formed following MNase digestion (Figure 3.2, Right, WT hCHD2 and ATP lanes). While 
hCHD2 exhibits robust assembly of periodic nucleosomal arrays (Figure 3.2, Right, WT 
hCHD2 and ATP lanes) (Liu et al., 2014), hCHD1 does not (Figure 3.2, Right, WT 




Human CHD1 Is an Inefficient Remodeler 
 Besides chromatin assembly, other types of remodeling activities exist such as 
nucleosome sliding or disassembly. These activities can be detected with a general 
restriction endonuclease accessibility (REA) assay. REA assays have been used 
successfully to investigate the remodeling activity of other enzymes including the 
chromatin assembly factors dACF (a heterodimer that contains the ISWI ATPase) and 
dCHD1 (Alexiadis and Kadonaga, 2002; Torigoe et al., 2013). This assay relies on the 
 
Figure 3.2. Human CHD1 is an inefficient nucleosome assembly factor. Left, 
flow-chart of experimental setup for in vitro nucleosome assembly reactions. Core 
histones (1.4 ug) were pre-incubated with the histone chaperone dNAP-1 (13 ug). 
Naked plasmid DNA (1.4 ug), Topo I, and WT hCHD1 or hCHD2 (100 nM) was then 
added in the presence or absence of ATP along with an ATP regeneration system. 
The reactions were then partially digested with a low (left-hand lane) or a high (right-
hand lane) concentration of MNase. The digested DNA was precipitated with ethanol, 
analyzed by agarose gel electrophoresis, and visualized by staining with ethidium 
bromide. A 123-bp repeat marker (M) was run between each pair of samples. Right, 
a representative agarose gel showing the presence of a DNA ladder formed upon 
ATP-dependent assembly of nucleosomes by hCHD2 and less so by hCHD1. 
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principle that when a plasmid is reconstituted into chromatin via salt dialysis, specific 
restriction endonuclease cut sites are occluded by the presence of nucleosomes, which 
are made accessible by remodeling (Alexiadis and Kadonaga, 2002; Almer et al., 1986; 
Varga-Weisz et al., 1997; Boyer et al., 2000; Fan et al., 2003). For this analysis, we 
used a 3.2 kb plasmid (pGIE-0) that contains 15 HaeIII restriction cut sites. To facilitate 
the comparison of the remodeling activities exhibited by the different proteins, we 
established a Digestion Index (DI) that takes into account the difference between the 
amount of DNA fragments larger than 1 kb (i.e., less digested) and the amount of DNA 
smaller than 1 kb (i.e., more digested) relative to the total amount of DNA in each lane 
(see Experimental Procedures for formula). The plasmid alone is completely digested 
by HaeIII, regardless of the absence or presence of ATP (Figure 3.3A, compare lane 2 
with lane 1). Reactions that contain the plasmid-assembled chromatin are not affected 
by the absence or presence ATP either but are only partial digested due to occlusion of 
some HaeIII sites (Figure 3.3A, compare lanes 3 and 4 with lanes 1 and 2). Our positive 
control, dACF, efficiently remodels nucleosomes (Figure 3.3A, compare lane 6 with lane 
5; Figure 3.3B) while WT hCHD1 remodels to some degree but not as efficiently (Figure 
3.3A, compare lane 8 with lane 7; Figure 3.3B). As expected, catalytically-inactive Mut 
hCHD1 exhibits no remodeling activity at all, consistent with its lack of ATPase activities 







The CDs and DBD Regulate the ATPase Activity of Human CHD1 
 The chromodomains (CDs) and DNA-binding domain (DBD) of CHD1 from yeast 
(yCHD1) have been shown to play important roles in the regulation of the biochemical 
activities of yCHD1 (Hauk et al., 2010; Ryan et al., 2011; McKnight et al., 2011; Patel et 
al., 2013; Nodelman and Bowman, 2013). However, the chromodomains of yeast and 
human CHD1 have been found to display different activities when it comes to binding 
methylated H3K4 tails (Santos-Rosa et al., 2003; Sims et al., 2005, 2007; Flanagan et 
Figure 3.3. Human CHD1 lacks robust remodeling activity. (A) A restriction 
endonuclease accessibility (REA) assay was used to measure the extent of 
chromatin remodeling by hCHD1. The indicated proteins (100 nM) were incubated 
with the restriction enzyme HaeIII and plasmid chromatin (1 µg). Indicated lanes 
correspond to reactions containing 3 mM ATP. Following digestion with HaeIII, the 
DNA was deproteinized, purified, and resolved by agarose gel electrophoresis. (B) A 
Digestion Index (DI) was calculated for each reaction (see Experimental Procedures). 
The graphed data represent mean and SD [n=3]. Student’s t-test was used to 
calculate statistical significance; *** = extremely statistically significant (P < 0.0001). 
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al., 2005; Stein and Wang, 2011). To understand the role that the CDs and DBD play in 
the regulation of hCHD1 activity, we cloned, expressed, and purified a series of hCHD1 
proteins missing either the DBD-containing C-terminal region (Core+CD) or the CD-
containing N-terminal region (Core+DBD), or both, leaving the conserved ATPase 
domain (Core) (Figure 3.4A). 
To study how the accessory domains regulate the activity of hCHD1, we first 
measured the ability of the hCHD1 truncation proteins to hydrolyze ATP in the absence 
of plasmid DNA or in vitro assembled chromatin.  As observed with WT hCHD1, all of 
the truncation proteins exhibit little to no activity in the absence of DNA or chromatin 
(Figure 3.4B, Basal; Figure 3.4C, bars 1, 7, 10, and 13). We then examined the ability of 
the truncation proteins to hydrolyze ATP in the presence of DNA or pre-assembled 
chromatin. We found the core ATPase domain of CHD1 is preferentially stimulated by 
plasmid DNA, despite also being strongly stimulated by chromatin to wild-type levels 
(Figure 3.4B, DNA and Chromatin; Figure 3.4C, bars 8 and 9). This finding is consistent 
with the prediction that SNF2-like ATPases are DNA-dependent (Eisen et al., 1995; 
Henikoff, 1993). 
We next examined the Core+CD protein, which contains the core ATPase 
domain and the tandem CDs but lacks the DBD (Figure 3.4A). The Core+CD protein 
shows almost no DNA-stimulated or chromatin-stimulated ATPase activity (Figure 3.4B, 
DNA and Chromatin; Figure 3.4C, bars 11 and 12). This finding suggests the activity 
seen for the core domain alone is inhibited by the chromodomains, which is enhanced 
by removal of the DNA-binding domain.    
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We then examined the Core+DBD protein, which contains the core ATPase 
domain and the C-terminal DNA-binding domain (Figure 3.4A). Like the Core ATPase 
domain, the Core+DBD is stimulated preferentially by DNA (Figure 3.4B, DNA and 
Chromatin; Figure 3.4C, bars 14 and 15), but at levels higher than those observed with 
WT hCHD1 (Figure 3.4C, bars 2 and 3) or for the Core protein (Figure 3.4C, bars 8 and 
9). This finding further implicates the N terminus and CDs in repressing the ATPase 
activity of the core ATPase domain.  
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The inhibition of ATPase activity by regions such as the CDs, which are able to sense 
unique features of chromatin such as specific histone modification patterns in the 
histone tails (Brehm et al., 2004), is consistent with models proposed for yCHD1 and 
 
Figure 3.4. The N-terminal region containing the tandem chromodomains of 
hCHD1 inhibits activity of the core ATPase domain. (A) Left, a series of hCHD1 
deletion proteins was generated that removed the C-terminal region containing the 
putative DNA-binding domain (Core+CD), removed the N-terminal region containing 
the tandem chromodomains (Core+DBD), or removed both regions (Core). Right, as 
for WT hCHD1, the truncation proteins were purified from baculovirus-infected cells 
and analyzed by SDS-PAGE and Coomassie staining. (B) ATPase reactions 
consisting of hCHD1 (100 nM) and 50 ng/µl of DNA or in vitro salt-dialyzed, pre-
assembled chromatin were performed. The fraction of ATP hydrolyzed was 
measured at various time points (0, 0.5, 1, 5, 15, 30, 60, and 90 minutes). (C) For 
comparison, we took the experiments shown in (B) and graphed the fraction of ATP 
hydrolyzed at the 15-minute time point. All values are mean and SD [n=3]. Student’s 
t-test was used to calculate statistical significance; *** = extremely statistically 
significant (P < 0.0001), ** = very statistically significant (P < 0.001), * = statistically 
significant (P < 0.01), and n.s. = not significant. 
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other remodeling enzymes (Alexiadis et al., 2004; Lake et al., 2010; Hauk et al., 2010; 
Clapier and Cairns, 2012). Our results also suggest the DBD acts to increase the affinity 
of hCHD1 to both naked DNA and DNA present in the context of chromatin, leading to 
an overall increase in ATPase activity when compared to the core ATPase domain.   
 
The Chromodomains of Human CHD1 Block Binding to DNA 
Since the chromodomains appear to inhibit the DNA-stimulated activity of the 
core ATPase, we examined how loss of the CDs (Core+DBD) affects the binding of 
hCHD1 to DNA. Surprisingly, WT hCHD1 does not bind DNA efficiently (Figure 3.5A). In 
fact, WT hCHD1 binds as inefficiently as hCHD1 lacking the DNA-binding domain 
(Core+CD) (Figure 3.5B). However, removal of the N-terminal region containing the 
tandem chromodomains (Core+DBD) led to strong DNA-binding by hCHD1 (Figure 
3.5C). Based on our analyses from a DNA binding curve (Figure 3.5D), the Core+DBD 
has an approximate Kd of 80 nM. The fact that the Core+DBD protein shows enhanced 
DNA binding (Figure 3.5E) likely explains its higher DNA-dependent ATPase activity, as 
compared to WT hCHD1 (Figure 3.4C, compare bar 14 with bar 2). This further 
reinforces the model that the N terminus plays an inhibitory role in cis by reducing the 




 In this study, we showed human CHD1 (hCHD1) displays inefficient assembly 
and remodeling activities when compared with human CHD2 (hCHD2). We also showed 
the N-terminal half containing the tandem chromodomains strongly inhibits both the 




Figure 3.5. The N-terminal region containing the tandem chromodomains of 
human CHD1 blocks DNA binding. EMSAs were performed using increasing 
amounts (0, 10, 20, 50, 100, or 200 nM) of (A) full-length WT hCHD1, (B) Core+CD, 
or (C) the Core+DBD on a 40 bp dsDNA probe. (D) DNA binding curve for full-length 
hCHD1 (WT), Core+CD, and Core+DBD proteins. (E) For comparison, the fraction of 
DNA bound by WT hCHD1 and the two truncation proteins at 200 nM was calculated 
and graphed. All values are mean and SD [n=3]. Student’s t-test was used to 
calculate statistical significance; *** = extremely statistically significant (P < 0.0001). 
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Human CHD1 May Require Other Factors for Remodeling and Assembly Activities 
 While CHD1 from yeast and flies exhibit robust assembly and remodeling activity, 
human CHD1 does not. This could be due to a variety of factors, both technical and 
biological. The obvious one to consider is the quality of purification. However, purified 
recombinant hCHD1 displays robust ATPase activity in the presence of plasmid DNA 
and in vitro assembled chromatin (Figures 3.1C-E), suggesting a biological explanation 
exists for the inefficient remodeling activities observed. Furthermore, hCHD1 has no 
preference for DNA or chromatin substrates, unlike human CHD2 (Liu et al., 2014). This 
could point toward distinctions between substrate recognition by hCHD1 and hCHD2 in 
vivo or could be a reflection of a missing histone modification. The histones used for in 
vitro assembly of chromatin substrates are purified from Drosophila melanogaster 
embryos and the modification state unknown. Given that hCHD2 does not recognize 
methylated histone H3 tails while hCHD1 does (Sims et al., 2005; Flanagan et al., 2005; 
Sims et al., 2007; Stein and Wang, 2011), this could explain the differences in assembly 
and remodeling activities between the two proteins. It is also entirely possible a histone 
modification that is refractory for hCHD1 binding but not binding by hCHD2 is present 
on the purified Drosophila core histones. Use of mass spectrometry to identify the 
existing modification states of the core histones used in this study would clarify whether 
histone post-translational modifications are a contributing factor to the inefficient 
assembly and remodeling activities observed for hCHD1. In addition, hCHD1 may 
require additional protein subunits to aid in its activity in vivo. Since we are using 
recombinant hCHD1 protein, if any cofactors are needed for maximum activity, they are 
missing in our in vitro system. Identification of such cofactors would also point toward 
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the different roles for hCHD1 and hCHD2 in the cell, as hCHD2 does not appear to 
require any cofactors for robust enzymatic activity (Liu et al., 2014). 
 
The CD-Containing N-Terminal region 
Our findings show the addition of the CD-containing N-terminal region to the 
ATPase domain (Core+CD) abrogates the ability of the core ATPase domain to be 
stimulated by both DNA and chromatin (Figure 3.4C, bars 11 and 12), supporting the 
model that the chromodomains of CHD1 serve an inhibitory role (Hauk et al., 2010). 
Since the chromodomains of hCHD1 recognize the trimethylated histone H3K4 tail, this 
specific modification may be needed to provide specificity for chromatin. Since we see 
that the chromodomains block DNA-binding by CHD1 as well, the interaction with both a 
specific histone modification and DNA could be necessary for hCHD1 to efficiently 
disrupt histone-DNA contacts when remodeling nucleosomes. 
Future studies will help shed light on why hCHD1 is not an efficient enzyme in 
vitro. Our studies here have helped elucidate the strong inhibitory role the 
chromodomains play in regulating the activity of hCHD1 and set the foundation for 
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4.1. BIOLOGICAL SIGNIFICANCE OF CHROMATIN REMODELING AND ASSEMBLY 
FACTORS 
 The sites of assembly of eukaryotic DNA into nucleosomes and higher-order 
structures influence chromatin dynamics and gene regulation (Politz et al., 2013; 
Ghirlando and Felsenfeld, 2013). DNA sequences harbor some nucleosome positioning 
information (Zhang et al., 2011), but ATP-dependent protein machineries called 
chromatin remodelers are needed to provide dynamic flexibility of chromatin 
compaction/decompaction in response to cellular signals (Workman and Kingston, 
1998; Hota and Bartholomew, 2011; Clapier and Cairns, 2009; Bartholomew, 2014). 
Remodelers utilize the energy from ATP hydrolysis to assemble, reposition (slide), 
disassemble, create ordered arrays of nucleosomes (spacing), or alter the histone 
composition within nucleosomes (histone exchange) (Clapier and Cairns, 2009). As 
essential regulators of DNA accessibility, remodelers act in coordination with histone 
modifying enzymes to modulate the chromatin landscape (Bartholomew, 2014).  
 A subset of remodelers catalyzes nucleosome assembly (Ito et al., 1997a; 
Nakagawa et al., 2001; Torigoe et al., 2011; Robinson and Schultz, 2003; Lusser et al., 
2005), which is important for the maintenance of genomic integrity (Kadam and 
Emerson, 2002; Groth et al., 2007). While the bulk of canonical histone incorporation via 
histone chaperones occurs during DNA synthesis behind the replication fork (Krude, 
1999; Annunziato, 2005, 2013), ATP-dependent assembly factors are needed for 
nucleosome maturation (Torigoe et al., 2011; Nakagawa et al., 2001; Glikin et al., 
1984). Nucleosome assembly also occurs in conjunction with transcription in order to 
maintain proper chromatin structure over promoter regions and the gene body 
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(Annunziato, 2013; Kadam and Emerson, 2002; Groth et al., 2007; Ahmad and 
Henikoff, 2002; Das and Tyler, 2013). Furthermore, chromatin assembly plays an 
important role in re-establishing proper chromatin structure after the repair of DNA 
damage. Since nucleosome assembly plays such an integral role in the regulation of 
chromatin dynamics, genomic stability and gene regulation (Ito et al., 1997b; Tyler, 
2002; Polo and Almouzni, 2006; Haushalter and Kadonaga, 2003), identifying and 
characterizing ATP-dependent assembly factors are important goals of the chromatin 
field.    
 
4.2. HUMAN CHD2: A NEW CHROMATIN ASSEMBLY FACTOR – IN VIVO 
IMPLICATIONS 
 Chromodoomain Helicase Domain protein 2 (CHD2) is an important regulator of 
proper development. Experiments performed in mice and zebrafish models have 
revealed loss of CHD2 function can lead to stunted growth and severe developmental 
defects (Marfella et al., 2006; Suls et al., 2013). CHD2 is needed for regulating the 
expression of tissue-specific genes in myoblast cells (Harada et al., 2012). Moreover, 
deletion or mutations of the CHD2 gene have been linked to developmental defects and 
epileptic encephalopathies in humans (Suls et al., 2013; Kulkarni et al., 2008; Carvill et 
al., 2013; Lund et al., 2014; Courage et al., 2014; Chénier et al., 2014). While these in 
vivo findings establish the biological significance of CHD2, a comprehensive view of the 
mechanistic underpinnings of CHD2 function was missing.      
 Chapter 2 of my dissertation work detailed the characterization of the enzymatic 
activities of recombinant human CHD2 (hCHD2) (Liu et al., 2014). Using in vitro 
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chromatin assembly and remodeling assays, we showed hCHD2 catalyzes the 
assembly of plasmid DNA into nucleosomal arrays and the remodeling of nucleosomes. 
Radiometric ATPase assays demonstrated chromatinized DNA preferentially stimulates 
the ATPase activity of hCHD2, and electrophoretic mobility shift assays revealed 
hCHD2 requires a minimal length of 40 base pairs for stable binding to DNA (Liu et al., 
2014). Moreover, systematic truncation of hCHD2 uncovered the regulatory roles of 
conserved sequences flanking the central ATPase domain. The N-terminal half of 
hCHD2 containing the tandem chromodomains confers not only substrate specificity but 
also constrains the ATP hydrolysis and DNA-binding by hCHD2 (Liu et al., 2014). This 
region is also needed for efficient coupling of ATPase activity to subsequent remodeling 
(Liu et al., 2014). We also provide empirical evidence for binding to DNA by hCHD2, 
corroborating sequence alignment predictions of a putative C-terminal DNA-binding 
domain. This DNA-binding domain senses DNA of a minimal length and enhances 
remodeling activity (Liu et al., 2014).  
 The assembly activity of CHD2 could be recruited for multiple purposes in the 
cell. Myoblast differentiation requires the marking of nucleosomes in the regulatory 
regions of muscle genes by the incorporation of histone variant H3.3 (Harada et al., 
2012). Loss of CHD2 leads to depletion of H3.3 at these genes (Harada et al., 2012). In 
light of the assembly activity of CHD2, this activity is likely needed for the assembly of 
nucleosomes containing H3.3 variants. A preliminary next step would be to determine 
whether the efficiency of chromatin assembly by CHD2 increases in the presence of 
histone variants such as H3.3 versus canonical histones. Moreover, since we now know 
the regulatory roles of each of the accessory domains, we could use the various CHD2 
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truncation proteins to probe whether specific targeting of CHD2 and H3.3 incorporation 
are dependent on the ability of CHD2 recognize chromatin-specific features or bind 
DNA. We could also use a more detailed series of CHD2 truncations to map the region 
responsible for interactions with the transcription factor MyoD, which binds specific DNA 
sequences and recruits CHD2 to muscle-specific genes (Harada et al., 2012).  
 Additionally, chromatin assembly by CHD2 could also play a role in DNA 
damage. Phosphorylated histone variant H2A.X (γ-H2A.X) marks sites of double-strand 
breaks (Rogakou et al., 1998) and upon UV-irradiation, loss of CHD2 in mouse 
embryonic fibroblasts delays γ-H2A.X clearance (Nagarajan et al., 2009). This could be 
an indirect effect, as the role of CHD2 might be to regulate the gene expression of a 
protein needed for the repair of double-strand breaks, as in the case of muscle-specific 
genes (Harada et al., 2012). Alternatively, loss of CHD2 could be directly affecting γ-
H2A.X clearance; the repair of DNA damage might actually be in tact and CHD2 is 
rather needed for the reassembly of canonical nucleosomes at the site of the repaired 
DNA lesion. The following questions remain: Is CHD2 needed for the proper repair of 
DNA damage? If so, which repair pathway(s) is CHD2 a part of? As a corollary, many 
melanoma cancers, which are sensitive to UV-induced DNA damage, have mutations in 
CHD2 (Cerami et al., 2012; Gao et al., 2013). Are the CHD2 mutations found in 
melanoma cancers drivers of oncogenesis or are they merely byproducts of the genetic 
instability that occurs when a normal cell becomes cancerous? If CHD2 has a role in 
DNA repair, then does loss of CHD2 result in aberrant DNA damage, and is this a 
contributor to the onset of skin cancer? Further investigations into the role of CHD2 in 
the DNA damage response will resolve these questions.  
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 Furthermore, the in vivo role(s) of chromatin assembly and nucleosome 
remodeling by CHD2 is likely to be context-specific. For instance, tissue-specific 
expression of CHD2 may differ across development. CHD2 may act as part of distinct 
multi-subunit complexes depending on species, tissue type, and developmental window. 
While challenging, purification of endogenous CHD2 from different tissues would 
provide much information regarding the proteins CHD2 interacts with in the cell. This 
information would help answer questions regarding the recruitment of CHD2 to specific 
genomic loci and how the activity of CHD2 is modulated in vivo. Biochemical 
characterization of human CHD2 has now established tools and laid the foundation for 
exploring the cellular roles of CHD2. As future studies continue to delve into the 
functions of CHD2, the biological relevance of the assembly and remodeling activities of 
CHD2 will become clearer. 
 
4.3. HUMAN CHD1: MISSING CO-ACTIVATORS?  
 Chromodomain Helicase DNA-binding protein 1 (CHD1) has a conserved role in 
regulating gene expression though it appears species-specific differences exist in the 
mode through which CHD1 is recruited to genes. In Saccharomyces cerevisiae and 
Drosophila melanogaster, yeast Chd1p (yCHD1 hereafter) and fruit fly Chd1 (dCHD1 
hereafter) localize to actively transcribed regions of the genome (Simic et al., 2003; 
Stokes et al., 1996). Mammalian CHD1 and yCHD1 have been found to interact with 
multi-subunit complexes known to be involved in transcriptional activation (Pray-Grant 
et al., 2005; Lin et al., 2011). Consistent with these observed roles in transcription 
regulation, CHD1 also recognizes histone marks associated with actively transcribed 
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genes (Quan and Hartzog, 2010; Lee et al., 2012; Sims et al., 2005, 2007; Flanagan et 
al., 2005; Stein and Wang, 2011). Given the role for CHD1 in transcription activation, it 
is not surprising CHD1 is needed to preserve euchromatic regions, which are important 
for maintaining the pluripotency of embryonic stem cells (Gaspar-Maia et al., 2009). 
Moreover, yCHD1 and dCHD1 can assemble periodic nucleosomal arrays (Robinson 
and Schultz, 2003; Lusser et al., 2005). While the assembly activities of yCHD1 and 
dCHD1 have not been directly linked to a specific in vivo role, it might be needed for 
establishing proper chromatin structure such as that found at gene promoter regions 
(Albert et al., 2007; Mavrich et al., 2008; Valouev et al., 2008; Valouev et al., 2011). 
However, despite what has been learned about CHD1 from using yeast, fruit fly, and 
mice models, an in-depth study of the functional role of the human CHD1 counterpart 
was lacking. 
In Chapter 3 of my dissertation work, the characterization of the biochemical 
properties of human CHD1 (hCHD1) is described. When compared to hCHD2, hCHD1 
exhibits weaker chromatin assembly and remodeling activity despite having robust 
ATPase activity in the presence of DNA and chromatin substrates. Moreover, ATP 
hydrolysis by hCHD1 appears to be equally activated by DNA or chromatin. ATPase 
activity increases with the removal of the chromodomain-containing N-terminal region. 
We also observed that hCHD1 binds DNA only when the chromodomain-containing N-
terminal region is removed. Together, these results suggest binding to DNA and full 
activation of the ATPase activity of hCHD1 requires the release of chromodomain-
dependent inhibition of the ATPase and/or DNA-binding domains. Since purified, 
recombinant hCHD1 is an active ATPase in the presence of DNA and chromatin 
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substrates, it is likely we are missing a specific co-factor or accessory subunit that is 
needed for efficient assembly and remodeling by hCHD1 in vivo. Since hCHD1 has 
been observed to interact with the Mediator complex (Lin et al., 2011), perhaps specific 
components of the transcription pre-initiation complex are needed for full activation of 
hCHD1.    
 
4.4. BROADER IMPLICATIONS / AREAS OF FUTURE INVESTIGATION 
 By looking at a comparison of the findings for both hCHD1 and hCHD2, we can 
make general conclusions about the CHD1/2 subfamily of CHD remodelers (Table 4.1).  
 
 
Table 4.1. Comparison of human CHD1 and CHD2 activities. ATPase activities of 
hCHD1 and hCHD2 are compared in terms of whether DNA or chromatin (Chr) 
stimulated equally (DNA = Chr), DNA was the preferred substrate (DNA > Chr), or 
vice versa (DNA < Chr). The effects of systematic truncation of regulatory regions on 
the ATPase activities of hCHD1 and hCHD2 are also shown. One, two, or three up 
arrows correspond to qualitative increases in ATPase activity. The same holds true 
for observed decreases in ATPase activity (represented by one, two, or three down 
arrows). The number of plus signs represents the efficiency of chromatin assembly 
(more plus signs means more efficient activity). The same is true for nucleosome 
remodeling and binding to DNA. Data for hCHD2 from Liu et al., 2014.  
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Our data suggests the N-terminal chromodomains have evolved an inhibitory role on the 
ATP hydrolysis and DNA-binding activities for both CHD1 and CHD2. Use of the N-
terminal region to inhibit enzymatic activity has been observed for other SNF2-like 
ATPases (Hauk et al., 2010; Alexiadis et al., 2004; Lake et al., 2010; Clapier and 
Cairns, 2012; Mueller-Planitz et al., 2012) and appears to be a recurring theme used in 
the mechanism of chromatin remodeling enzymes (Hauk and Bowman, 2011; Manning 
and Peterson, 2013). Perhaps instead of acquiring a chromatin-sensing ATPase 
domain, the evolution of a mechanism in which a DNA-dependent ATPase domain is 
inhibited allowed for greater diversity in the types of chromatin remodelers and their 
regulatory mechanisms. Instead of having a chromatin-activated ATPase, a variety of 
inhibition release mechanisms can be used to activate the central DNA-dependent 
ATPase, providing selectivity for nucleosomal DNA (by sensing histone epitopes in the 
context of chromatin) and/or for nucleosomal substrates with various histone 
modifications. This also preserves the DNA translocase activity, which is presumably 
needed for disrupting histone-DNA contacts during chromatin remodeling. Moreover, 
different remodelers could have also evolved distinct regions responsible for 
interactions with factors that bind specific DNA sequences, allowing for the recruitment 
of remodelers to specific sites in the cell. For both hCHD1 and hCHD2, we see the N-
terminal region containing the tandem chromodomains serves a strong inhibitory role on 
the ATPase and DNA-binding activities of the two proteins. This then leads to the 
following question: what is needed to remove this strong inhibitory effect? 
Activation of hCHD1 and hCHD2 in the cell (releasing inhibition by N-terminal 
chromodomains) could be achieved by similar yet subtly distinct mechanisms, which 
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can make a significant difference in vivo. Since the chromodomains of hCHD1 
preferentially bind to histone H3 tail peptides with tri-methylated H3 lysine 4 (H3K4me3) 
while those of hCHD2 do not, a general mechanistic model for the activation of CHD1 in 
the cell can be proposed. This model takes into account my dissertation work and that 
of (Hauk et al., 2010). Activation of the enzymatic activity of hCHD1 likely requires a 
specific histone modification recognized by the tandem chromodomains (such as 
H3K4me3) for release of their inhibition (Figure 4.1A). Given the roles of CHD1 in 
regulating gene activation, and that H3K4me3 is commonly associated with the 
nucleosomes of active gene promoters (Santos-Rosa et al., 2002), H3K4me3 could 
serve both as a signal for the recruitment of CHD1 to specific genomic loci and as an 
activator of its activity (Figure 4.1A). Subsequent activation of the ATPase and DNA-
binding activities of CHD1 would then lead to remodeling and/or assembly of chromatin 
in coordination with transcriptional activation. If the Drosophila core histones used in our 
chromatin assembly and remodeling assays lack the H3K4me3 modification, this could 
account for the inefficient activity of hCHD1 observed in vitro when compared to that of 
hCHD2. This can be confirmed by identification of histone modifications via mass-
spectrometry or by the use of recombinant histones with the H3K4me3 modification in 
our chromatin assembly and remodeling assays. It is also possible an inhibitory histone 
modification is present. If so, then identification of this inhibitory modification might 
provide some insight as to when and where the cell would not want CHD1 to be active.  
For hCHD2, targeting of its activity in the cell likely occurs through an interaction 
partner (Harada et al., 2012) and not via a specific histone modification. Regions 
outside of the accessory domains are well conserved among the sequences of CHD2 
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from different vertebrate species but less so between CHD1 and CHD2. These 
conserved sequences might be used to interact with a DNA site-specific factor for 
recruiting hCHD2 to distinct locations in the cell (Figure 4.1B), removing the need for 
recognition of a specific histone modification even though chromatin-specific features 
are required for release of N-terminal inhibition.  
 
 
Figure 4.1. Recruitment of CHD1/CHD2 to the nucleosome in vivo. (A) Human 
CHD1 recognizes a specific histone modification on the H3 tail (H3K4me3), which 
serves both to recruit hCHD1 and to release N-terminal inhibition. H4 tail at SHL 2 
helps stimulate ATPase activity while DNA-binding domain recognizes extra-
nucleosomal DNA. Central ATPase and DNA-binding domain coordinate to remodel 
the nucleosome. (B) Human CHD2 requires an accessory factor (X), which binds 
specific DNA sequences and targets hCHD2 to appropriate locations in the cell. H3 
tail then releases N-terminal inhibition, allowing for activation of remodeling activity.  
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The conserved regions that differ between hCHD1 and hCHD2 could contain regulatory 
motifs that differentiate hCHD1 from hCHD2 and would be sources of future studies.  
While two means of targeting hCHD1 or hCHD2 to a specific site in vivo are 
proposed (Figure 4.1), release of N-terminal inhibition is likely to be a general 
mechanism for not only CHD1 and CHD2 but for the remaining seven vertebrate CHD 
proteins as well. Other CHD proteins might recognize different histone modifications or 
be recruited via different interaction partners. It is also possible histone modifications 
and site-specific factors work together to provide the appropriate targeting of CHD 
proteins in vivo. The more we characterize the CHD1/CHD2 subfamily, the more we will 
learn about what makes this subfamily distinct from all other CHD proteins and why we 
have nine CHD proteins and not just one, like in yeast.  
As there are ~25 genetically non-redundant remodelers identified in humans 
(Hargreaves and Crabtree, 2011), an unresolved question in the CHD field is whether 
CHD1 and CHD2 have redundant roles in vivo. Homozygous mice containing a partial 
deletion of the CHD2 gene leading to truncation of the DNA-binding domain are not 
viable, while the heterozygous mice exhibit decreased survival rates (Marfella et al., 
2006).  This finding suggests CHD1 function cannot compensate for the loss of CHD2 in 
mice. However, a conclusive study has not been conducted in which CHD1 and CHD2 
protein expression levels are measured in tissues throughout mouse development. Loss 
of CHD1 has also been observed to increase the ability of oncogenic cells to cross the 
extracellular matrix in in vitro invasion assays, suggesting loss of CHD1 is a contributing 
factor to cancer metastasis. The effects of CHD2 overexpression on the ability of cancer 
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cells to pass through extracellular matrix in a CHD1 deletion background would also 
answer whether CHD2 and CHD1 serve non-redundant roles in the cell.   
Differences in the in vitro activities exhibited by hCHD1 and hCHD2 point toward 
the likelihood that hCHD1 and hCHD2 have different roles in the cell. Perhaps CHD1 is 
needed to create nucleosome-depleted regions (NDRs) at the sites of active gene 
promoters while CHD2 acts to regulate tissue-specific genes and/or DNA repair. Since 
NDRs contain both stretches of free DNA and specifically positioned nucleosomes, this 
might explain why hCHD1 exhibits no substrate preference and why its assembly 
activity is so inefficient. If CHD1 establishes chromatin structure around NDRs, then this 
would also explain why CHD1 does not display robust remodeling activity in our 
restriction endonuclease accessibility (REA) assay. The salt-dialyzed chromatin used in 
our REA assays is reconstituted from Drosophila core histones and the plasmid pGIE-0. 
This plasmid was originally designed to study the activation of gene transcription in vitro 
and contains the adenovirus E4 core promoter sequence (Lin et al., 1988; Pazin et al., 
1998). If a majority of the positions of reconstituted nucleosomes were established 
directly by the sequence of the plasmid DNA, then extensive repositioning of the 
nucleosomes by hCHD1 would not be needed. This could explain why we do not see 
much increase in DNA accessibility in our restriction endonuclease accessibility assays. 
If so, then remodeling by hCHD2 appears to be less dependent on pre-established 
chromatin structure, suggesting hCHD1 and hCHD2 localize to different regions of the 
gene body. This can be tested with the use of various restriction enzymes and mapping 
of the nucleosome positions in our salt-dialyzed chromatin. Additionally, with the 
development of specific antibodies for hCHD1 and hCHD2, chromatin 
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immunoprecipitation could then be used to determine where in the genome hCHD1 and 
hCHD2 localize.  
Before this study, only two types of remodelers (ISWI-containing ACF and 
yeast/fruit fly CHD1) demonstrated chromatin assembly activity (Ito et al., 1997a; 
Robinson and Schultz, 2003; Lusser et al., 2005); now, a third one, human CHD2 has 
been added (Liu et al., 2014) with important implications for its role in vivo. This 
expands the number of known chromatin assembly factors and brings up the following 
questions: How many chromatin assembly factors does the cell need? Why do we have 
more than one? Do they function in different contexts? The answers to these questions 
in the future will certainly shed light into how eukaryotic genetic material is compacted 
and assembled into the nucleus while maintaining the dynamic flexibility needed to 
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A.1. ABSTRACT 
 Polymerase Q (POLQ) is an error-prone polymerase with the ability to bypass 
various types of DNA lesions and plays an important role in DNA repair. While much is 
known about the enzymatic properties of the C-terminal A-family polymerase domain, 
the roles of the N-terminal ATPase domain and the long central linker containing three 
RAD51-binding motifs remain less understood. Using several biochemical assays, we 
have characterized the ATPase and RAD51-binding activities of human POLQ. Our 
data show that single-stranded DNA (ssDNA) selectively stimulates the ATPase activity 
of POLQ, POLQ stably binds to ssDNA, and both the ability to hydrolyze ATP and bind 
to RAD51 are needed for POLQ-dependent inhibition of RAD51-ssDNA nucleofilament 
assembly in vitro. This work offers an initial mechanism for the anti-recombinase activity 
of POLQ observed in vivo. 
 
A.2. INTRODUCTION 
Large-scale genomic studies reveal approximately half of epithelial ovarian 
cancers (EOCs) have mutations in genes that code for proteins involved in the 
regulation of DNA repair mediated by homologous recombination (HR) (Cancer 
Genome Atlas Research Network, 2011). This suggests many EOCs have defects in 
the homologous recombinational (HR) repair pathway (Cancer Genome Atlas Research 
Network, 2011), which is used to repair many types of DNA aberrations including 
double-strand breaks (DSBs) and collapsed replication forks (Thompson and Schild, 
1999, 2001; Krejci et al., 2012; Mason et al., 2014). Misregulation of HR-dependent 
repair can lead to defects in DNA replication and cell death (Thompson and Schild, 
2001; Krejci et al., 2012). Other cancers with a loss of the HR repair pathway have been 
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found to be dependent on an alternative repair pathway involving poly-ADP ribose 
polymerase or PARP (Farmer et al., 2005; Bryant et al., 2005), sparking widespread 
interest in the use of PARP inhibitors for chemotherapy (Lord and Ashworth, 2008). 
Therapeutic treatment of advanced stage epithelial ovarian cancers (EOCs) remains 
limited (Cancer Genome Atlas Research, 2011) and would be aided by elucidation of 
the mechanisms EOCs utilize to overcome cellular toxicity in the case of a defective HR 
pathway (Thompson and Schild, 2001; Krejci et al., 2012). 
Several pieces of evidence indicate human POLQ may act as an anti-
recombinase in EOCs (Ceccaldi et al., 2014). A bioinformatics screen comparing large-
scale genomic data from various primary cancers and their healthy tissue counterparts 
found the human POLQ gene was not only highly overexpressed in multiple cancers but 
also co-expressed with many genes involved in the regulation of the HR repair pathway 
(Ceccaldi et al., 2014). Gene set enrichment analysis of microarray data for POLQ gene 
expression across several types of cancers indicated POLQ is highly overexpressed in 
EOCs, even more so than in lung, stomach, colon, or breast cancers (Ceccaldi et al., 
2014). Given that EOCs likely have high levels of HR deficiencies, the upregulation of 
POLQ might act as a survival mechanism in cancer cells with defective homologous 
recombinational repair (Ceccaldi et al., 2014). Consistent with this hypothesis, 
knockdown of POLQ in HR-deficient EOCs resulted in enhanced cell death and 
increased sensitization to chemotherapeutic drugs (Ceccaldi et al., 2014). Moreover, 
knockout of POLQ in mice exhibit synthetic lethality with important HR genes (Ceccaldi 
et al., 2014).  
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These in vivo findings led to collaboration between R. Ceccaldi and I, with a 
background in protein purification and training as a biochemist, in an effort to investigate 
the biochemical properties of human POLQ. While the activities of the polymerase 
domain of POLQ have been well defined, the functional role(s) of the N-terminal region 
and central spacer remain less clear. Weak ATPase activity in response to single-
stranded DNA (ssDNA) has been reported (Seki et al., 2003). The microarray data also 
revealed POLQ was co-expressed with many RAD51-binding ATPases (Ceccaldi et al., 
2014).  RAD51 is an important mediator of homology strand invasion in HR-mediated 
DNA repair (Krejci et al., 2012) and defects in the HR repair pathway can lead to the 
buildup of unresolved toxic RAD51/recombination intermediates in the cell (Gangloff et 
al., 2000; Saintigny et al., 2002; Krejci et al., 2003; Veaute et al., 2003; Doe and Whitby, 
2004; Liberi et al., 2005; Magner et al., 2007). The identification of several RAD51-
binding motifs in the central linker of POLQ (Ceccaldi et al., 2014) suggest POLQ might 
be a key regulator of RAD51 dynamics in EOCs and prompted us to delineate both the 
ATPase and RAD51-binding activities of POLQ.  
The biochemistry reported in Ceccaldi et al., 2014 is explained in further detail 
here; we have characterized the ATPase, DNA-binding, and RAD51-interacting 
properties of a purified recombinant fragment of POLQ consisting of the N-terminal 
ATPase domain and an essential RAD51-binding motif. We have also defined the 
contribution of the ATPase and RAD51-binding motif toward POLQ prevention of 
RAD51-ssDNA filament assembly in vitro and have made steps towards developing a 
coherent model for the in vivo activity of human POLQ as an anti-recombinase. 
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A.3. EXPERIMENTAL PROCEDURES 
 
Cloning FLAG-Tagged Human POLQ 
To facilitate subcloning, a silent mutation (A390A) was introduced into the human 
POLQ (hPOLQ) gene sequence to remove the unique Xho1 cutting site. The gene 
sequence corresponding to a hPOLQ fragment containing the ATPase domain with the 
essential RAD51-binding site (amino acids 1-1000) was PCR-amplified and subcloned 
into the pFastBac vector with a C-terminal FLAG tag (POLQ-1000-C-FLAG). An 
ATPase catalytically-dead mutant version of POLQ-1000 (POLQ-1000-A-dead) was 
generated by mutating catalytic residues in the Walker A and B motifs to alanines 
(K121A and D216A/E217A, respectively). The POLQ-1000-ΔRAD51 construct consists 
of an internal deletion of nucleic acids corresponding to amino acids 847-894, which 
contain the relevant RAD51-binding site. Point mutations and internal deletions were 
introduced using the QuikChange II XL Site-Directed Mutagenesis Kit (Agilent 
Technologies) and confirmed by DNA sequencing. 
 
Purification of the N-terminal Half of Recombinant Human POLQ from Insect Sf9 Cells 
Insect sf9 cells were seeded in 15-cm dishes at 80-90% confluency and infected 
with POLQ-1000-C-FLAG baculovirus (amplification 2). Three days post-infection, cells 
were harvested and lysed in Lysis Buffer [20 mM Tris-Cl, pH 7.6, 500 mM NaCl, 0.01 % 
NP40, 0.2 mM EDTA, 20% Glycerol, 1 mM DTT, 0.2 mM PMSF] supplemented with 
Halt Protease Inhibitor Cocktail (Thermo Scientific) and Calpain I inhibitor (Roche). After 
a 3-4 hour incubation with FLAG resin (Sigma) at 4 °C, the protein was eluted in Lysis 
Buffer supplemented with 0.2 mg/ml of FLAG peptide (Sigma). Elutions were pooled 
	   150 
and concentrated approximately 50-fold in a microfuge concentrator (Millipore) with a 
molecular weight cut-off of 10 kDa. Purity was assessed by SDS-PAGE and the protein 
quantified by comparing its staining intensity (Coomassie-R250) with that of BSA 
standards when run in an 8% tris-glycine SDS-PAGE gel. A catalytically-dead version of 
POLQ (POLQ-1000-A-Dead) and one containing an internal deletion of the RAD51-
binding site (POLQ-1000-ΔRAD51) were purified in the same manner.  
 
Preparation of ssDNA, dsDNA, Forked DNA Substrates 
Single-stranded DNA (ssDNA), double-stranded DNA (dsDNA), and forked DNA 
used for ATPase assays were designed as previously described (Yusufzai and 
Kadonaga, 2008). An oligonucleotide 30 bases in length and 5’ fluorescently-labeled 
with IRDye 700 (IDT) was used as the ssDNA probe. This 30mer was annealed to its 
complement to form the dsDNA and forked DNA substrates. For the forked DNA 
substrate, the unlabeled strand complements 15 sequential bases at the 5’ end of the 
fluorescently-labeled strand. Since radiometric ATPase assays are very sensitive to 
ATP hydrolysis, we removed unannealed ssDNA from the dsDNA and forked DNA 
annealing reactions by running them in 8% polyacrylamide/0.5X TBE gels. The gels 
were run at room temperature, imaged with a fluorescent imager (Li-Cor), and the 
appropriate bands purified from the gel. Briefly, the fluorescently-labeled dsDNA or 
forked DNA was excised from the gel, soaked in 1X TE overnight at 37 °C, the 
supernatant containing the eluted DNA separated from the gel fragments with 
subsequent ethanol precipitation of the DNA. The DNA pellet was then resuspended in 
1X TE and quantified using the Nanodrop 2000 (Thermo Scientific) for use in 
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radiometric ATPase assays. For electrophoretic mobility shift assays (EMSAs), the 
ssDNA substrate was a 60mer oligonucleotide 5’-fluorescently-labeled with IRDye 700 
(IDT); its design was based on the linker DNA region in a plasmid containing the 601 
nucleosome positioning sequence. The dsDNA substrate was the same fluorescently-
labeled 60mer annealed to its complement.  
 
Radiometric ATPase Assay 
Activation of the ATPase activity of the N-terminal half of POLQ (POLQ-1000) 
was assessed via a radiometric ATPase assay. Each 10 µl reaction consisted of 200 nM 
ATP in Reaction Buffer [20 mM Tris-Cl, pH 7.6, 5 mM MgCl2, 0.05 mg/ml BSA, 1 mM 
DTT] and 5 µCi of [γ-32P]-ATP. For corresponding reactions, ssDNA, dsDNA, and 
forked DNA were added to the reaction in excess at a final concentration of 600 nM. 
Once all of the non-enzymatic reagents were combined, purified human POLQ-1000 
(WT or A-dead) was added to the ATPase reaction with final concentrations of 2, 10, 20, 
100, and 200 nM. After incubation for 90 minutes at room temperature, Stop Buffer [125 
mM EDTA, pH 8.0] was added and approximately 0.05 µCi was spotted onto PEI-
coated thin-layer chromatography (TLC) plates (Sigma). Unhydrolyzed [γ-32P]-ATP was 
separated from the released inorganic phosphate (32Pi) with 1 M acetic acid, 0.25 M 
lithium chloride. TLC plates were dried and exposed to a storage phosphor screen and 
imaged with the BioRad Imager PMC. Spots corresponding to [γ-32P]-ATP and the 
released inorganic phosphate (32Pi) were quantified (in units of pixel intensity) and the 
fraction of ATP hydrolyzed calculated for each POLQ concentration.  
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Electrophoretic Mobility Gel Shift Assay (EMSA) 
Each 10 µl gel shift reaction included purified human POLQ-1000 (0, 5, 10, 20, 
50, 100, 200 nM) and a ssDNA or dsDNA probe (final concentration 5 nM) in Binding 
Buffer [20 mM Tris-Cl, pH 7.6, 5 mM magnesium acetate, 0.1 µg/µl BSA, 5% glycerol, 1 
mM DTT, 0.2 mM EDTA, and 0.01% NP-40]. The samples were incubated for 1 hour on 
ice and resolved on a 5% polyacrylamide/0.5X TBE gel at 4°C. The gel was then 
scanned using a fluorescent imager (Li-Cor).          
     The QuantityOne software (BioRad)) was used to quantify the intensity of the 
free and bound ssDNA or dsDNA bands. We then adjusted for background and used 
these values to calculate the fraction of DNA bound for each lane. Curve fitting was 
done with the Prism software (GraphPad) using the Allosteric Sigmoidal model and an 
estimated Kd calculated. The graphed data represent mean and SD [n=3].  
 
RAD51-ssDNA Nucleofilament Assembly Assay 
We assessed the ability of POLQ-1000, POLQ-1000-A-dead, and POLQ-1000- 
ΔRAD51 to prevent filament assembly in RAD51-ssDNA nucleofilament assembly 
assays (Barber et al., 2008; Ward et al., 2010). Binding reactions (10 µl) were 
conducted at room temperature and contained 0.5 ng of a 60mer 5’ 32P-end-labelled 
ssDNA substrate, human RAD51 (hRAD51) at a final concentration of 0.5 µM, and/or 
POLQ-1000 (WT, A-dead, and ΔRAD51) at final concentrations of 0, 20, or 100 nM in 
Binding Buffer [40 mM Tris-Cl, pH 7.5, 50 mM NaCl, 10 mM KCl, 2 mM DTT, 5 mM 
ATP, 5 mM MgCl2, 1 mM DTT, 100 mg/ml BSA].  After a 5-minute incubation with 
hRAD51 and a subsequent 5-minute incubation with the POLQ proteins or vice versa, 
	   153 
an equimolar amount of cold ssDNA substrate was added to quench the reaction. 
Products were then analyzed by electrophoresis in a 10% polyacrylamide/0.5X TBE gel 
at 4 °C and visualized by autoradiography. 
 
Substitution Peptide Arrays 
To identify key amino acids mediating the interaction between POLQ and 
RAD51, a substitution peptide array analysis (Ward et al., 2010) was carried out for 
each of the three RAD51-binding motifs. For each array, 400 peptides (each 20 amino 
acids in length) were synthesized and spotted onto cellulose membranes. Each peptide 
carried a unique sequence in which each of the 20 amino acids spanning the RAD51-
binding motif was mutated to each of the other 19 amino acids (original amino acid also 
included as a positive control). Spotted membranes were activated in 50% methanol 
and blocked overnight in TBS + 0.1% Tween 20 (TBS-T) + 5% milk. The membrane 
was then incubated overnight with purified hRAD51 protein at 50 mg/membrane in TBS-
T + 5% milk. Bound hRAD51 was detected by incubation with anti-hRAD51 antibodies 
and ECL chemiluminescence. Ponceau staining of the membranes detected efficiency 
of peptide spotting. 
 
A.4. RESULTS 
Single-Stranded DNA (ssDNA) Selectively Stimulates ATP Hydrolysis by Human POLQ 
 Full-length human POLQ (hPOLQ) consists of an N-terminal ATPase domain 
separated from the C-terminal polymerase domain by a long central linker containing 
three RAD51-binding motifs (Figure A.1A, POLQ). A combination of GST pull-down 
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experiments and sequence alignment analysis initially identified two putative RAD51-
binding regions in the central linker (Ceccaldi et al., 2014). Peptide array screens 
revealed this region actually contains three 20-amino-acid RAD51-interacting motifs 
(Ceccaldi et al., 2014). The most N-terminal RAD51-binding site (Figure A.1A, dark gray 
rectangle) was found to be both necessary and sufficient for hPOLQ binding to RAD51 
(Ceccaldi et al., 2014). Purification of recombinant full-length hPOLQ has been 
challenging as hPOLQ is a large protein (~250 kilodaltons or kDa) and susceptible to 
proteolysis (Seki et al., 2004). Initial immunoaffinity purification attempts of C-terminal 
FLAG-tagged full-length hPOLQ and a truncation of hPOLQ containing the N-terminal 
ATPase and the three putative RAD51-binding sites (Figure A.1A, POLQ-1416) from 
Sf9 insect cells yielded very little protein; this was consistent with previous purification 
attempts that experienced low expression and issues with proteolysis (Seki et al., 2003; 
Seki et al., 2004). However, subsequent removal of the two C-terminal RAD51-binding 
sites (Figure A.1A, POLQ-1000) led to increased yields of ~100-fold (Figure A.1B). 
Since this truncation would allow for study of both the ATPase and RAD51-binding 
activities of hPOLQ with higher protein yield, we used it in subsequent biochemical 
assays. We also purified a catalytically-dead version of POLQ-1000 (A-dead) in which 
catalytic residues from the Walker A (K121) and Walker B (D216/E217) motifs were 
mutated to alanine (Figures A.1A-B). 
We then wanted to confirm our purified POLQ-1000 is catalytically active using a 
radiometric ATPase assay. After incubation of the ATPase reactions for 1.5 hours at the 
desired POLQ-1000 concentration, the amount of unhydrolyzed [γ-32P]-ATP and 
released inorganic phosphate (32Pi) was resolved on PEI-cellulose TLC plates (a 
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representative TLC plate is shown in Figure A.1C). Because POLQ-1000 binds RAD51 
and has been implicated in mediating replicative stress and antagonizing the HR repair 
pathway (Ceccaldi et al., 2014), we measured the effects of adding ssDNA, dsDNA, or 
forked DNA (at saturating conditions) on the ATPase activity of POLQ-1000. Using this 
assay, we found POLQ-1000 exhibits low levels of basal ATPase activity, is slightly 
stimulated by the addition of dsDNA, and is highly stimulated by ssDNA and forked DNA 
(Figure A.1D). To confirm that POLQ-1000-A-dead is catalytically inactive, we 
measured the fraction of ATP hydrolyzed under basal conditions and in the presence of 
ssDNA, dsDNA, and forked DNA substrates. In all conditions tested, POLQ-1000-A-
dead exhibited nearly undetectable levels of ATPase activity (Figure A.1D).  
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POLQ-1000 Binds ssDNA with Higher Affinity than dsDNA 
The N-terminal half of POLQ (POLQ-1000) hydrolyzes ATP at higher levels in the 
presence of ssDNA versus dsDNA, suggesting POLQ-1000 has the ability to sense the 
 
 
Figure A.1. The ATPase domain of recombinant human POLQ is selectively 
stimulated by ssDNA. (A) Schematic of domain architecture for full-length POLQ, 
POLQ-1416, and POLQ-1000. ATPase and polymerase domains (gray), RAD51-
binding motif that is both necessary and sufficient for RAD51-binding by POLQ (dark 
gray rectangle) and the other two RAD51-binding motifs (light gray rectangles) are 
shown. The catalytic lysine of the Walker A motif (K121) and the catalytic aspartate 
and glutamate residues of the Walker B motif (D216/E217) are shown as dark gray 
lines. (B) Coomassie-stained SDS-PAGE gel of recombinant human, C-terminal 
FLAG-tagged wild-type (WT) and catalytically inactive (A-dead) POLQ-1000 purified 
from insect Sf9 cells. (C) Representative image of TLC plate from radiometric 
ATPase reactions for WT POLQ-1000 at 2, 10, 20, 100, and 200 nM. Final 
concentration of ssDNA, dsDNA, and forked DNA was 600 nM. (D) Quantification of 
fraction of ATP hydrolyzed by WT or A-dead POLQ-1000 under basal conditions (no 
DNA) or in the presence of 600 nM single-stranded DNA (ssDNA), double-stranded 
DNA (dsDNA), or forked DNA. Values shown are mean and SD [n=3]. 
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different substrates. We first used electrophoretic mobility gel shift assays (EMSAs) to 
test whether POLQ-1000 binds to ssDNA and found that it does (Figure A.2A). We then 
tested binding of POLQ with dsDNA (Figure A.2A). Next, for each substrate, we 
approximated the POLQ-1000 binding affinities from a DNA binding curve (Figure 
A.2B). For the ssDNA substrate, we used a 5’ fluorescently-labeled oligonucleotide 60 
bases in length. The dsDNA substrate is simply the same 60mer annealed to its 
complement. We found that POLQ-1000 binds ssDNA selectively over dsDNA. The 
ssDNA binding affinity (or estimated Kd) for POLQ-1000 is ~50 nM (Figure A.2B). In 
contrast, the Kd for POLQ-1000 in the presence of dsDNA is ~5-fold less at ~250 nM 
(Figure A.2B). This correlates well with the selective stimulation of ATP hydrolysis by 
POLQ-1000 in the presence of ssDNA versus dsDNA (Figure A.1D).  
 
Figure A.2. POLQ-1000 (N-terminal half of POLQ) binds specifically to ssDNA. 
(A) A representative gel showing an electrophoretic mobility shift assay (EMSA) with 
5’ fluorescently-labeled ssDNA or dsDNA (final concentration 5 nM) in the presence 
of increasing amounts of POLQ-1000 (0, 5, 10, 20, 50, 100, and 200 nM). After 
incubation, DNA-binding reactions were resolved by native PAGE and imaged with a 
fluorescent scanner. (B) DNA binding curve for POLQ-1000 in the presence of 
ssDNA or dsDNA. Values shown are mean and SD [n=3].  
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POLQ-1000 Prevents RAD51-ssDNA Nucleofilament Assembly In Vitro 
 Given the anti-recombinase activities observed for POLQ in vivo, and the 
RAD51-binding activity exhibited by POLQ (Ceccaldi et al., 2014), we suspected POLQ 
might be needed in HR-deficient tumors to aid in the prevention of the buildup of toxic 
RAD51 intermediates (Gangloff et al., 2000; Saintigny et al., 2002; Krejci et al., 2003; 
Veaute et al., 2003; Doe and Whitby, 2004; Liberi et al., 2005; Magner et al., 2007). 
One way POLQ could do this is by directly preventing formation of the RAD51-ssDNA 
filament. The Boulton Laboratory has developed a RAD51-ssDNA nucleofilament 
assembly assay to study recombination in vitro (Barber et al., 2008; Ward et al., 2010). 
In collaboration with the Boulton Laboratory, we tested whether wild-type (WT) POLQ-
1000 is able to prevent RAD51-ssDNA nucleofilament assembly in vitro. We also tested 
the effects of removing either its ATPase activity (A-dead) or RAD51-binding activities 
(ΔRAD51). POLQ-1000-ΔRAD51 has an internal deletion of amino acids 847-894 
containing the first RAD51-binding site (Figure A.3A) and was purified analogously to 
WT and A-dead POLQ-1000 (Figure A.3B).  
Both the ATPase and RAD51-binding activities were found to aid in the 
prevention of RAD51-ssDNA nucleofilament assembly by POLQ-1000. The presence of 
WT POLQ prevented RAD51-ssDNA filaments from forming at substoichiometric 
amounts (Figure A.3C, leftmost section). Surprisingly, loss of ATPase activity (A-dead) 
does not completely abolish prevention of filament assembly while loss of the RAD51-
binding site (ΔRAD51) does (Figure A.3C, central and rightmost sections, respectively).  
 
 
	   159 
 
Identification of Key Residues in RAD51-Binding Motifs 
We next wanted to learn more about the types of interactions governing the 
interaction between POLQ and RAD51. To do this, substitution peptide arrays were 
carried out for each of the three RAD51-binding motifs identified in the central linker of 
 
 
Figure A.3. ATPase and RAD51-binding activities of POLQ-1000 needed to 
prevent RAD51-ssDNA filament assembly. (A) A schematic showing domain 
architecture of POLQ-1000 and internal deletion of amino acid residues 847-894 
containing first RAD51-binding motif (POLQ-1000-ΔRAD51). The N-terminal 
ATPase domain (gray) and the RAD51-binding site (dark gray rectangle) are 
indicated. (B) Coomassie-stained gel of purified recombinant POLQ-1000-
ΔRAD51. (C) Representative native gel from RAD51-ssDNA nucleofilament 
assembly assays. RAD51 is present at a final concentration of 0.5 µM. Wild-type 
POLQ-1000 (WT) containing both ATPase and RAD51-binding activities prevents 
filament assembly at substoichiometric concentrations (20, 100 nM). Catalytically-
inactive POLQ-1000 (A-dead) retains some ability to prevent filament assembly 
while loss of RAD51-binding (ΔRAD51) completely abolishes this activity.  
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POLQ (Figure A.4). A 20-amino-acid POLQ peptide sequence spanning each RAD51-
binding motif was selected for peptide design. Each substitution array consisted of 400 
unique peptide sequences in which each of the 20 amino acids spanning the RAD51-
binding motif was mutated to each of the other 19 amino acids (original amino acid also 
included as a positive control). Individual spots correspond to a single unique 20mer 
peptide.  
Immunblotting against human RAD51 (hRAD51) reveals specific amino acid 
residues for RAD51 motif 1 that are necessary for the interaction between RAD51 and 
POLQ (Figure A.4, top left). Single substitution of polar residue threonine 865 for 
nonpolar residues isoleucine or leucine abrogates RAD51-binding (Figure A.4, top 
left).  Moreover, positively-charged amino acids arginine 867 or lysine 868 to negatively 
charged residues aspartate or glutamate leads to loss of RAD51-binding (Figure A.4, 
top left). Loss of hRAD51 interaction is not due to any errors in peptide spotting as 
Ponceau staining reveals efficient spotting at these positions (Figure A.4, bottom left). It 
does not appear mutation of any single residue for RAD51 motif 2 is sufficient to abolish 
interaction with hRAD51 (Figure A.4, top middle) while spotting efficiency for motif 3 is 
quite poor (Figure A.4, bottom right).  
 







Figure A.4. Substitution peptide array identifies key residues needed for 
RAD51-binding by human POLQ. The RAD51-binding motif used for the array is 
indicated above each array. Each array consists of 400 peptides (each 20mer in 
length) synthesized and spotted onto cellulose membranes. Amino acid one-letter 
codes are used. Positions of first and last amino acids of 20mer peptide are indicated 
on top of the array above the amino acid letters. The original amino acid sequence is 
listed at the top of the array and the amino acid mutation is listed on the right side of 
the array. A single spot corresponds to one peptide containing a single point mutation 
at the indicated amino acid location. Anti-hRAD51 immunoblotted membranes on top 
and Ponceau stained membranes on bottom.  
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A.5. DISCUSSION 
 We have characterized the biochemical properties of the N-terminal half of 
human POLQ (POLQ-1000). Using radiometric ATPase assays we have shown POLQ-
1000 is specifically stimulated by both ssDNA and forked DNA. Electrophoretic mobility 
shift assays (EMSAs) were used to demonstrate this specificity could in part be 
explained by the higher binding affinity POLQ-1000 exhibits for ssDNA when compared 
to dsDNA. In addition, we have found POLQ-1000 utilizes both its ATPase and RAD51-
binding activities in preventing the in vitro assembly of RAD51-ssDNA filaments.  
 
N-Terminal ATPase Domain 
 Results from the ATPase assay show POLQ-1000 is selectively stimulated by 
both ssDNA and forked DNA. It is possible that POLQ-1000 is merely recognizing the 
ssDNA half of the forked DNA and not the actual fork junction. Various forked structures 
can be used to test this in subsequent ATPase experiments. The ATPase results 
correlate well with the anti-recombinase activity of POLQ (Ceccaldi et al., 2014), as the 
protein is likely recruited to sites where there is ssDNA in the cell.      
 
Putative DNA-Binding Domain 
We have found evidence through EMSAs with POLQ-1000 that the N-terminal 
half of POLQ possesses a DNA-binding domain (DBD). A more detailed series of C-
terminal truncations are needed in order to narrow down exactly which amino acids 
correspond to the DBD. Once the amino acid boundaries for the DBD have been 
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identified, future experiments could then uncover how the DBD provides selectivity for 
ssDNA over dsDNA.  
 
RAD51-Binding Motif of Human POLQ 
 The RAD51-binding motif is crucial for the function of POLQ-1000 in preventing 
the assembly of RAD51-ssDNA filaments. Given the strong binding of RAD51 to ssDNA 
and its role in homology strand invasion during HR-mediated DNA repair (Krejci et al., 
2012), misregulation of RAD51 filament formation is very toxic to the cell due to the 
buildup of unresolved RAD51/recombination intermediates (Gangloff et al., 2000; 
Saintigny et al., 2002; Krejci et al., 2003; Veaute et al., 2003; Doe and Whitby, 2004; 
Liberi et al., 2005; Magner et al., 2007; Flygare et al., 2001; Richardson et al., 2004). 
Since RAD51 is commonly overexpressed in cancer cells and tumors (Mason et al., 
2014), in the event of an HR deficiency, POLQ may act to sequester RAD51 in the cells 
as a survival response mechanism.  Based on the results from the RAD51-ssDNA 
filament assembly assays, we have set forth a model for how POLQ might utilize both 
its ATPase and RAD51-binding activities to prevent filament assembly (Figure A.5).  
When POLQ encounters ssDNA, its ATPase activity is activated. Because RAD51 uses 
ATP to stabilize the binding site at the interface between two RAD51 monomers, it 
cannot form stable RAD51 oligomers due to depletion of ATP levels. Consequently, 
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RAD51-Binding Surface  
 
The higher sensitivity of the first RAD51-binding site to single amino-acid 
mutations in the peptide array suggests the first RAD51-binding site of POLQ is the 
more relevant RAD51-binding site. This correlates well with GST-RAD51 pull-down 
experiments (Ceccaldi et al., 2014). Loss of RAD51-binding with mutation of amino 
acids that are polar to nonpolar (T865I or T865L) or positive to negative (R867D, 
R867E, K868D, K868E) suggests the interaction between POLQ and RAD51 is 
electrostatic in nature (Figure A.4, top left).  
Future studies will help delineate the mechanism through which POLQ acts as an 
anti-recombinase in vivo. The substitution array has narrowed down key residues in the 
RAD51-binding motif. Pull-down experiments with GST-RAD51 can be used to first 
validate the mutations identified in the substitution array. Once verified, we can then test 
 
 
Figure A.5. Model for how human POLQ inhibits RAD51-ssDNA filament 
assembly. ATP hydrolysis by human POLQ is activated by ssDNA, which depletes 
ATP levels and shifts equilibrium in favor of the RAD51 monomer form (orange). POLQ 
is then able to bind RAD51 monomers, further shifting the equilibrium and disfavoring 
formation of RAD51-ssDNA filaments (purple). RAD51 monomers and oligomers with 
ATP (black dot) bound at the interface between two RAD51 oligomers are shown. ADP 
is depicted as a gray dot. The ATPase domain of POLQ (green) and the polymerase 
domain (yellow) are indicated. The N and C termini of POLQ are labeled N and C, 
respectively. Half arrows represent equilibrium reaction.  
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whether these point mutations affect the POLQ activity both in vitro and in vivo by 
looking at prevention of RAD51-ssDNA nucleofilament formation and/or chromosomal 
aberrations in HR-deficient cells. This is of particular significance for the development of 
novel therapeutic approaches targeting epithelial ovarian cancers (EOCs). Inhibition of 
the activities of the ATPase and RAD51-binding functions of POLQ given their 
importance both in vitro and in vivo may sensitize EOCs to therapeutic drugs that have 
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